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Over the past thirty years, numerous fused polycyclic ether natural products have
been isolated from small marine organisms. These compounds revealed a variety of
interesting biological properties, which has attracted the interest of many synthetic
groups. The common structural characteristic of these compounds is an array of trans 
fused ether rings. Several iterative strategies have been reported to build six  and
seven membered cyclic ethers, which are the two most common units in these natural
products.
The objective of work described in the ﬁrst part of this thesis was to develop new
synthetic methodology to access these motifs. Each unit must be built in the minimum
number of steps and the new methodology must be ﬂexible enough to obtain both six 
and seven membered rings from a common precursor. They key reaction of the strat 
egy will be ring closing metathesis, as previous work in our group showed that this is
a powerful reaction to create cyclic ethers.
The second part of this thesis focus on the total synthesis of one of the marine
polyether natural products, gambieric acid A. This compound was isolated in 1992 and
has so far eluded total synthesis.
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First, the synthesis of the tricyclic B D core, which has been developed in our group,
was optimised and performed on a large scale. The synthetic route relies on the ring 
closing metathesis reaction to construct two of the cyclic ethers from a commercially
available glucose derivative.
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Several strategies for the coupling with the tetrahydrofuran A ring were then inves 
tigated. The initial method envisioned for the fragment coupling was a nucleophilic
substitution of an alkyl iodide by a lithiated dithiane.
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However, this strategy revealed unsuccessful. Instead, a more converging approach
using a diastereoselective Tsuji reaction was developed, which allowed the formation of
the complete carbon skeleton of the A D fragment.
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Introduction
1.1 Polyoxacyclic Natural Products
1.1.1 Red Tides
A red tide, or algal bloom, is a natural phenomenon occurring in coastal waters, where
under speciﬁc conditions (temperature, salinity and nutrients), microorganisms such as
algae, can grow very quickly and results in discolouration of the surface water. Among
all the algal species responsible for these blooms, a few of them are toxic. The most
important species are members of the dinoﬂagellate family, especially Karenia brevis,
which is responsible for the ’Florida red tide’, and Alexandrium fundyense, which can be
found along the Northern East coast of the United States. They usually produce toxins
that aﬀect the central nervous system of ﬁsh and often result in numerous deaths.1
The red tide phenomenon is not very well understood, especially the exact conditions
required for it to start. However, high temperatures combined with a lack of wind
and rainfall could be at the root of red tides. When nutrients are abundant in the
environment, the algae grow by simple cell division, a quick process which allows a
single mother cell to generate hundreds of progeny. These tides can be spread over
large areas and can have dramatic eﬀects on the local environment. Even non toxic
algae can harm the local ecosystem by depriving it of light, oxygen and nutrients.
Humans are barely aﬀected, but some cases of respiratory irritation have been reported
by individuals when a strong coastal wind has transported the microorganisms.
When nutrients are rare, the microorganisms are able to switch to sexual reproduc 
tion and create dormant cells called cysts that settle to the bottom sediments. These
cysts can survive for many years in harsh conditions until suitable conditions reappear.
Although these events are mainly natural, human activities can inﬂuence their fre 
quency, especially through agriculture and water pollution, by providing nutrients such
10as phosphates and nitrates to algae, thus stimulating the appearance of red tides.
1.1.2 Marine toxins: Brevetoxins, Gambieric Acids and Others
In order to gain a better understanding of red tide events, scientists managed to isolate
various metabolites from the algae. Several families of compounds have been identiﬁed
such as tetrodotoxin, saxitoxin or palytoxin and they all possess very speciﬁc and potent
pharmacological activities.2 However, polycyclic ethers are one of the most impressive
classes of these metabolites. Brevetoxins A and B were ﬁrst discovered in the early
80’s.3 Later, similar compounds such as ciguatoxins,1,4 gambieric acids,5,6 yessotoxins,7
maitotoxin8–10 and the gymnocins11,12 were identiﬁed (Figure 1.1).
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Figure 1.1: Brevetoxin B and Gambieric acid A
All these compounds contain arrays of trans fused cyclic ethers, in which the ring
size may vary between ﬁve and nine members. The oxygens are placed alternatively on
the northern and southern edge of the ring system. The strereochemistry of the carbon
atoms adjacent to the oxygen strictly alternates between R and S (Scheme 1.1).
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Scheme 1.1: General representation of polycyclic ethers
Finally, it shall be noted that the marine polycyclic ethers usually contain eight  or
nine membered rings in the central regions and six  or seven membered rings at the
periphery.
1.1.3 Toxicology
Although structurally similar, polycyclic ethers display diverse biological activities. For
example, brevetoxins are known to be responsible for mass ﬁsh deaths during red tides,
but recent research has shown that certain ﬁsh and seagrass actually accumulate high
concentrations of brevetoxins. These species could act as toxin vectors in unusual ma 
rine animal mortalities, even in the absence of the toxin producing algae.13 Ciguatoxins,
on the other hand, are known to be the causative agents of ciguatera poisoning4 and
the yessotoxins have been implicated in outbreaks of diarrhetic shellﬁsh poisoning.7
Brevetoxins are highly neurotoxic and the voltage gated sodium channels of excitable
membranes have been identiﬁed as their biological target. The molecules can bind to
the α subunit of the sodium channel which results in a conformational change in the
channel, stabilising and maintaining its disposition in an open/pre open state.14 This
prevents the sodium/potassium exchange pump from restoring the resting potential
across the membrane, which eventually leads to permanent depolarisation.
Toxicological studies have shown that molecular size is an important factor in the
potency of the brevetoxins.15,16 This accounts for the low toxicity of hemibrevetoxin
B, which contains only four rings and has a molecular weight of 490, and the greater
toxicity of brevetoxin A (10 rings, MW = 867 g.mol−1) (Figure 1.2). Computational
studies have also indicated that the hydrophobicity of polycyclic ethers is an important
factor in their bioactivity, the most hydrophobic being the most potent.16
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1.1.4 Biosynthesis
Since these molecules have been discovered, several models have been proposed to ex 
plain their biosynthesis. The carbon backbone was initially thought to be built through
the standard polyketide pathway, using linear Claisen type condensations of acetate
units.17–19 However, 13C labelled studies showed that some carboxyl derived carbons
were missing in the carbon skeleton, and this was explained by a mixed polyketide syn 
thesis. It was thought that the microorganisms could use dicarboxylic acids, generated
by the citric acid cycle. The carbon chain would then be produced exactly as in a nor 
mal polyketide synthesis but the elongation process might occur via a modiﬁed fatty
acid synthesis. Later, Shimizu proposed another origin of the longer chains present
in the skeleton.20 After a standard Claisen condensation of two acetate units followed
by β elimination, the α,β unsaturated carboxylic acid could be epoxidised to give the
corresponding glycinic acid, which could aﬀord, after decarboxylation, the aldehyde
with one less carbon or the corresponding carboxylic acid, if this last step occurs in an
oxidative manner (Scheme 1.2).
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Scheme 1.2: Formation of propionic acid from acetic acid
Once the carbon backbone was created, hypotheses regarding the formation of the
ether rings were suggested. The ﬁrst hypotheses were based on a report by Cane,
Celmer and Westley, who studied the biosynthesis of monensin, a polyether ionophore
antibiotic isolated from Streptomyces cinnamonensis.21,22 They suggested that mon 
13ensin could be obtained from a triene intermediate, which would be epoxidised and
cyclised in a cascade of SN2 epoxide opening reactions (Scheme 1.3).
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Scheme 1.3: Biosynthesis of monensin by epoxide openings
Nakanishi ﬁrst proposed that brevetoxin B could be formed by successive ring closure
of the poly epoxide precursor, which would be initiated by the attack of the carboxylate
anion of the left terminal acid and the acidic activation of the right terminal alkene
(pathway A, Scheme 1.4).23 An alternative model proposed by Shimizu used the same
poly epoxide precursor but the right terminal double bond was changed into a se 
condary alcohol. The cyclisation cascade then started with the attack of this alcohol
to the closest epoxide and the activation of the left terminal carboxylic acid (pathway
B, Scheme 1.4).24 The propagation was then identical as pathway A, but was occurring
in the opposite direction. After the discovery of hemibrevetoxin B, Shimizu proposed
a slightly diﬀerent mechanism, where the starting point of the cyclisation would be the
opening of the cis epoxide followed by a hydride ion transfer and consecutive trans 
epoxide openings (pathway C).25
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Scheme 1.4: Hypotheses for the biosynthesis of brevetoxin B
Recently, these mechanisms have been questioned by Gallimore and Spencer.26 The
direct application of the Cane Celmer Westley model to the brevetoxin family is not
fully satisfactory, especially concerning the cyclisation process. In the original monensin
model, the three cyclisation reactions occur in a favoured exo tet SN2 fashion. However,
when this is applied to the brevetoxins, the ring closing operation is a disfavored endo 
tet manner, violating Baldwin’s rules.27
At the same time, Giner proposed another model for the cyclisation process, based
on the rearrangement of an epoxy ester obtained from a cis alkene.28 Under acidic
conditions, the ester would open the epoxide to form an intermediate cation, which
would form a bicyclic orthoester (Scheme 1.5). Subsequent rearrangement would lead
15to the cyclic ether.
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Scheme 1.5: Epoxy-ester pathway for tetrahydropyrans formation
This model has the advantage that the acyclic precursor requires only cis double
bonds, whereas the Nakanishi model requires that there be a mixture of trans alkenes
to generate the cyclic ethers in addition to the cis alkenes present in brevetoxin B.
However, Giner never managed to obtain the six membered ring selectively during
the cyclisation process, and only obtained a 1:1 mixture of ﬁve  and six membered
products.
Finally, the group of Janda proposed a simpler route to the polyether system.29,30
They managed to direct the endo cyclisation of an hydroxy epoxide using a ”catalytic
antibody” that mimics the endo transition state and modiﬁes the energy balance in
favour of the endo cyclisation. A similar biological tool could be a monooxygenase
enzyme that epoxidises the double bond and maintains the hydroxy epoxide system in
such a manner that the endo pathway would be preferred to the exo. Once the product
is released, the enzyme can move to the next double bond (Scheme 1.6).
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Scheme 1.6: Enzymatic route to polyethers
161.2 Synthesis of Polycyclic Ethers
Because of their highly complex chemical structures and interesting biological prop 
erties, the polycyclic ethers have attracted the interest of many synthetic groups.
These eﬀorts have culminated in the total synthesis of several members of the ma 
rine polyether class, such as brevetoxins A31 and B,32–34 ciguatoxin CTX 3C,35 gam 
bierol,36–38 gymnocin A39,40 and brevenal.41
These complex syntheses have been achieved by two diﬀerent strategies. The most
common and, so far, most eﬀective is a convergent approach where small cyclic units
are built separately and coupled together to form larger fragments of the natural prod 
uct. This approach has been applied in all the synthesis mentioned above. The second
one is an iterative approach, whereby all the rings are built successively using the same
basic reaction. A ﬂexible methodology is required to accomodate the diﬀerent ring
sizes and substitution patterns. The concept is simple and attractive but, so far, it
has mainly been successfully applied to the smallest polycyclic ether, hemibrevetoxin
B42–44 or small polycyclic sub units. Very recently, a total synthesis of gambierol was
reported by Mori and co workers which is the ﬁrst total synthesis based on an iterative
approach.45
Detailed reviews of all iterative methodologies for the preparation of polycyclic
ethers have been published previously.46,47 The following section details the major
advances made in this ﬁeld over the past ﬁfteen years.
1.2.1 Recent Progress in the Iterative Synthesis of Polycyclic Ethers
For the iterative synthesis of the marine polyether family of compounds, two main
classes of reaction can be deﬁned, depending on a carbon oxygen or a carbon carbon
bond is formed during the cyclisation process.
C O Bond Formation
• 6-endo Cyclisation of Epoxysulfones
Mori and co workers have developed an iterative strategy for polycyclic ether synthesis
based on an epoxide opening reaction, which is outlined in Scheme 1.7.48 Diol 1 was
converted into triﬂate 2 in 93% yield. Nucleophilic addition of oxiranyl lithium 3 to
triﬂate 2 created the carbon backbone 4 and installed the oxygen atom required for the
formation of the next ether ring. Subsequent deprotection of secondary hydroxyl group
under acidic conditions induced an exclusive 6 endo cyclisation with concomitant elim 
ination of phenylsulﬁnic acid to give ketone 5 in 80% yield. The electron withdrawing
17nature of the sulfone promotes the cyclisation reaction, which is normally disfavoured
according to Baldwin’s rule.27 Stereoselective reduction of ketone with sodium boro 
hydride and deprotection of primary silyl ether gave diol 6 in 91% yield. This method
has also been applied to systems bearing axial methyl groups and 1,3 diaxial methyl
groups.49,50
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Scheme 1.7: Conditions: a) Tf2O, 2,6-lutidine, CH2Cl2, −78 ◦C then TBSOTf, −78 ◦C to 0 ◦C, 93%;
b) DMPU, THF, −100 ◦C, 90%; c) p-TsOH·H2O, CHCl3, 55 ◦C, 80%; d) NaBH4, MeOH:CH2Cl2,
−78 ◦C; e) TBAF, THF, rt, 91% (2 steps).
The direct formation of oxepanes was circumvented by employing a ring expansion
reaction of tetrahydropyranones.51 When ketone 5 was treated with trimethylsilyldia 
zomethane under Lewis acid conditions followed by in situ silyl enol ether hydroly 
sis, oxepane 7 was obtained in 76% yield (Scheme 1.8). Further deprotection and a
hydroxy directed reduction aﬀorded diol 8 in quantitative yield.
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Scheme 1.8: Conditions: a) TMSCHN2, BF3·Et2O, CH2Cl2, −78 ◦C; b) PPTS, MeOH, rt, 76% (2
steps); c) TBAF, THF:AcOH, rt; d) Me4NBH(OAc)3, MeCN, AcOH, −20 ◦C to rt, 99% (2 steps).
This approach gave access to the simplest six membered ring in ﬁve steps and an
overall yield of 61%. This method also allows the installation of angular methyl groups
and the access to oxepane rings by a one carbon ring expansion of tetrahydropyranones.
18Mori used this methodology to complete a formal total synthesis of hemibrevetoxin
B.43 More recently, they prepared the ABCDEF core of the yessotoxins,52 the ABCD
fragment of gambierol53 and ﬁnally reported the total synthesis of gambierol using this
methodology.45
• 6-endo Cyclisation of Tungsten Vinylidene
McDonald and Bowman have developed an iterative synthesis of polycyclic ethers
based on the 6 endo cyclisation of a tungsten vinylidene intermediate.54 Treatment
of hydroxy alkyne 9 with a photo generated solution of [W(CO)5(THF)]55 aﬀorded
the tungsten vinylidene intermediate 10 (Scheme 1.9). Subsequent stannylation with
tributyltin triﬂate and triethylamine56 gave the tin substituted cyclic enol ether 11
in 60% yield. Tin lithium exchange, followed by addition of copper cyanide formed a
high order cyanocuprate, which displaced triﬂate 12 to give silyl protected acetylene
13 in 54% yield. Epoxidation and subsequent reduction of the resulting mixed acetal
gave an inseparable 3:1 mixture of diastereomers in favour of the desired trans isomer.
Deprotection of the alkyne and acetylation of the free hydroxyl group gave the acetate
derivative. The diastereoisomers were then separated by ﬂash column chromatogra 
phy and subsequent removal of the acetate group gave hydroxy alkene 14 as a single
isomer.
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Scheme 1.9: Conditions: a) W(CO)6, THF, hν, rt; b) Bu3SnOTf, Et3N, Et2O, 60%; c) nBuLi, CuCN,
THF, −78 ◦C then 12, −78 ◦C to 0 ◦C, 54%; d) mCPBA, MeOH, 0 ◦C; e) Et3SiH, BF3·Et2O, CH2Cl2,
−50 ◦C to 0 ◦C; f) TBAF, THF, rt; g) Ac2O, Et3N, DMAP, CH2Cl2, rt; h) K2CO3, MeOH:H2O, rt,
40% (5 steps).
This method requires seven steps per iteration in an overall yield of 10%. The main
problem with this sequence is obviously the poor diastereoselectivity during epoxidation
19of the enol ether 13 which means that an additional two step procedure is required
to remove the undesired diastereomer. Incorporation of angular methyl groups and
synthesis of larger size rings have not been reported with this methodology.
• Acid-Mediated Annulation and RCM (C-O and C-C Bond Formation)
Rainier and co workers have developed two closely related iterative approaches
based on the formation and functionalisation of enol ethers. One method employs
a ring closing metathesis (RCM) reaction57–59 and the other an acid mediated cyclisa 
tion/elimination event to accomplish both ring closure and enol ether formation.59,60
Starting with glucal 15, both strategies share a one pot epoxidation/alkylation proto 
col, which installs the carbon backbone and the bridgehead stereocentres, to aﬀord 16
and 20a,b (Scheme 1.10). Takai methylenation61 of acetate 16 and subsequent RCM
with molybdenum catalyst 17 gave the desired methyl substituted cyclic enol ether 18
in 50% overall yield. Use of the corresponding formate ester, to prepare unsubstituted
enol ethers, resulted in low yields from the Takai methylenation reaction. Otherwise,
heating acetals 20a,b in the presence of PPTS eﬀected ring closure and elimination to
provide cyclic enol ethers 21a,b in high yield.
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Scheme 1.10: Conditions: a) DMDO, CH2Cl2 then allylmagnesium bromide, THF, 0 ◦C; b) Ac2O,
Et3N, DMAP, CH2Cl2, rt, 77% (2 steps); c) CH2Br2, Zn, TiCl4, PbCl2, TMEDA, THF, 65 ◦C, 65%;
d) catalyst 17 (15 mol%), hexanes, 76%; e) DMDO, CH2Cl2 then 19a/19b, CuI, THF, −30 ◦C to
0 ◦C, 54% (n=1), 65% (n=2); f) PPTS, pyridine, dichlorobenzene, 140 ◦C, 91% (n=1), 72% (n=2).
20The acid mediated cyclisation strategy allows the iterative synthesis of both six  and
seven membered ring systems in three steps and in 46% and 47% yield respectively.
However, this method does not permit the preparation of substituted cyclic enol ethers.
The metathesis approach is slightly longer than the acid cyclisation (ﬁve steps) but
allows the formation of tri  and tetra substituted enol ethers.62
Rainier and Cox have applied their methodologies to the formal total synthesis of
hemibrevetoxin B44,63 and the synthesis of the ABCD ring system of gambierol.64 This
segment contains the challenging 1,3 diaxial methyl groups. Enol ether 23 was pre 
pared from dihydropyran 22 using the methodology described previously (Scheme 1.11).
Epoxidation of 23 and ring opening with methanol, followed by O allylation furnished
acetal 24. Treatment of 24 with PPTS in pyridine delivered the enol ether interme 
diate 25 which underwent an in situ Claisen rearrangement to deliver ketone 26 with
the two methyl groups installed.
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Scheme 1.11: Conditions: a) mCPBA, MeOH, −60 ◦C to rt, 92%; b) NaH, allylbromide, THF, reﬂux,
78%; c) PPTS, pyridine, 100 ◦C, 97% (d.r. = 8:1).
Recently, Rainier and co workers reported a two directional approach based on a
modiﬁed Takai Ukimoto protocol.65 During their synthetic studies towards gambieric
acid A, they found that using dibromoethane instead of dibromomethane gave the
cyclised adduct as the major product.66 Applying these conditions to a variety of dienyl
diesters 27a-d gave access to the corresponding tricyclic products 28a-d in good yields
(Scheme 1.12). Six  and seven membered rings possessing a simple methyl group or a
longer side chain were all formed selectively and no acyclic product was observed.
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Scheme 1.12: Conditions: a)TiCl4, TMEDA, Zn dust, PbCl2, CH3CHBr2, THF, reﬂux.
This strategy was also applied to more complex substrate 29 and, after further
modiﬁcations, the heptacyclic fragment 32 was obtained with complete stereoselectivity
(Scheme 1.13).
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Scheme 1.13: Conditions: a)TiCl4, TMEDA, Zn dust, PbCl2, CH3CHBr2, THF, CH2Cl2, reﬂux, 50%;
b) DMDO, CH2Cl2, −78 ◦C to 0 ◦C; c) Dibal-H, CH2Cl2, −78 ◦C, 65% (2 steps); d) TPAP, NMO,
4Å MS, CH2Cl2, rt, 92%; e) HF·Py, THF, rt, 91%; f) EtSH, Zn(OTf)2, CH2Cl2, reﬂux; g) Bu3SnH,
AIBN, toluene, reﬂux, 61% (2 steps).
The methods described above provide rapid and eﬃcient entry to substituted tetrahy 
dropyrans but this C glycoside strategy does suﬀer from some limitations. Firstly, the
anomeric epoxides formed are generally unstable. Secondly, the production of vast
quantitites of DMDO is impractical. Finally, the one pot epoxidation/nucleophilic
ring opening sequence frequently leads to mixtures of isomers and is highly substrate
dependent.
• Tandem Oxonium Ylide Formation and [2,3]-Sigmatropic Rearrangement
Marmsäter and West have described an iterative approach to polyether synthesis
based on the [2,3] shift of cyclic oxonium ylides.67 This strategy is fundamentally dif 
ferent from the three methods depicted previously. Alcohol 33 was converted into
α diazoketone 34 in three steps (Scheme 1.14). Ozonolysis with oxidative workup
followed by O allylation and carbonyl activation/diazomethane acylation gave the cy 
clisation precursor in 55% yield from alcohol 33. Treatment of α diazoketone 34 with a
catalytic amount of copper (II) triﬂuoroacetylacetonate gave bicyclic ketone 36 via the
intermediate oxonium ylide 35 in 80% yield. Unfortunately, ketone 36 was formed with
the undesired conﬁguration at the newly created stereocentre, the allyl chain being in
axial position. This compound was therefore epimerised with DBU and reduced in a
one pot procedure to give an 8:1 mixture of alcohol 37 and its epimer in 94% yield. A
second iteration was accomplished to aﬀord the tricyclic polyether system 38 in 20%
overall yield from alcohol 37.
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Scheme 1.14: Conditions: a) O3, CH2Cl2:MeOH, −78 ◦C then H2O2, HCO2H, 85%; b) NaH, allyl-
bromide, THF, reﬂux, 95%; c) (COCl)2, DMF, CH2Cl2, rt then CH2N2, Et2O, −45 ◦C to rt, 67%; d)
Cu(tfacac)2, CH2Cl2, reﬂux, 80%; e) DBU, toluene, reﬂux then LiAlH4, THF, 0 ◦C, 95%.
This group also investigated several approaches to introduce an angular methyl
group at the bridgehead position.46,68 Incorporation of the methyl substituent in the
diazo ketone 39 furnished the ylide rearrangement product 40 in a disappointingly
low yield (Scheme 1.15). However, tertiary allylic ether 41 underwent conversion into
ketone 42 in moderate yield. Allyl vinyl ether 43, arising from an apparent [1,4] shift
was also isolated. Both 42 and 43 could be converted into the desired ketone 44 in
68% yield from 41.
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Scheme 1.15: Conditions: a) Cu(tfacac)2, CH2Cl2, reﬂux; b) DBU, toluene, 80 ◦C, 99%; c) toluene,
reﬂux, quant.
24Finally, formation of seven membered rings was also investigated, but without any
success.68 When diazo ketone 45 was subjected to copper(II) catalyst, the only isolated
product was spirocyclic C H insertion product 46 (Scheme 1.16).
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Scheme 1.16: Conditions: a) Cu(tfacac)2, CH2Cl2, reﬂux, 55%.
This method permits the construction of six membered cyclic ethers in 5 steps and
an overall yield of 38%. The incorporation of angular methyl groups has also been
accomplished.
• SiMe3-Based Homologation-Epoxidation-Cyclisation
Heﬀron and Jamison have recently reported an iterative approach to the synthesis
of laddered polytetrahydropyrans based on a strategy that emulates the three funda 
mental processes in laddered polyether biosynthesis: chain homologation, stereoselec 
tive epoxidation and endo selective, stereospeciﬁc hydroxy epoxide cyclisation.69 It was
found that a TMS group enabled eﬃcient and selective emulation of all three biogenetic
processes and was amendable to rapid, iterative synthesis of a polyether sub unit. Af 
ter highly selective hydroalumination iodination of alcohol 47, direct propargylation
gave vinylic silane 48 in high yield (Scheme 1.17). Transient acetate protection of
the primary alcohol, followed by highly enantioselective Shi epoxidation70 (>95% ee)
and deprotection gave epoxide 49. Lewis acid promoted hydroxyepoxide cyclisation
completed construction of the ﬁrst tetrahydropyran 50. Desilylation cleanly removed
the TMS group with retention of conﬁguration to give alcohol 51. Reiteration of these
same four steps gave the THP triad 52 in a total of 18 steps and 3% overall yield.
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Scheme 1.17: Conditions: a) Dibal-H, I2, Et2O; b) 1-(trimethylsilyl)-1-propyne, nBuLi, TMEDA,
CuI, DMAP, THF, −78 ◦C to rt, 76% (2 steps); c) Ac2O, Et3N, DMAP, CH2Cl2, 0 ◦C;
d) 1,2:4,5-di-O-isopropylidene-β-D-erythro-2,3-hexodiulo-2,6-pyranose, Oxone, K2CO3, nBu4NHSO4,
Na2B4O7·10H2O MeCN, DMM; e) LiOH, H2O, THF, MeOH, 65% (3 steps); f) BF3·Et2O, CH2Cl2,
0 ◦C, 80%; g) TBAF, THF, rt; h) nBuLi, TMSCl, THF, −78 ◦C to rt, 72% (2 steps).
Jamison’s methodology permits the rapid construction of unsubstituted fused six 
membered ether ring systems. Incorporation of angular methyl groups and synthesis
of larger ring systems using this methodology has not been reported.
C C Bond Formation
• Radical Cyclisation of β-(Alkynyloxy)acrylates
Recently, van Boom and co workers reported the iterative addition of vinyl radicals,
derived from alkynes, to vinylogous carbonates to form trans fused polycyclic ethers.71
This study was based on the early work of Lee and co workers,72,73 who described
the addition of tributyltin radicals to alkynes to facilitate intramolecular addition of
vinyl radicals to β alkoxy acrylates, which upon acidic destannylation furnished cis 2,6 
disubstituted tetrahydropyrans. The iterative sequence was initiated by the intramolec 
ular addition of the tributyltin radical to alkynes 53a-d, aﬀording vinyl radicals that
underwent smooth addition to the vinygolous ester to deliver, after acidic destannyla 
tion, bicyclic systems 54a-d in good yields (Scheme 1.18). The cyclisation reactions
proceeded uneventfully for the formation of ﬁve , six  and seven membered rings, but
the substrate for the eight membered ring (n=3) reacted to give mainly hydrostan 
nylation products. The exo cyclic double bond was converted stereoselectively into
the trans alcohol by ozonolysis and in-situ reduction of the intermediate ozonide with
sodium borohydride. Protection of the alcohol as a silyl ether and reduction of the
ester, followed by Dess Martin oxidation gave the intermediate aldehyde. Alkyne 55
26was obtained from the aldehyde using the Corey Fuchs procedure.74 Finally, deprotec 
tion of the silyl ether gave the free alcohol, which upon reaction with ethyl propiolate
gave the bicyclic β (alkynyloxy)acrylate 56 in high yield. Cyclisation, as previously
described, gave the tricyclic ether 57 in 87% yield.
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Scheme 1.18: Conditions: a) Bu3SnH, AIBN cat., toluene, 80 ◦C; b) TsOH, CH2Cl2; c) O3, NaBH4,
MeOH:CH2Cl2 (7:1), −70 ◦C to rt, 92%; d) TBSOTf, iPr2NEt, CH2Cl2, 0 ◦C, 89%; e) LiAlH4, Et2O,
0 ◦C, 91%; f) DMP, pyridine, CH2Cl2; g) CBr4, PPh3, CH2Cl2, 86% (2 steps); h) nBuLi, THF,
−50 ◦C, 92%; i) TBAF, THF, 91%; j) ethyl propiolate, NMM, CH2Cl2, 99%.
This methodology allows the highly stereoselective preparation of ﬁve , six  and
seven membered cyclic ethers, but each iteration takes ten steps. The incorporation of
angular methyl groups has not been reported.
• Samarium Induced Reductive Cyclisations
Nakata and co workers have disclosed a very eﬃcient approach to the synthesis of
polycyclic ethers based on a stereoselective samarium iodide induced reductive cycli 
sation reaction.75–77 In this strategy, carbon carbon bond construction sets both of the
bridgehead stereocentres. Aldehyde 58 was treated with samarium (II) iodide to give
the bicyclic system 59 as a single isomer in 92% yield (Scheme 1.19). The ester func 
tion was selectively reduced to the aldehyde which was then protected as a thioacetal
to give 60 in 99% yield over the two steps. Hetero Michael addition of the alcohol
60 onto ethyl propiolate, followed by removal of the thioacetal with methyl iodide in
aqueous acetonitrile gave the cyclisation precursor 61 in 90% yield. The second radical 
mediated reductive cyclisation proceeded as before to deliver the tricyclic ether 62 as
a single isomer in 86% yield.
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Scheme 1.19: Conditions: a) SmI2, MeOH, THF, 0 ◦C; b) Dibal-H, toluene, −78 ◦C; c) propane-1,3-
dithiol, BF3·Et2O, CH2Cl2, 0 ◦C, 99% (2 steps); d) ethyl propiolate, NMM, CH2Cl2, rt; e) MeI, aq.
MeCN, rt, 90% (2 steps).
The complete selectivity observed is the result of chelation of the samarium to the
ester function which forms the seven membered transition state 63 (Figure 1.3). The
ketyl radical then attacks the β alkoxyacrylate to give radical 64, which is then reduced
and protonated.75–77
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Figure 1.3: Cyclisation model of ketyl radical
The samarium induced reductive cyclisation reaction was also used to construct
oxepanes with excellent diastereoselectivity, but in those cases, the cyclisation event
occured with concomitant lactonisation (Scheme 1.20).75–77 Moreover, cyclisation is not
limited to aldehydes, but is also applicable to methyl ketones, thus providing a direct
access to ring systems containing angular methyl groups.78,79
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Scheme 1.20: Conditions: a) SmI2, MeOH, THF, 0 ◦C.
Nakata’s methodology allows the preparation of six  and seven membered cyclic
ether systems in only ﬁve steps per iteration and with excellent levels of diastereoselec 
tivity. This approach also allows the incorporation of angular methyl groups. Nakata
used this strategy for the synthesis of the C’D’E’F’ fragment of maitotoxin,80 the FG
ring system of gambierol80 and in the total synthesis of brevetoxin B.33
1.2.2 Biomimetic Approaches to the Synthesis of Polycyclic Ethers
• Lewis-Acid Promoted Epoxide Openings
McDonald and co workers have recently examined the original Shimizu24 and Nakan 
ishi23 proposal for biomimetic cascade of endo epoxide openings (Scheme 1.21).81 Gera 
nylgeraniol 65 was converted into tetraepoxide 66 using a three step sequence involving
Sharpless enantioselective epoxidation82 of the allylic alcohol, followed by Shi epoxi 
dation70 of the residual alkenes and protection of the primary alcohol as a tert butyl
carbonate. Treatment of tetraepoxide 66 with boron triﬂuoride etherate at −40 ◦C
furnished tetracyclic ether 67 in 27% yield.
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Scheme 1.21: Conditions: a) Ti(OiPr)4 (5 mol%), (-)-DET (6 mol%), TBHP, CH2Cl2, −25 ◦C; b) 68
(60 mol%), Oxone, MeCN, DMM, H2O, pH = 10.5, 0 ◦C; c) Boc2O, Et3N, DMAP, CH2Cl2, 30% (3
steps); d) BF3·Et2O, CH2Cl2, −40 ◦C, 27%.
This strategy was also applied to laddered THP synthesis by employing 1,4,7 
triepoxides as the cyclisation precusor.83 Isoprene 69 was converted to triepoxide 70
in a lenghty 12 step sequence (Scheme 1.22). As expected, boron triﬂuoride ether 
ate promoted oxacyclisation of dimethylcarbamate triepoxide 70 and gave the desired
all fused trans,trans tricyclic compound 71 in 31% yield.
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Scheme 1.22: Conditions: a) BF3·Et2O, CH2Cl2, rt, 31%.
Until 2005, McDonald had only studied substrates with internal trisubstituted epox 
ides. However, alkyl substitution is not found at all ring junctions in the naturally
occuring polycyclic ethers. Very recently, they have extended their biomimetic cascade
strategy to include substrates with one or more internal disubstituted epoxides.84 Oxa 
cyclisation of substrates 72 and 74, bearing one or two internal disubstituted epoxides,
resulted in the formation of trans,syn,trans fused polycyclic ethers 73 and 75 in 35%
and 25% yield respectively (Scheme 1.23).
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Scheme 1.23: Conditions: a) BF3·Et2O, CH2Cl2, −40 ◦C; b) Ac2O, pyridine.
The success of McDonald’s approach relies on gem dimethyl groups, stabilisation of
the positively charge transition state and assistance of the carbonate/carbamate group
as the nucleophile terminating the cascade. Overall, despite poor yields, this approach
provides a potentially powerful method for the construction of polycyclic ethers.
• Water Promoted Epoxide Openings
In 2007, the Nakanishi cascade biosynthesis of brevetoxin B received another strong
argument in its favour when Jamison and co workers described a water promoted
epoxide opening to access trans fused tetrahydropyran rings.85 They proposed that
a substrate already containing a THP would cyclise to give a six membered ring
by decreasing the entropy disadvantage and giving a more stable intermediate. In 
deed, trans bicyclo[4.4.0]decane derivatives are typically less strained than their trans 
bicyclo[4.3.0]nonane counterparts.
Epoxy alcohol 76 was treated under a variety of conditions and it was found that
deionised water in a 1:1 mixture with THF gave the best ratio in favour of the six 
membered product 77 (11:1) (Scheme 1.24). Other hydrogen acceptor additives such
as methanol and ethylene glycol also gave good selectivity (8:1 and 9:1 respectively).
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Scheme 1.24: Selective 6-endo epoxide opening
31The authors suggested a mechanism involving a double hydrogen bond activation
of the epoxy alcohol 76. Both the nucleophile (hydroxyl group) and the electrophile
(epoxide) can be activated by two hydrogen bonded water molecules, creating a net 
work of hydrogen bonds (Figure 1.4). This model reasonably explains the enhanced
regioselectivity in water (relative to other solvents) as well as the marginal eﬀects of
temperature on selectivity.
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Figure 1.4: Hydrogen-bonding model
These conditions were then applied to cascade sequences to generate more than
one tetrahydropyran in a single pot operation. Bis  and tris epoxides 79 and 81 were
heated in water at 70 ◦C to give respectively tricyclic and tetracyclic products 80 and
82 in very good yields (Scheme 1.25).
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Scheme 1.25: Cascade epoxide openings
Finally, introduction of angular methyl groups was also investigated and it was
found that both distal and proximal positions are suitable for this transformation. Bis 
epoxides 83 and 85, containing a methyl group at the distal or proximal position of
the nucleophile were stirred in neutral hot water and gave both tricyclic products 84
and 86 in moderate to good yields (Scheme 1.26). While Lewis acids have already
been shown to work with distal methyl groups,83 this was the ﬁrst example of an endo 
selective epoxide opening reaction with a proximal methyl group, even though the yield
was quite modest.
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Scheme 1.26: Introduction of methyl angular groups
By ﬁnding reaction conditions compatible with a biological media (water at pH=7),
Jamison and co workers got closer to a genuine biosynthetic approach. The cascade
reactions proved to be highly eﬃcient and modiﬁcations to the substrate, such as
introduction of angular methyl groups, did not aﬀect the outcome of the reaction.
1.2.3 Clark Group Strategy Toward Polyether Synthesis
Clark and co workers have developed several strategies for the preparation of polycyclic
ethers using an approach based on the formation of rings by RCM/ring closing enyne
metathesis (RCEM). Three diﬀerent strategies have been pursued. Firstly, six  and
seven membered cyclic enol ethers 88 were prepared in good yields by RCM of 87 with
the Schrock catalyst 17 (Scheme 1.27).86 Eight  and nine membered cyclic allylethers
90 were also prepared in good yields.87
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Scheme 1.27: Conditions: a) catalyst 17 (9-14 mol%), pentane, rt; b) catalyst 17 (25 mol%), benzene,
60 ◦C.
33This strategy was used in a stereoselective synthesis of the cyclic core of (+) 
laurenyne.88 RCM of diene 91 with 5 mol% of Grubbs’ second generation catalyst
92 gave the eight membered cyclic ether core 93 in essentially quantitative yield
(Scheme 1.28). Clark and co workers also used this strategy in the synthesis of func 
tionalised polycyclic ether sub units.89
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Scheme 1.28: Conditions: a) Grubbs II catalyst 92 (2 mol%), toluene, 80 ◦C, 99%.
The construction of sub units of marine polycyclic ethers was also achieved by RCM
and hydroboration of enol ethers.90 Acyclic enol ethers 95a,b were formed by methyle 
nation of esters 94a,b using the Takai protocol (Scheme 1.29).91 Treatment of 95a,b
with molybdenum catalyst 17 furnished the cyclised products, which were subjected
to hydroboration to give the functionalised cyclic ethers 96a,b in moderate yield but
with excellent levels of diastereocontrol.
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Scheme 1.29: Conditions: a) TiCl4, TMEDA, CH2Br2, Zn, THF, rt; b) catalyst 17 (9-14 mol%),
pentane, rt; c) ThxBH2, THF, −20 ◦C then aq. NaOH, 30% H2O2.
In further work, Clark and Hamelin reported the synthesis of polycyclic ethers by
two directional double RCM.92 This strategy permitted the construction of polyether
fragment 99 possessing a variety of ring sizes in good to excellent yields (Scheme 1.30).
This strategy has been successfully employed to synthesise the F J fragment of the
gambieric acids.93
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Scheme 1.30: Conditions: a) Grubbs I catalyst 98 (20-30 mol%), CH2Cl2, rt or reﬂux.
Finally, Clark and co workers have developed a synthesis of cyclic ethers by catalytic
RCEM of alkynyl ethers.94,95 Six  and seven membered alkenyl substituted cyclic enol
ethers 101 were prepared from 100 in high yields (Scheme 1.31). It was also shown
that the ruthenium catalyst 92 was tolerant of a wide range of alkyne substituents.
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Scheme 1.31: Conditions: a) Grubbs II 92 (5 mol%), toluene, 80 ◦C.
The diene products 101 obtained using this methodology were functionalised by
catalytic cross metathesis (CM) with a large range of alkenes.96 This permitted the
synthesis of highly functionalised six  and seven membered cyclic ethers 102 bearing
a diverse range of side chains in good to excellent yields (Scheme 1.32). In addition to
allowing rapid chain extension, CM allows selective functionalisation of the side chain
without aﬀecting the enol ether, which can be functionalised at a later stage.
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Scheme 1.32: Conditions: a) Grubbs II catalyst 92 (5 mol%), H2C=CHR, toluene, 70 ◦C.
351.2.4 Summary
Over the years, a variety of synthetic methods have been developed to access this
interesting class of natural products. These methods all possess advantages and dis 
advantages in terms of yield, number of steps, selectivity and ﬂexibility. However, the
lack of application in total synthesis shows that optimisation studies remain to be done
in many cases.
1.3 Oleﬁn Metathesis
1.3.1 Introduction
The word metathesis is derived from the Greek metatithenai, and literally means to
transpose: meta , change and tithenai , to place. In chemistry, metathesis is a unique
carbon skeleton redistribution in which unsaturated carbon carbon double bonds are
rearranged in the presence of metal carbene complexes.97
Oleﬁn metathesis has been known in polymer synthesis since the late 1950’s with
the discovery by Karl Ziegler that certain transition metals could promote the poly 
merisation of oleﬁns under mild conditions. By the late 1960’s, the Phillips group had
developed a commercial process   the trioleﬁn process   and made the scientiﬁc com 
munity aware of this unique reaction. However, the scope of this reaction was limited
to the polymerisation of simple unfunctionalised alkenes.
The discovery that metal alkylidene complexes could promote oleﬁn metathesis, at
the beginning of the 1980’s, was the ﬁrst step towards the development of this reaction
in organic synthesis. The development of well deﬁned molybdenum and ruthenium
carbene complexes in the 1990’s led to a dramatic expansion in the ﬁeld.98 Over the
past decade, oleﬁn metathesis has emerged as one of the most powerful tools for the
formation of carbon carbon bonds and this was recognised in 2005 through the award
of the Nobel prize in Chemistry to Yves Chauvin, Robert H. Grubbs and Richard R.
Schrock ”for the development of the metathesis method in organic synthesis”.
Oleﬁn metathesis can occur between alkenes (diene metathesis) but can also be ex 
tended to other π systems such as between an alkene and an alkyne (enyne metathesis)
or two alkynes (diyne metathesis).99 The reaction can be classiﬁed into ﬁve closely
related reaction types (Scheme 1.33). Firstly, in the case of acyclic dienes, the reaction
can be both intramolecular (ring closing metathesis   RCM) and intermolecular (cross
metathesis   CM). In addition, polymerisation may occur (acyclic diene metathesis
polymerisation   ADMET) instead of RCM. Strained cyclic alkenes can react by ring 
opening metathesis (ROM), which can also be followed by polymerisation (ROMP).
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Scheme 1.33: Important types of metathesis reactions.
1.3.2 Mechanism
The initially proposed metathesis mechanism involved pair wise exchange of alkylidenes
through a ’quasicyclobutane’ mechanism in which two oleﬁns coordinated to the metal
and exchanged alkylidene groups through a symmetrical intermediate (Scheme 1.34).100
With a few assumptions, this mechanism could account for the outcome of most of the
basic metathesis transformations.
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Scheme 1.34: Quasicyclobutane mechanism of metathesis.
Chauvin proposed a new mechanism to explain a surprising set of observations.101
He observed that in some cases where a pair wise mechanism, such as the ’quasi 
cyclobutane’ mechanism, predicted only the two oleﬁns resulting from pair wise ex 
change of the two ends of the starting oleﬁns, the oleﬁns resulting from cross prod 
ucts were observed very early in the reaction. This led Chauvin to propose that the
mechanism for oleﬁn metathesis consisted of a sequence of formal [2+2] cycloaddi 
tions/cycloreversions involving alkenes, metal alkylidenes and a metallocyclobutane
intermediate (Scheme 1.35). The ﬁrst step in the catalytic process is a [2+2] cycload 
37dition between oleﬁn 104 and the transition metal alkylidene complex 103 to give the
ﬁrst metallocyclobutane 105. This metallocycle undergoes a [2+2] cycloreversion reac 
tion to liberate ethene 106 and a new metal carbene 107, which carries the alkylidene
substituent R1. As before, 107 reacts with another alkene 108 to form the second
metallocycle 109. After a further [2+2] cycloreversion, the new disubstituted alkene
110 is liberated and the catalyst 103 is regenerated and can re enter the catalytic cy 
cle. This mechanism is now widely accepted as the true mechanism of the metathesis
reaction.
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Scheme 1.35: Chauvin mechanism of metathesis.
Due to the reversible nature of all the steps in the catalytic cycle, it is necessary to
displace the equilibrium in favour of the desired product to avoid a mixture of all the
possible alkenes. In the case of RCM, the starting diene is transformed into two alkenes
and, as such, the reaction is entropically favoured. Furthemore, if one of the alkenes
is volatile (ethylene for example), the cycloreversion step becomes irreversible. The
substitution pattern of the alkene is also an important factor because it determines the
kinetics of the reaction. In general, the more substituted the alkene, the less reactive
it is.
1.3.3 Catalysts
The number of catalyst systems that initiate oleﬁn metathesis is very large. From
the mid 1950’s to the early 1980’s, all oleﬁn metathesis reactions were accomplished
with poorly deﬁned, multicomponent homogeneous and heterogeneous catalyst sys 
tems.102 These systems consisted of transition metal salts combined with main group
alkylating agents or deposited on solid supports. Some of the classic combinations
38include WCl6/Bu4Sn, WOCl4/EtAlCl2, MoO3/SiO2 and ReO7/Al2O3, among many
others.103 Although used in many commercial processes, these catalysts require harsh
Lewis acidic conditions that are incompatible with most functional groups. They were
therefore unsuitable for organic synthesis. Understanding the mechanism of oleﬁn
metathesis greatly inﬂuenced work on catalyst development in that it provided both a
design rationale and a way to begin explaining catalyst activity. Subsequent eﬀorts to
synthesise alkylidene and metallacylobutane complexes led to the discovery of the ﬁrst
single component homogenous catalysts for oleﬁn metathesis during the late 1970’s and
early 1980’s.
Titanocene Based Catalysts
Tebbe demonstrated that a titanium methylene complex would catalyse the non produc 
tive metathesis exchange of the methylenes between two terminal oleﬁns. The reac 
tion of two equivalents of AlMe3 with Cp2TiCl2 produces the complex Cp2Ti(µ Cl)(µ 
CH2)AlMe2 111, commonly known as Tebbe’s reagent, and methane (Scheme 1.36).104
In the presence of a Lewis base, such as pyridine, the reagent is functionally equivalent
to ”Cp2Ti=CH2”.105
Cp2TiCl2 + 2    AlMe3 Ti
Cl
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Scheme 1.36: Synthesis and use of Tebbe’s reagent.
Although catalyst 111 is not a particulary active metathesis catalyst, it served as
an excellent model system because the complex is reasonably stable and the propagat 
ing alkylidene can be observed and studied.104 These titanium complexes also undergo
stoechiometric ’Wittig type’ reactions with aldehydes and ketones to give the corre 
sponding methylene derivatives. Most importantly, Evans and Grubbs showed that
these complexes convert esters into vinyl ethers, a reaction for which conventional
Wittig reagents are not suitable (Scheme 1.36).106 The mechanism of this reaction is
identical to that of the oleﬁn metathesis except that the ﬁnal step is irreversible.107
39Tungsten, Molybdenum and Rhenium Catalysts
Schrock has developed a wide variety of well deﬁned catalysts based on molybdenum,
tungsten and rhenium (Figure 1.5).108 The most important system is the alkoxy imido 
molybdenum complex represented by 17. One of the major advantage of this system
is its high reactivity towards a broad range of substrates with many steric or electronic
variations. For example, it has been shown that complex 17 can bring over 1000
equivalents of cis 2 pentene to equilibrium in less than one minute at 25 ◦C. The
alkoxides in the [Mo] system can be readily altered to adjust the activity of the complex;
when R1 is a tert butyl, the complex reacts only with strained cyclic oleﬁns, making it
an ideal ROMP catalyst.109
17
Mo
Me(CF3)2CO
Me(CF3)2CO
N Ph
Me
Me
iPr iPr
M
R1O
R1O
N R2
Me
Me
Ar
M  = Mo, W
R1 = alkyl, aryl
R2 = Me, Ph
Ar  = 2,6-(iPr)2Ph
Re
R1O
R1O
R2
Me
Me
R2
Me
Me
Figure 1.5: Molybdenum, tungsten and rhenium catalysts.
Critical drawbacks of this Mo based system are, however, its thermal unstability on
storage, its moderate to poor functional group tolerance and its high sensitivity to air,
moisture or even trace impurities present in solvents.
Ruthenium Catalysts
During the 1990’s, Grubbs and co workers developed a series of well deﬁned ruthenium
alkylidene catalysts that initiate oleﬁn metathesis.102 The ruthenium carbene com 
plexes have drawn a lot of attention, not only because they exhibit high reactivity in
a variety of ROMP, RCM and cross metathesis processes under mild conditions, but
also, because of their remarkable tolerance toward many diﬀerent organic functional
groups.110 Catalytic activity is not signiﬁcantly reduced in the presence of air, moisture
or minor impurities in solvents. They can be conveniently stored, even under air atmo 
sphere, without decomposition for several weeks or months. Although the ruthenium
carbene complexes often exhibit relatively lower propagation rates,111 especially with
sterically bulky substrates, when compared to the Schrock catalyst 17, their availabil 
ity and ease of use has made them the catalysts of choice for the metathesis reaction,
with all but the most diﬃcult substrates.
40The ﬁrst generation Grubbs’catalyst 98112 possesses two phosphine ligands whereas
the second generation ruthenium complex 92113 has one phosphine ligand and one
N heterocyclic carbene (NHC) ligand (Figure 1.6). This structural alteration im 
proved the stability and reactivity of the catalyst compared to complex 98. The other
main ruthenium catalyst 112 in wide spread use was reported by Hoveyda.114 An iso 
propyloxy ether group attached to the phenyl carbene unit already connected to the
ruthenium replaces the phosphine ligand of 92. Although many variations of these cat 
alysts have been reported,115–119 the three described above are commercially available
and generally used most frequently.
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Figure 1.6: Ruthenium catalysts.
In contrast to the Schrock catalyst 17, the three complexes shown in Figure 1.6
are pre catalysts; the active species are generated under the reaction conditions. An
understanding of the mechanism of the catalyst formation is therefore crucial in order to
improve catalyst design.111,120 Two possible mechanistic pathways have been envisaged
(Scheme 1.37). Complex 113 could exchange the phosphine ligand for an oleﬁn via the
14 electron complex 114 (dissociative pathway) or by ﬁrst coordinating the oleﬁn and
forming the 18 electron complex 116. The latest studies by Grubbs and co workers
suggest that 114 is the key intermediate for the oleﬁn metathesis reaction with no
evidence for the formation of 116.
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Scheme 1.37: Mechanism of metathesis using ruthenium catalysts.
Other ﬁndings by Grubbs also account for the increase of reactivity of the NHC com 
plexes. In the case of the ﬁrst generation Grubbs’ catalyst 98, the loss of a phosphine
ligand is facile (k−1 large) but the re coordination of the phosphine is much faster than
the coordination of the oleﬁn (k1/k2>>1). Therefore, the active species 114 is formed
more frequently but carries out fewer turnovers. Substitution of a phosphine ligand
by an NHC ligand will stabilize the metal complex thanks to the strong sigma donor
character of the NHC. The dissociation of the phosphine will therefore be slower (k−1
small) but the re binding rate of the phosphine will also decrease. The catalyst will
be more stable and once the catalytic species 114 is generated, it can perform a larger
number of turnovers.
1.3.4 Ring-Closing Metathesis (RCM)
The most common metathesis reaction used in organic chemistry is ring closing metathe 
sis (RCM). Various reviews have detailed the use of RCM in the synthesis of small
(ﬁve membered rings) to large ring systems97,99,121 e.g. the 22 membered core of san 
glifehrin, as shown in scheme 1.38.122
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Scheme 1.38: Conditions: a) Grubbs I catalyst 98, CH2Cl2, reﬂux, 57%.
As my subject is mainly concerned with the preparation of cyclic ethers, the following
section will focus on the use of RCM for their synthesis.
Synthesis of Cyclic Ethers by RCM
Clark (see chap 1.2.3) and Rainier (see chap 1.2.1) have both used a RCM approach
for the synthesis of polycyclic ethers. However, other groups have also prepared cyclic
ethers using this strategy. Nicolaou combined methylenation and ring closing metathe 
sis into a domino process which allowed the transformation of acyclic oleﬁnic ester into
cyclic enol ethers.32 The eﬃciency of this technique is illustrated by the synthesis of a
hexacyclic polyether (Scheme 1.39).123
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Scheme 1.39: Conditions: a) Tebbe’s reagent 111, reﬂux, 57%.
Hirama also used the RCM reaction for the synthesis of medium ring cyclic ethers
(Scheme 1.40).124 He found that the yields for the preparation of seven  to ten membered
43rings were uniformly excellent.
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Scheme 1.40: Conditions: a) Grubbs I catalyst 98 (12-21 mol%).
Van Boom and co workers have disclosed a route to bicyclic ethers based on the
RCM of diene carbohydrate derivatives.125 RCM of dienes 118 and 120 with Grubbs’
ﬁrst generation catalyst 98 gave the trans fused ethers 119 and 121 in good to excellent
yields (Scheme 1.41).
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Scheme 1.41: Conditions: a) Grubbs I catalyst 98 (4 mol%), toluene, rt, 93%; b) Grubbs I catalyst
98 (3-5 mol%), CH2Cl2, rt, 63%.
More recently, Snapper and co workers have reported the preparation of cyclic enol
ethers through a ruthenium catalysed RCM oleﬁn isomerisation sequence.126 RCM of
diene 122 in dichloromethane followed by passage of forming gas (N2:H2 = 95:5)
through the solution and heating at 70 ◦C gave the cyclic enol ether 123 in 50%
yield (Scheme 1.42). The oleﬁn isomerisation is thought to proceed through several in 
termediates to provide the less substituted enol ether, although the speciﬁc ruthenium
catalyst responsible for the isomerisation is still in question.
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Scheme 1.42: Conditions: a) Grubbs II catalyst 92 (10 mol%), CH2Cl2, rt then N2:H2 (95:5), 65-70 ◦C,
50%.
Cyclic Ether Synthesis by RCM of Enol Ethers
The ﬁrst report of the RCM of enol ethers appeared from the Grubbs group, who
showed that enol ethers were suitable substrates for RCM.127 Treatment of acyclic enol
124 with Schrock catalyst 17 gave the six membered cyclic enol ether 125 in 84%
yield (Scheme 1.43). Ruthenium catalyst 126 did not catalyse the RCM of acyclic enol
ethers but slowly catalysed the dimerisation of starting material.
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Scheme 1.43: Conditions: a) Schrock catalyst 19 (13 mol%), n-pentane, rt, 84%.
As seen before, the Clark’s and Rainier’s groups reported soon after that the synthe 
sis of six membered cyclic enol ethers was possible using Schrock catalyst 17. Postema
and co workers also reported the use of Schrock catalyst to access C1 glycals from
the corresponding acyclic dienes.128,129 A variety of acyclic dienes derived from tri O 
benzyl D glucal was exposed to the Schrock catalyst and delivered the corresponding
cyclic products in average to good yields (Scheme 1.44).
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Scheme 1.44: Conditions: a) Schrock catalyst 17 (25-50 mol%), toluene, reﬂux.
Even though these experiments demonstrated the feasibility of the reaction, the con 
ditions required for the operation   glove box, high catalyst loadings   were not ideal
for a routine use in a research laboratory.
The ﬁrst reports of eﬃcient use of the diﬀerent Grubbs catalysts for the RCM of enol
ethers appeared in 1998 and 2001. First, Sturino and Wong reported the formation of
substituted dihydropyrans by RCM reaction of enol ethers using Grubbs’ ﬁrst gener 
ation catalyst 98.130 Three enol ethers (entries 1, 2 and 3) were treated with Grubbs
I catalyst 98 in benzene at reﬂux and the dihydropyrans were obtained in average to
excellent yields (Table 1.1). However, the reaction was very sensitive to the substitu 
tion pattern of the substrate: if an alkoxy group was present at the allylic position, the
reaction was completely shut down (entries 4, 5 and 6). The addition of a gem dimethyl
substituent restored the reactivity, probably due to the Thorpe Ingold eﬀect (entry 7).
1,1 Disubstituted enol ethers were also unreactive under the same conditions (entry 8).
46Entry Substrate Yield Entry Substrate Yield
O Ph
O
O
O 1 95% 5 0%
O
BnO
O
O
O
BnO
2 69% 6 0%
O
BnO
O
OBn
3 45% 7 45%
O
OBn
O
Ph
Ph
4 0% 8 0%
Table 1.1: Conditions: Grubbs I catalyst 98 (20 mol%), benzene, reﬂux.
Three years later, Rainier and co workers described the ﬁrst use of Grubbs’ second
generation catalyst 92 for the RCM of enol ethers.58 This time, 1,1 disubstituted enol
ethers were tolerated and the catalyst gave the same yields as the Schrock catalyst 17
without the inconvenience of using a glove box (Scheme 1.45).
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Scheme 1.45: Conditions: Grubbs II catalyst 92 (20 mol%), benzene, rt.
47Seven membered cyclic enol ethers were also prepared by RCM, but only using
the Schrock catalyst 17 (Scheme 1.46).131 The catalyst loadings were high but the
oxepenes 128 and 130 were formed in very good yields. This study also demonstrated
the ineﬃciency of the Grubbs second generation catalyst 92 to eﬀect the ring closure.
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Scheme 1.46: Conditions: a) Schrock catalyst 17 (20 mol%), toluene, 60 ◦C.
1.3.5 Isomerisation Reactions with Metathesis Catalysts
Since the late 1990’s, non metathesis reactions promoted by ruthenium carbene com 
plexes have been reported such as isomerisation,132 hydrogenation,133 radical reac 
tion,134 silane activation,135 cycloisomerisation,136 cyclopropanation,137 etc.
The isomerisation of carbon carbon double bonds was ﬁrst described by Grubbs,132
and is probably the most studied non metathetic reaction. Later, Roy and co workers
developed an isomerisation reaction of O allyl glycosides using a combination of ﬁrst 
generation Grubbs’ catalyst 98 with N allyltritylamine and N,N diisopropylethylamine
(Scheme 1.47).138
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Scheme 1.47: Isomerisation of allylic ethers with Grubbs’ ﬁrst-generation catalyst 98 .
Aly reported the deprotection of allylic amines via a ruthenium catalysed isomeri 
sation followed by hydrolysis of the enamine intermediate.139 This methodology was
later applied by Cossy to allylic or homoallylic ethers and amines.140
The isomerisation reaction can also be used in tandem with the metathesis reaction.
48Tandem RCM/Isomerisation Reactions
Snapper ﬁrst described the synthesis of cyclic enol ethers through a RCM/isomerisation
sequence (see chap. 1.3.4).
Schmidt introduced the use of additives to promote the isomerisation reaction after
completion of the RCM.141 Hydride sources, such as NaH or NaBH4, were found to
be very eﬃcient at providing the less substituted cyclic ethers (Scheme 1.48). He also
reported some spectroscopic evidence of the formation of a Ru H species during the
reaction.142 However, the real nature of the catalyst involved and the mechanism are
still open to question.
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Scheme 1.48: Conditions: a) Grubbs I catalyst 98 (5 mol%), toluene, rt then NaH or NaBH4 (50
mol%), 110 ◦C, 64-94%.
Tandem Isomerisation/RCM Reactions
Clark reported competitive isomerisation occuring during RCM of enol ethers. When
diene 131 was subjected to molybdenum catalyst 17, a 2:1 mixture of eight  and nine 
membered cyclic enol ethers (132 and 133 respectively) was obtained (Scheme 1.49).86,90
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Scheme 1.49: Conditions: a) Schrock catalyst 17 (33 mol%), 60 ◦C, 40%.
Micha used a combination of two compatible ruthenium catalysts to realise the two
diﬀerent steps.143 The ﬁrst complex RuCl(CO)H(PPh3)3 isomerised the terminal oleﬁn
before the Grubbs II catalyst 92 closed the ring by RCM (Scheme 1.50).
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Scheme 1.50: Conditions: a) Grubbs II catalyst 92 (5 mol%), RuCl(CO)H(PPh3)3 (5 mol%), benzene,
reﬂux, 94%.
1.3.6 Summary
Oleﬁn metathesis has developed into an indispensable tool for advanced organic and
polymer synthesis. The application of RCM has revolutionised the logic of retrosyn 
thetic analysis and has become a key reaction in organic synthesis. The continued
development of new molybdenum and ruthenium catalysts has resulted in a tremen 
dous expansion in the usefulness of the metathesis reactions.
Although metathesis reactions of dienes will continue to be important, recent de 
velopments indicate that metathesis of other π systems will become more important
in the near future. Signiﬁcant progress is being made towards a deeper understand 
ing of enyne144 and diyne145 metathesis. Another area of continued interest is the
development of asymmetric metathesis reactions.146,147
It can be concluded that metathesis in general, and oleﬁn metathesis in particu 
lar, are among the most important advances in preparative chemistry in recent years,
although many stimulating discoveries certainly still lie ahead.
1.4 Gambieric Acids
1.4.1 Isolation and Biological Activity
The gambieric acids A D were ﬁrst isolated in 1992 by Yasumoto and co workers from
a culture of the marine dinoﬂagellate Gambierdiscus toxicus (GII1 strain).5,6 These di 
noﬂagellates usually grow on dead corals and were collected near the Gambier Islands
in French Polynesia (Figure 1.7).
50Figure 1.7: Gambierdiscus toxicus, magniﬁcation x2000.
The gambieric acids exhibit very high antifungal activity against Aspergillus niger
and several other fungi. They are 2000 times more potent than amphotericin B, which
is a natural product currently used as an antifungal drug.148 They also possess some
cytotoxicity but they are much less neurotoxic than other marine polycyclic ether
natural products such as the brevetoxins, which means that the gambieric acids have
some potential as antifungal drugs. Interestingly, it has also been shown that gambieric
acid A inhibits the binding of PbTx 3, a brevetoxin B derivative, to site 5 on the
voltage gated sodium channels of excitable membranes.149
However, the biological evaluation is still far from complete. Indeed, the extraction
process is very long and low yielding: 5000 L of culture kept at 25 ◦C for 38 days,
followed by numerous extractions and column chromatographies gave only 6 mg of a
mixture of the acids. Completing the total synthesis of these compounds would allow
further toxicity and activity studies to be conducted and a more complete bioactivity
proﬁle to be developed.
1.4.2 Structure
The structures of the gambieric acids were established using extensive 1D and 2D
NMR studies.5 It was found that all of them share a common skeleton made of a nine
trans fused six , seven  and nine membered cyclic ethers and a side chain containing a
trisubstituted THF ring (Figure 1.8). Structural diﬀerences lie in the presence of an an 
gular methyl group at the C12 position for gambieric acids B and D and an ester at the
end of the other side chain for gambieric acids C and D. The absolute conﬁguration was
only established later.150 The conﬁguration of the alcohol at the C9 position was de 
termined by forming the Mosher’s ester with α methoxy α triﬂuoromethylphenylacetic
acid. Analysis of the modiﬁcation of the chemical shift of the protons around the
C9 position suggested a R conﬁguration at this position. The methyl group on the
side chain attached to the J ring was assigned R conﬁguration by HPLC analysis of
the compound obtained after oxidative cleavage of the trisubstituted double bond and
derivatisation of the corresponding carboxylic acid. The absolute conﬁguration of the
51A ring was determined by NMR analysis of the phenylglycine methyl ester. The car 
bons C11 and C12 were then assigned based on NOE analysis and 3JH,H values and
the conﬁgurationof centres in the remainder of the polycyclic core was then deduced.
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Figure 1.8: Gambieric acids A-D.
Recently, Sasaki and co workers recently reported the synthesis of the proposed AB
fragment of gambieric acid B.151 The NMR spectrum obtained showed important dif 
ferences when compared to the spectrum described in the isolation paper and so they
suspected that the relative conﬁguration of the polycyclic core to the THF containing
side had been misassigned. To conﬁrm their hypothesis, they prepared the four diﬀer 
ent diastereomers (134a to 134d) of the AB model system and compared the NMR
spectrum of these compounds to those of the natural products (Figure 1.9).
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Figure 1.9: Four diastereomers of the AB fragment of gambieric acid B.
52They concluded that the data for 134c matched best with the data for natural
products. Since the conﬁguration of the alcohol at C9 has been unambiguously assigned
by the Mosher’s ester protocol150 and 134c possess the opposite conﬁguration, they
claimed that the absolute conﬁgurations of the stereogenic centres in the polycyclic core
(rings B J) should be reversed (Figure 1.10). Later, they prepared the AB fragment
of gambieric acid A and the ABC fragment of gambieric acid B and obtained good
correlations between the NMR data for this tricyclic fragment and that of the natural
product.152
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Figure 1.10: Proposed structure of gambieric acid B by Sasaki and co-workers.
1.4.3 Previous Synthetic Studies Towards the Total Synthesis of Gambieric
Acids
The interesting biological properties of the gambieric acids coupled with their very
challenging chemical structures have attracted the interest of many synthetic groups.
Although several total syntheses of other polycyclic ether natural products have been
described in the literature,31,33–37 the total synthesis of any gambieric acids has not
been published. The following sections provide a brief review of the diﬀerent synthetic
eﬀorts towards fragments of these molecules.
Evans’ approach to BC and Ĳ fragments
Evans and co workers reported an iterative methodology, using a radical cyclisation of
an acyl selenide, to access trans fused ether ring systems containing six  and seven 
membered rings.153 This represents the construction of the BC and Ĳ fragments of the
gambieric acids.
Secondary alcohols 135a,b were ﬁrst alkylated with methylpropiolate and the primary
53silyl ether was oxidised using Jones conditions to deliver the corresponding carboxylic
acids 136a,b (Scheme 1.51). Using the Crich protocol,154 triethylamine followed by
phenylselenyl chloride and tri n butylphosphine, acyl selenides 137a,b were obtained
in high yields. Cyclisation occurred upon treatment with tris(trimethylsilyl)silane and
triethylborane to deliver the two cyclic ethers 138a,b and 139a,b. Surprisingly, the
formation of the seven membered ring 138b was completely selective towards the for 
mation of the cis product (dr > 19:1), whereas the tetrahydropyranone 138a was
obtained with a 5.7:1 selectivity and had to be reﬂuxed with a catalytic amount of
DBU to deliver the desired isomer 138a as the sole product.
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Scheme 1.51: Conditions: a) methylpropiolate, (nBu)3P, CH2Cl2, rt; b) Jones’ oxidation, acetone,
−10 ◦C to rt; c) Et3N, CH2Cl2, rt then PhSeCl, Bu3P, THF, rt; d) (Me3Si)3SiH, Et3B, benzene, air,
rt; e) DBU, toluene, 95%.
The tetrahydropyranone 138a was then selectively reduced using LiAlH4 and the
primary alcohol was protected as a TBS ether to give alcohol 140, which could then
undergo another synthetic sequence to furnish bicyclic compound 141 (Scheme 1.52).
Selective reduction of oxepinone 138b proved to be much more diﬃcult and ﬁnally
L selectride was found to give only one alcohol 142 but with the undesired cis relative
conﬁguration. After reduction of the lactone and protection of the primary alcohol
as previously, the stereochemistry of the secondary alcohol was inverted using the
Mistunobu protocol to aﬀord alcohol 144. An iterative sequence was then applied and
delivered the bicyclic system 145.
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rt, 90%; f) DEAD, PPh3, p-nitrobenzoic acid, toluene, reﬂux, 96%; g) KOH, MeOH:H2O (9:1), rt,
86%.
The increased selectivity for the formation of the second ring, >19:1 for the six 
membered substrate and 17:1 for the seven membered precursor, can be explained by
a transition state, in which the pyran and oxepine rings lock the substituents of the
newly forming pyran ring in pseudo equatorial environments (Figure 1.11).
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Figure 1.11: Transition states for the second radical cyclisation.
Yamamoto’s synthesis of the A and J ring
In 2001, Yamamoto and co workers reported their ﬁrst synthetic eﬀorts towards the
total synthesis of the gambieric acids.155 They published an approach for the synthesis
of the tri substituted tetrahydrofuran A ring relying on Evans alkylation chemistry and
Brown’s chiral boron complexes to generate the desired stereocentres (Scheme 1.53).
Treatment with TBAF triggered the cyclisation to give tetrahydrofuran 147 in high
55yield and with complete stereoselectivity.
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Scheme 1.53: Conditions: a) TBAF, THF, rt, 84%.
They also disclosed their strategy for the preparation of the terminal tetrahydropy 
ran J ring possessing the side chain present in the natural product.156 They ﬁrst pre 
pared the six membered cyclic ether 149 by an acid catalysed 6 endo cyclisation of
hydroxyepoxide 148 (Scheme 1.54). Several functional group manipulations were re 
quired to access the desired aldehyde 150.
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Scheme 1.54: Conditions: a) cat. PPTS, CH2Cl2, rt, 78%.
The other fragment required for coupling, vinyl iodide 152, was synthesised in six
steps from commercially available (S) Roche ester 151 (Scheme 1.55). Vinyl iodide 152
was then treated with tBuLi and the corresponding vinyl lithium reagent was added
to the aldehyde 150 to aﬀord the desired alcohol 153 as a mixture of diastereomers.
56The hydroxyl group was then removed using the Barton deoxygenation procedure to
deliver the J ring fragment 154 in poor yield.157
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Scheme 1.55: Conditions: a) tBuLi, Et2O then 150, −78 ◦C, 76%; b) CS2, KH, Et2O, rt then MeI,
rt, 98%; c) Bu3SnH, AIBN, benzene, reﬂux, 25%.
Rainier’s Approach to the A E subunit
As discussed before (see p. 17), Rainier and co workers have developed several strate 
gies for the synthesis of polycyclic ether units. In 2007, they reported a synthesis of
the A E fragment of gambieric acid A using their methodology.66
Their synthesis started from alcohol 155, which was obtained from D glucose in 11
steps. Esteriﬁcation with carboxylic acid 156 followed by a three step deoxygenation
procedure gave the required precursor 157 (Scheme 1.56). Methylenation of the ester
using Takai Utimoto conditions gave the corresponding enol ether, which was treated
with the Grubbs second generation catalyst 92 to give bicyclic compound 159 in good
yield.61 Epoxidation of the enol ether followed by reductive opening with Dibal H gave
alcohol 160, the conﬁguration of which was conﬁrmed by NOE studies. Cyclisation
under acidic conditions gave the system containing the seven membered E ring in high
yield. Subsequent DMDO epoxidation of the enol ether 161 followed by treatment with
allylmagnesium chloride introduced the last side chain. Further steps were required to
set the exact conﬁguration of both centres and obtain the desired alcohol 162 as a
single diastereoisomer. This fragment corresponds to the C E subunit of gambieric
acid A.
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Scheme 1.56: Conditions: a) 156, DCC, DMAP, CH2Cl2, rt, 92%; b) CSA, MeOH, rt, 91%; c)
CS2, NaH, MeI, rt; d) Bu3SnH, AIBN, toluene, 110 ◦C, 72% (2 steps); e) TiCl4, Zn, PbCl2, CH2Br2,
TMEDA, THF, reﬂux; f) Grubbs II, benzene, reﬂux, 80% (2 steps); g) DMDO, CH2Cl2, rt; h) Dibal-H,
CH2Cl2, −78 ◦C, 95% (2 steps); i) PPTS, Pyr., PhCl, 135 ◦C, 80%.
Next, they prepared the A ring as a single diastereomer using a BF3·Et2O catalysed
addition of trimethylallylsilane onto lactol 164 (Scheme 1.57). Oxidative cleavage of
the terminal alkene 165 followed by a Mukaiyama aldol type reaction with 166 gave
hydroxy ester with 167 in very good yield. Protection of secondary alcohol and ester
hydrolysis gave carboxylic acid 168.
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c) allylTMS, BF3·Et2O, CH2Cl2, −78 ◦C, quant. (dr > 95:5); d) OsO4, NMO, THF, tBuOH, H2O,
rt, 98%; e) Pb(OAc)4, benzene, rt, quant.; f) 166, Me2AlCl, toluene, −78 ◦C, 86% (dr = 5.1:1); g)
TIPSOTf, 2,6-lutidine, CH2Cl2, −78 ◦C, 83%; h) LiOH, THF, H2O, rt, 93%.
The alcohol partner 169 was a model of the C E fragment prepared in eight steps
from intermediate 161 (Scheme 1.58). Esteriﬁcation was realised using Yamaguchi
conditions and delivered ester 170 quantitatively.158 Treatment under Takai Utimoto
conditions using dibromoethane instead of dibromethane gave directly the cyclised
product with 171 in reasonable yield.
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59Sasaki’s Approach
The Sasaki group reported their ﬁrst synthetic eﬀorts towards the total synthesis of
gambieric acids in 2005 with the synthesis of the central C G fragment.159 They started
the synthesis with the preparation of the six membered G ring 173 from known alco 
hol 172 (Scheme 1.59).160 Protection of secondary alcohol as a silyl ether followed by
oxidative cleavage and Wittig reaction gave unsaturated ester 173. Stereoselective 1,4 
addition with methylmagnesium bromide in the presence of isopropylsalicylaldimine
copper(II) complex gave 174 as a single diastereoisomer. Reduction of the ester, de 
hydration and TBAF treatment gave terminal alkene 175. The synthesis of the CD
system started from another known alkene 176,161 which was transformed in four steps
to the corresponding methyl ketone 177. The secondary alcohol was converted into
the enol ether 178 and samarium induced reductive cyclisation of keto ester 178 cre 
ated the two additional stereocentres in a completely selective fashion. Reduction of
the ester followed by Wittig methylenation gave alkene 180, hydroboration and two
oxidation reactions completed the homologation sequence and delivered the desired
carboxylic acid 181.
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Scheme 1.59: Preparation of G and CD fragments. Conditions: a) iso-propylsalicylaldimine copper,
MeMgBr, TMSCl, THF, −45 ◦C, 92%; b) SmI2, THF, MeOH, 0 ◦C, 99%.
Intermolecular esteriﬁcation was conducted under Yamaguchi conditions to deliver
ester 182 (Scheme 1.60).158 The ester was then partially reduced to the mixed acetal,
60which was treated with TMSCN and TMSOTf to obtain carboxylic acid 183 after
TBS deprotection and hydrolysis of the nitrile group. Another Yamaguchi reaction
gave lactone 184 as a separable 1:1 mixture of diasteromers. Further partial ester
reduction followed by acetate formation gave mixed acetal 185, which was treated
with allyltrimethylsilane under Lewis acid conditions to furnish diene 186. Final RCM
with Grubbs’ second generation catalyst delivered the pentacyclic C G fragment 187
in excellent yield.
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Scheme 1.60: Completion of the C-G fragment. Conditions: a) 2,4,6-trichlorobenzoyl chloride, Et3N,
DMAP, toluene, 40 ◦C, 93%; b) 2,4,6-trichlorobenzoyl chloride, Et3N, DMAP, toluene, reﬂux, 38%; c)
allylTMS, BF3·Et2O, CH3CN, −40 ◦C to 0 ◦C, 67%; d) Grubbs II catalyst 92, CH2Cl2, reﬂux, 98%.
Once the strategy for the synthesis of the two biggest rings had been established on
a small fragment, the synthesis of the whole nonacyclic core was reported.162 The B D
fragment was prepared in 32 steps from known alcohol 188 (Scheme 1.61). Successive
Wittig reactions gave unsaturated ester 189 which was reduced and engaged in an
enantioselective Sharpless epoxidation reaction. Further oxidation of primary alcohol
and Wittig methylenation gave alkene 190. Deprotection and acid catalysed epoxide
opening formed the C ring and the resulting alcohol 191 was then submitted to a
61reaction sequence developed earlier to aﬀord intermediate 192. Samarium mediated
cyclisation gave the D ring. Transformation of the ester to the corresponding alkene
and treatment of the mixed acetal with 1,3 propanedithiol gave dithiane 194. Another
samarium mediated cyclisation reaction of precursor 195 delivered lactone 196 with the
seven membered B ring installed. Another ﬁve steps of oxidation/reduction/protection
were necessary to access the desired carboxylic acid 197.
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Scheme 1.61: Synthesis of the B-D fragment. Conditions: a) SmI2, MeOH, THF, 0 ◦C to rt, 81%; b)
SmI2, MeOH, THF, rt, 89%.
The G J fragment was prepared using methodology previously reported by Nakata
and co workers.163 Aldehyde 199 was obtained in ten steps from known alcohol 198
and alkyne 201 was prepared in six steps from known alcohol 200 (Scheme 1.62).
Alkyne 201 was deprotonated with tBuLi and reacted with aldehyde 199 to give alcohol
62202. Oxidation of the alcohol followed by treatment with sodium methoxide gave
methoxyenone 203 after TBS cleavage. Acid catalysed hetero Michael addition gave
dihydropyranone which was reduced selectively with Dibal H to give alcohol 204.
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pyridine, THF, 0 ◦C to rt, 91%; e) PPTS, toluene, 100 ◦C, 87%; f) DIBAL-H, toluene, −78 ◦C, 93%;
.
Hydroboration of the enol ether moiety followed by a couple of functional group
transformations gave hydroxyketone 205 and the I ring was constructed by treatment
of this substrate with Et3SiH and TMSOTf (Scheme 1.63). Protecting group intercon 
versions gave the tetracyclic compound 206 which was converted to the corresponding
terminal alkene using selenium chemistry. Final protecting group manipulations gave
desired alcohol 207.
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The nonacyclic core was then completed following the strategy developed earlier. Af 
ter a Yamaguchi esteriﬁcation, carboxylic acid 208 was obtained rapidly (Scheme 1.64).
Lactone formation followed by partial reduction and acetate formation gave mixed
acetal 209. AllylTMS addition and ﬁnal RCM delivered the fully functionalised B J
fragment 210 of the gambieric acids. This represents to date the biggest fragment of
the gambieric acids ever assembled.
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58%; d) Grubbs II catalyst 92, CH2Cl2, 40 ◦C, 67%.
As mentioned before (see chap 1.4.2), this group also reported a synthesis of the A B
fragment.151,152,164 They planned to prepare the B ring using samarium chemistry then
attach the required side chain with a Suzuki Miyaura cross coupling reaction before
forming the A ring.
Desired cyclisation precursor 212 was obtained in ﬁve steps from known alcohol 211
(Scheme 1.65). Samarium induced cyclisation delivered the bicyclic lactone 213 with
complete stereoselectivity. Reduction to the corresponding lactol followed by Wittig
oleﬁnation and alcohol protection gave α,β unsaturated ester 214. Another reduction
gave the allylic alcohol which was subjected to a Sharpless epoxidation reaction. Epoxy 
65alcohol 215 was then converted to the corresponding propargylic alcohol according to
the Takano protocol and two steps were then necessary to access Z vinyl iodide 216.165
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Scheme 1.65: Synthesis of the B ring. Conditions: a) SmI2, MeOH, THF, rt, 74%; b) DIBAL-H,
CH2Cl2, −78 ◦C, quant.; c) (+)-DET, Ti(OiPr)4, tBuOOH, 4Å MS, CH2Cl2, −20 ◦C; 83%.
The coupling partner 218 was generated from alcohol 217 in two steps and engaged
in a Suzuki Miyaura cross coupling to deliver alcohol 219 (Scheme 1.66). Protecting
group manipulation gave alcohol 220 which cyclised upon treatment with NBS to give
tetrahydrofuran 221 after removal of the bromide under radical conditions. Oxidation
of the primary alcohol to the carboxylic acid followed by complete deprotection deliv 
ered the carboxylic acid 134, the spectroscopic data for which were compared with the
natural product.
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Scheme 1.66: Synthesis of the A-B fragment. Conditions: a) I2, PPh3, imidazole, THF, rt, 96%; b)
tBuLi, B-MeO-9-BBN, Et2O, −78 ◦C; c) 216, PdCl2(dppf)·CH2Cl2, Ph3As, Cs2CO3, DMF, 50 ◦C,
75% (2 steps); d) TBSOTf, Et3N, CH2Cl2, 0 ◦C; e) DDQ, THF, pH 7 buﬀer, rt, 80% (2 steps); f)
NBS, CH3CN, rt; g) Bu3SnH, AIBN, toluene, 110 ◦C, 69% (2 steps).
The stereochemical outcome of the cyclisation step could be explained by the fol 
lowing model (Scheme 1.67). If the bromination had occurred in a syn fashion relative
to the adjacent OTBS group, the transition state 222 required for the cyclisation re 
action would reveal an important steric interaction between the OTBS group and the
methyl group at the C5 position. However, if the bromination occurred at the opposite
face, the new transition state 224 would not have this interaction, making it lower
in energy and therefore the favored reaction pathway. The relative conﬁguration of
the three substituents was conﬁrmed by NOESY studies on tetrahydrofuran 221 after
debromination.
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Scheme 1.67: Explanation of the stereoselectivity for the formation of tetrahydrofuran 221.
Very recently, Sasaki and co workers reported the synthesis of the G J fragment
possessing the revised absolute conﬁguration.166
Clark’s Approach
In 2004, Clark reported the stereoselective synthesis of the A ring fragment of gam 
bieric acid A.167 The synthesis started from L dimethylmalate 226 which underwent a
regioselective reduction of one of the ester to give intermediate 227 after silyl protection
(Scheme 1.68). Formation of the E crotyl ether was achieved using trichloroacetimidate
68228 under acidic conditions. Hydrolysis under basic conditions gave the corresponding
carboxylic acid which was converted into an acid chloride followed by treatment with
an excess of diazomethane to deliver the key diazoketone 229.
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CO2Me
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Scheme 1.68: Preparation of diazoketone 229. Conditions: a) NaBH4, BH3·SMe2, THF, rt, 92%;
b) tBuPh2SiCl, imidazole, DMF, 89%; c) E-crotyl 2,2,2-trichloroacetimidate, CF3SO3H, CH2Cl2, rt,
60%; d) Me3SiOK, Et2O, rt, 86%; e) (COCl)2, DMF, CH2Cl2, rt, then CH2N2, Et2O, 0 ◦C to rt, 74%.
When treated with copper acetylacetonate, the [2,3] sigmatropic rearrangement
could proceed via an exo transition state 230 to give tetrahydrofuranone 231 with
the methyl group possessing the undesired conﬁguration, or an endo transition state
232 that would deliver the desired compound 233 (Scheme 1.69). The endo character
of the mechanism was established on the Z crotyl isomer and the desired tetrahydro 
furanone 233 was obtained in high yield and with excellent selectivity (>92:8).
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Scheme 1.69: Synthesis of the A fragment. Conditions: a) Cu(acac)2, THF, reﬂux, 88% (dr > 92:8).
Non selective hydroboration gave a diol which was fully oxidised to keto acid 234
69(Scheme 1.70). After esteriﬁcation of the carboxylic acid, sequential chemoselective
methylenation of the ketone using Nysted reagent and TBAF deprotection delivered pri 
mary alcohol 235. The remaining stereocentre was installed using a hydroxy directed
hydrogenation with Wilkinson’s catalyst and aﬀorded the A fragment 236 in excellent
yield.
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Scheme 1.70: Synthesis of the A fragment. Conditions: a) (c-C6H11)2BH, THF, 0 ◦C to rt, then H2O2,
pH 7 buﬀer, 86%; b) PDC, DMF, rt, 74%; c) CH2N2, Et2O, 0 ◦C, 99%; d) Zn(CH2ZnBr)2·THF, TiCl4,
THF, 0 ◦C to rt, 67%; e) TBAF, THF, rt, 99%; f) H2, (PPh3)3RhCl, PhMe, rt, 95%.
A year later, Clark reported a synthetic strategy for the construction of the F J
fragment of the gambieric acids.93 The developed approach involved a two directional
strategy based on the ring closing metathesis reaction to form all the cyclic ethers. As
discussed before (see chap. 1.2.3), the Clark group had already shown that RCM reac 
tion is a powerful tool for the construction of cyclic enol ethers and can accommodate
a variety of ring sizes and functional groups.
The synthesis started from tri O acetyl D glucal 237, which was quickly function 
alised to give alcohol 238 (Scheme 1.71). The side chain on the left side was introduced
in four steps to give diol 239. Double alkynyl ether formation followed by sequential
carbocupration reactions gave tetraene 240, which was then exposed to Grubbs II
catalyst 92 to aﬀord tricyclic compound 241.
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Scheme 1.71: Synthetic studies torwards the tricyclic G-I fragment. Conditions: a) KH, Cl2CCHCl,
THF, 0 ◦C then nBuLi, Et2O, −78 ◦C to −40 ◦C, 88%; b) PMBO-(CH2)3MgBr, CuBr, LiBr, THF,
−95 ◦C to −78 ◦C, 85%; c) (OCH2CH2O)CH(CH2)2MgBr, CuCN, LiCl, THF, −78 ◦C, 84%; d)
Grubbs II catalyst 92 (10 mol%), PhMe, 70 ◦C, 89%.
The synthesis continued with a stereoselective double hydroboration reaction that
transformed both enol ethers into the desired trans diol 242 (Scheme 1.72). Acetal
formation followed by TBS protection of the secondary alcohol and Grieco dehydra 
tion the primary alcohol gave tetracyclic compound 243. The TBS group was then
removed and the alcohol was oxidised to the corresponding ketone which was treated
with methylmagnesium iodide to introduce the second angular methyl group and de 
liver the tertiary alcohol 244. The acetal was then opened and reduced to the primary
alcohol which was eliminated using again selenium chemistry to deliver diol 245. Se 
quential alkylation of both hydroxyl groups gave the second RCM precursor. Grubbs II
catalyst 92 was again the catalyst of choice for the double ring closure and treatment
of the tetraene aﬀorded the nine  and six membered rings in high yield thus completing
the F J fragment 246.
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Scheme 1.72: Completion of the G-J fragment. Conditions: a) thexyl borane, THF, 0 ◦C to rt then
NaBO3·4H2O, buﬀer pH=7, 62%; b) TsOH, MeOH, rt, 71%; c) tBuMe2SiCl, DMAP, Et3N, CH2Cl2,
rt; d) CAN, MeCN, H2O, rt, 56%, (2 steps); e) o-O2NC6H4SeCN, (nBu)3P, THF, rt then H2O2,
NaHCO3 aq., 40 ◦C; f) TBAF, THF, rt, 83% (2 steps); g) Dess-Martin periodinane, CH2Cl2, 0 ◦C; h)
MeMgI, PhMe, −78 ◦C, 83% (2 steps); i) HCl aq., THF, 60 ◦C; j) NaBH4, MeOH, 0 ◦C, 84% (2 steps);
k) o-O2NC6H4SeCN, (nBu)3P, THF, rt then H2O2, NaHCO3 aq., 40 ◦C, 96%; l) CH2CH(CH2)3Br,
(nBu)4NI, THF, DMF, reﬂux, 66% (81% brsm); m) KH, Cl2CCHCl, THF, 0 ◦C then nBuLi, Et2O,
−78 ◦C to −40 ◦C; n) H2, Lindlar catalyst, quinoline, EtOAc, rt, 49% (2 steps); o) Grubbs II catalyst
92 (10 mol%), PhMe, 80 ◦C, 60%.
72Chapter 2
Synthesis of Six- and
Seven-Membered Cyclic Ethers by
Ring-Closing Metathesis
2.1 Introduction
Six  and seven membered rings are the most common units founds in natural polycyclic
ethers. The aim of this work is to develop a new methodology to prepare these struc 
tural motifs from a single precursor using ring closing metathesis. Indeed, metathesis
catalysts, such as Grubbs’ second generation catalyst, are known to be able to isomerise
alkenes under speciﬁc conditions (see chap. 1.3). Thus, starting from diene 247, it
should be possible to obtain by a simple RCM the seven membered product 248 and by
a tandem isomerisation RCM reaction the six membered product 249 (Scheme 2.2).
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Scheme 2.2: Synthesis of six- and seven-membered cyclic ethers from a single precursor
Furthermore, in order to minimise the number of steps required to create each ring,
73the side chain attached to the enol ether was chosen carefully. In order to obtain a
terminal alkene after the hydroboration reaction, which is necessary to convert the enol
ether 251 into the secondary alcohol, a vinyl silane was chosen. Indeed, hydroboration
of such functionality would be followed by Peterson elimination to give the desired
terminal alkene (Scheme 2.3). The alcohol 252 would then be ready for submission to
another synthetic sequence to create the next ether ring.
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Scheme 2.3: Iterative synthesis of polycyclic ethers
After preliminary studies done in the group, the dimethylphenylsilyl group was
chosen.168
Preliminary results
When diene 253 was submitted to standard RCM conditions, a mixture of two cyclic
products was obtained in a 1:1 ratio and 78% yield. The ﬁrst RCM product is the seven 
membered cycle 254, and the second is the six membered enol ether 255 resulting from
a tandem isomerization RCM (Scheme 2.4).168
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Scheme 2.4: Conditions: catalyst 92 (10 mol%), benzene, reﬂux, 78%.
A model system 256, with a simple methyl group as side chain, was then studied
and it was found that the addition of 20 mol% of 1,4 benzoquinone could prevent
the isomerization, leading to the selective formation the seven membered ring 257 in
good yield.169 Furthermore, when the reaction was carried out in a solution saturated
with ethylene, the six membered ring 258 could be produced with high selectivity
74(Scheme 2.5).
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Scheme 2.5: Model studies
The ﬁrst part of my project consisted in the application of these conditions to the
desired triene 253.
2.2 Results and Discussion
2.2.1 Synthesis of Triene 253
The ﬁrst objective was the preparation of triene 253, necessary to test the diﬀerent
RCM conditions. Tri O benzyl D glucal 260 was prepared in excellent yield in two
steps from commercially available tri O acetoxy D glucal 259. It was then epoxidised
in a completely stereoselective manner using in situ generated DMDO in quantitative
yield.170 This epoxidation method is much more convenient than the original procedure
where a highly diluted solution of DMDO in acetone had to be prepared.171 Only
three equivalents of Oxone were used, whereas a yield of about 5% is reported for the
distillation process. This procedure is considerably cheaper, leads to much less oxidative
Oxone waste and is much more practical to carry out on a large scale. The epoxide
was then opened by freshly prepared butenylmagnesium bromide to provide alcohol
261 in 50% yield. The free hydroxyl group was converted into the alkynylether 262
using the Greene protocol in 69% yield (Scheme 2.6).172 In order to avoid formation of
impurities that could aﬀect the subsequent carbocupration reaction, the last sequence
was performed in two steps (KH, trichloroethylene then nBuLi), the overall yield being
the same.
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Scheme 2.6: Preparation of alkynyl ether 262. Conditions: a) NaOMe, MeOH, rt; b) NaH,
BnBr, THF, DMF, rt, 96% (2 steps); c) Oxone, acetone, CH2Cl2, NaHCO3 aq., 0 ◦C to rt; d) 3-
butenylmagnesium bromide, THF, −20 ◦C, 50% (2 steps); e) KH, trichloroethylene, then nBuLi,
Et2O, −78 ◦C to −45 ◦C, 69%.
The bromide needed for the carbocupration reaction was prepared in three steps.
Commercially available 3 bromo 3 buten 1 ol 263 was ﬁrst protected as a silyl ether
in 87% yield using standard conditions (Scheme 2.7). The protected alcohol 264 was
then treated with tBuLi in THF to furnish the vinyl lithium which underwent a retro 
Brook rearrangement to provide vinyl silane 265 in 76% yield. The primary alcohol
was ﬁnally converted to the desired bromide 266 in 95% yield.
Br OH Br OSiMe2Ph
PhMe2Si OH PhMe2Si Br
264
265 266
263
a
b
c
Scheme 2.7: Preparation of bromide 266. Conditions: PhMe2SiCl, Et3N, DMAP, CH2Cl2, rt, 87%;
b) tBuLi, THF, −78 ◦C to −45 ◦C, 76%; c) PPh3, CBr4, CH2Cl2, rt, 95%.
Preparation of alcohol 263
Due to the cost of the starting alcohol 263, alternative preparative routes were ex 
plored. The addition of 9 Br 9 BBN to 4 butyn 1 ol 267, or its protected version,
appeared to be the most promising route to prepare 263.173 The bromination reaction
was ﬁrst tested on the free alcohol. NMR indicated that the required vinyl bromide had
formed but it was not possible to separate this from the 9 BBN related by products
(Scheme 2.8).
76Various protecting groups were then tested in order to modify the polarity of the
bromide product. First, the dimethylphenylsilyl group, required for the next step,
was introduced using same conditions as above, but this was found to be unstable
under the bromination reaction conditions. The alcohol was also protected as a PMB
ether in good yield, but once again, the protecting group was cleaved when exposed
to 9 Br 9 BBN. Finally, the very robust tert butyldiphenylsilyl group (TBDPS) was
chosen as this group has already been used in bromination reactions.174 3 Butyn 1 ol
was protected as the silyl ether in quantitative yield, then submitted to the action
of 9 Br 9 BBN. The desired vinyl bromide 269 was obtained as a mixture with tert 
butyldiphenylsilanol. The mixture was then directly treated with TBAF to give the
bromoalcohol 263, but in only 14% yield over two steps.
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R = PMB          268b        61%
R= TBDPS       268c      quant.
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R = PhMe2Si,          decomp.
R = PMB,                decomp.
OTBDPS 9-Br-9-BBN
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d
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Scheme 2.8: Preparation of alcohol 263. Conditions: a) PhMe2SiCl, Et3N, DMAP, CH2Cl2, rt; b)
NaH, nBu4NI, PMBCl, THF, rt; c) TBDPSCl, Et3N, DMAP, CH2Cl2, rt; d) TBAF, THF, rt, 14%
(2 steps).
As an alternative to the preparation of the vinyl bromide, the synthesis of the
corresponding vinyl iodide was explored. The synthesis of 3 iodo 3 buten 1 ol 270 had
already been reported by Shioiri and co workers and the application of their conditions
gave the desired product in 51 % yield (Scheme 2.9).175 It was not possible to obtain
completely pure product by column chromatography, but it was possible to carry out
the next two steps (silylation and retro Brook rearrangement) and obtain the desired
vinyl silane 265 in 61% over the two steps.
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Scheme 2.9: Alternative route to alcohol 265. Conditions: a) TMSCl, NaI, MeCN, H2O, rt, 51%. b)
PhMe2SiCl, Et3N, DMAP, CH2Cl2, rt; c) tBuLi, THF, −78 ◦C to −45 ◦C, 61% (2 steps).
Carbocupration
With the two coupling partners in hand, the carbocupration reaction was tested using
conditions previoulsy developed in the group. The Grignard reagent prepared from
bromide 266 was ﬁrst added to a solution of CuBr and LiBr in THF at very low
temperature (−90 ◦C) to form the lower order cuprate, and alkyne 262 was then added.
The desired triene 253 was obtained in 61% yield after column chromatography under
basic conditions (Et3N 1% v/v) (Scheme 2.10).
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Scheme 2.10: Conditions: a) CuBr, LiBr, Mg, THF, −90 ◦C then alkyne 262, −90 ◦C to −78 ◦C,
61%.
2.2.2 Tandem Isomerisation-RCM Reaction
Firstly, conditions previously developed on the model system were investigated, but
were much less successful on the more complex system (Table 2.1). Saturating the re 
action mixture reaction with ethylene gas gave little selectivity for six membered ring
formation (entry 2). Using another small alkene, such as styrene, had the same eﬀect
on the selectivity (entry 3). However, using the conditions described by Wicha and
co workers:143 cooperative use of RuCl(CO)H(PPh3)3 and Grubbs’ second generation
catalyst 92, led to the exclusive formation of the 6 membered cyclic enol ether in rea 
sonable yield (entry 4). It is interesting to note that only the mono substituted terminal
alkene is isomerised by the ruthenium hydride catalyst and the two 1,1 disubtituted
double bonds were left untouched.
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Entry Additive Yield Ratio 254:255
1 nonea 50% 50:50
2 ethyleneb 25% 25:75
3 styrene (40 mol%)b 86% 33:67
4 RuCl(CO)H(PPh3)3 (5 mol%)a 57% >1:99
Table 2.1: Ring-closing metathesis of triene 253. Conditions a) Grubbs II catalyst 92 (40 mol%),
additive, benzene, reﬂux; b) Grubbs II catalyst 92 (10 mol%), additive, benzene, reﬂux.
According to the original publication,143 two protocols can be followed in this reac 
tion. In the ﬁrst case, both catalysts were added at the beginning of the reaction and
the RCM did not start before one of the alkene had isomerised. On the other hand,
the isomerisation catalyst was added alone, and the reaction mixture was heated for 10
min before the Grubbs II catalyst was added. In our case, because it was known that
the starting triene was reactive towards the Grubbs catalyst, the two step protocol was
chosen: ﬁrst the triene 253 and the ruthenium hydride catalyst (1 mol%) were heated
at reﬂux at average concentration (0.05 M) to ensure a quick isomerisation. After 10
min, the progress of the reaction was checked by NMR and the Grubbs II catalyst (10
mol%) was added with some solvent to reach typical RCM concentrations (0.005 M).
As a safer alternative to benzene, the reaction was also carried out in toluene and only
the six membered product was obtained with the same yield as before (Scheme 2.11).
Along the desired product, some of the isomerised product 271 was also isolated, even
when an additional amount of Grubbs II catalyst (10 mol%) was added.
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Scheme 2.11: Conditions: a) RuCl(CO)H(PPh3)3 (5 mol%), then Grubbs II catalyst 92, toluene,
90 ◦C.
792.2.3 Attempted Selective Formation of the Seven-Membered Ring
Following the identiﬁcation of reaction conditions that would give the six membered
product exclusively from triene 253, focus moved towards the selective synthesis of
the seven membered cyclic ether 254. Several methods were envisioned to favour the
formation of the seven membered product and limit the isomerisation of the starting
material.
Use of additives during RCM reaction
Grubbs and co workers have reported that the addition of a benzoquinone can suppress
the isomerisation reaction catalysed by Grubbs catalysts.176 They suggested that the
benzoquinone could reoxidise the decomposed form of ruthenium catalyst responsible
for the isomerisation process. However, addition of several substituted benzoquinones
to our catalytic system led only to decomposition of the starting material or isomeri 
sation of the mono substituted double bond.
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Scheme 2.12: Range of benzoquinones used.
Prunet and co workers have shown that addition of a weak ligand for ruthenium,
such as triphenylphosphine oxide, can also prevent formation of isomerised products.177
But no such eﬀect was observed when this protocol was used on the model substrate
(Table 2.13, entry 1). Meyer reported that formation of bimetallic complexes between
the ruthenium catalyst and other transition metals such as tin or iron reduces the
decomposition rate of Grubbs catalyst and gives only the expected product of the
reaction.178 However, these additives are also strong Lewis acid and when added to the
reaction, led to the cleavage of the enol ether moiety (entry 2). Brönsted acids have also
been shown to prevent the underisable isomerisation occuring during the RCM reaction.
80Even though the precise mechanism by which the isomerisation reaction occurs is not
known, it is believed that a ruthenium hydride complex is responsible. Therefore, it
was envisioned that adding an hydride scavanger would sequester any hydride present
in the reaction mixture, and thus prevent isomerisation caused by the Grubbs catalyst.
Carboxylic acids176 as well as phosphoric acids179 have been proven as eﬃcient
isomerisation suppressors for some substrates, but when applied to this system, no
improvement was observed and the reaction led to an inseparable mixture of several
products (entries 3 and 4). 4 Nitrophenol, a milder Bronsted acid (pKa = 7.15), was
also tested but was not able to suppress the isomerisation reaction (entry 5).
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Scheme 2.13: Conditions: Grubbs II catalyst 92, additive (Ph3P(O), SnCl2, acetic acid, phenylphos-
phoric acid or 4-nitrophenol), benzene, reﬂux.
Modiﬁcations to the reaction conditions
Adding various additives always led to decomposition of the starting material, so a
diﬀerent approach was required. Changing the reaction conditions (solvent, catalyst,
temperature) was the next approach.
First, a range of solvents was tested with Grubbs second generation catalyst. Re 
ﬂuxing DCM did not provide a high enough temperature to activate the catalyst,
whereas reﬂuxing in DCE gave some cyclised product, but in poor yield (22 %) and
with incorrect selectivity (4:1 for the six membered ring) (Table 2.2, entries 1 and 2).
Recently, ﬂuorinated aromatic solvents have been shown to increase the activity of
metathesis catalysts in diﬃcult reactions.180 In our case, when using perﬂuorobenzene
or perﬂuorotoluene, only isomerised product was observed (entries 3 and 4). Activation
of the catalyst by microwave irradiation was also attempted, but no improvement was
observed and only isomerised product was obtained.
Screening various metathesis catalysts was also performed. Grubbs Hoveyda sec 
ond generation catalyst gave only isomerised product.114 A modiﬁed version of the
Grubbs Hoveyda catalyst   the Grela Grubbs catalyst 272   was also tested in diﬀerent
solvents.118 In reﬂuxing dichloromethane, no reaction was observed and in reﬂuxing
81benzene, complete isomerisation of the mono substituted alkene was accomplished in
2 h.
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Entry Solvent Catalyst Yield Ratio 254:255
1 DCM Grubbs II decomp. -
2 DCE Grubbs II 22% 1:4
3 C6F6 Grubbs II decomp. -
4 C7F8 Grubbs II decomp. -
benzene with microwave
5 irradiation (100 ◦C for Grubbs II decomp. -
23 min)
6 benzene Grubbs-Hoveyda II decomp. -
7 DCM Grela-Grubbs II isom. -
8 benzene Grela-Grubbs II isom. -
Ru
Cl
Cl
NMes MesN
O NO2
272
Grela-Grubbs II :
Table 2.2: Modiﬁcation of the solvent and catalyst
During the past decade, hundreds of metathesis catalysts have been developed, each
possessing speciﬁc applications.181 We chose to limit ourselves to catalysts that are
easily accessible, in order to be able to scale up the reactions if they were to be used
for the total synthesis of polycyclic ethers.
82Modiﬁcations of the substrate
• Modiﬁcation of the terminal alkene
For all the reactions carried out so far, it seems that the mono substituted double bond
is too reactive towards isomerisation. One possible way to force the reaction towards
formation of the seven membered product was to modify the alkene to decrease its
reactivity towards isomerisation, whilst maintaining its metathesis activity. It was en 
visioned that attaching one or two substituents to the end of the double bond, creating
a di  or tri substituted alkene, would make this alkene far less prone to isomerise.
However, this had already been attempted previously in our group: when diene 273
was treated with Grubbs II catalyst, a mixture of six  and seven membered products
274 and 275 was obtained in 71% yield (Scheme 2.14). It was then decided to attach
a phenyl group to the terminus of the double bond. This was supposed to stabilise the
alkene in two ways: ﬁrst, making the alkene di substituted should decrease or eliminate
the energy gained when a mono substituted alkene was turned into a di substituted
one, and second, conjugation between the alkene and the aromatic ring should make
potential isomerisation even more unfavourable. Nevertheless, when the di substituted
substrate 276 was treated with Grubbs II catalyst, the same ratio of products was
observed.182
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Scheme 2.14: Initial modiﬁcation of terminal alkene. Conditions: a) Grubbs II, benzene, reﬂux.
For the target system, it was decided to position two methyl groups at the terminus
of the double bond to give a tri substituted double bond which should be more stable
than the potential isomerised product. The introduction of the gem dimethyl group
could be achieved by cross metathesis of alcohol 261 and 2 methyl 2 butene.183,184
However, it is also possible to prepare 5 bromo 2 methyl 2 pentene185 and with this in
hand, the sequence previously used for preparation of the enol ether 253 was repeated.
83Epoxidation of tri O benzyl D glucal followed by addition of the Grignard reagent gen 
erated from 5 bromo 2 methyl 2 pentene aﬀorded alcohol 279 directly and in modest
yield (Scheme 2.15). The secondary alcohol was transformed into the corresponding
alkynyl ether 280 using the two step protocol. Finally, alkyne carbocupration was per 
formed using a much simpler side chain than before in order to facilitate the reaction.
The diene 281 was obtained in poor yield, but enough material was produced to realise
a couple of RCM reactions.
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Scheme 2.15: Preparation of modiﬁed substrate. Conditions: a) Oxone, acetone, CH2Cl2, NaHCO3 aq,
0 ◦C to rt; b) (4-methylpent-3-enyl)magnesium bromide, THF, −20 ◦C, 25% (2 steps); c) KH,
trichloroethylene, Et2O, rt; d) nBuLi, Et2O, −78 ◦C to −45 ◦C, 70% (2 steps); e) CuBr, LiBr,
pentylmagnesium bromide, THF, −90 ◦C to −78 ◦C, 25%
Diene 281 was then treated with Grubbs II catalyst in both reﬂuxing benzene
and hot toluene (80 ◦C), but the substrate was completely unreactive towards those
metathesis conditions (Scheme 2.16). The tri susbtituted alkene was probably too
hindered for the metathesis reaction to initiate.
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Scheme 2.16: RCM reactions of diene 281
84• Relay metathesis strategy
The last approach envisioned for this project was based on a relay metathesis process.
The relay RCM concept was introduced by Hoye and co workers in the early part of this
decade.186–189 This process involves the design of substrates that allow one to dictate
the sequence of metathesis events by guiding the metal atom through the individual
steps of the RCM cascade. This approach is particularly useful for substrates that do
not react well under standard RCM conditions. The initial substrate is modiﬁed to
introduce a small chain that will react quickly with the ruthenium catalyst, which will
carry on the ﬁrst RCM, that will liberate a small molecule, usually cyclopentene or
dihydrofuran, to generate a new alkylidene ruthenium which will then react to form
the desired product (Scheme 2.17).
E E Grubbs I
CH2Cl2
Ru
E E
E E
Grubbs I
E E
Ru
CH2Cl2
Ru
E E
E E
E= CO2Et
66%
Scheme 2.17: An example of relay RCM
It was thought that in the case of triene 253, the ruthenium catalyst reacted with
the terminal alkene ﬁrst, but then could not realise the ring closure step. The relay 
RCM strategy would be used to modify the order of these events by ﬁrst generat 
ing the ruthenium carbene at the enol ether moiety. The resulting alkylidene would
then react quickly with the terminal alkene to generate the seven membered product
(Scheme 2.18).
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Scheme 2.18: Relay RCM strategy
Kleĳn and Vermeer reported the formation of tri substituted enol ethers by sequen 
tial 1,2 addition of an alkyl copper followed by quenching the vinyl copper intermediate
with various electrophiles, such as iodine and allyl bromide.190 To obtain the desired
relay RCM substrate, 1 iodo  or 1 bromo 4 pentene was the electrophile of choice. But
despite the use of various temperatures, reaction times and additives (HMPA), the
trisubstituted enol ether was never obtained (Scheme 2.19). Only the 1,1 di substituted
product was observed, resulting from the 1,2 addition followed by quenching of the vinyl
cuprate intermediate.
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Scheme 2.19: Attempts to generate polyene 284.
862.3 Summary and Outlook
In summary, selective formation of the six membered product has been accomplished
using a combination of two ruthenium catalysts: ﬁrst, the ruthenium hydride catalyst
RuCl(CO)H(PPh3) carried out a single isomerisation of the terminal mono substituted
double bond, then the Grubbs II catalyst cyclised the intermediate triene to give the
six membered cyclic enol ether as the sole product.
Despite investigating several strategies, the selective formation of the seven membered
ring has not been achieved. The terminal alkene is very prone to isomerisation and
no method has been found to avoid the Grubbs catalyst decomposing and isomerising
the alkene. The relay RCM approach is attractive, but the formation of the desired
substrate requires further investigation.
87Chapter 3
Synthesis of the A-D Fragment of
Gambieric Acid A
3.1 Introduction
The retrosynthetic strategy for the total synthesis of gambieric acid A 285 developed
in our laboratory is presented in Scheme 3.2. The nine membered ring F would be
formed by RCM of diene 286. The second allyl side chain required for the metathesis
step would be introduced from lactone 287 following Sasaki’s procedure.159 Finally,
lactone 287 would be obtained by alkylation of carboxylic acid derivative 288 and
iodide 289.
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Scheme 3.2: Retrosynthesis of gambieric acid A
Iodide 289, which represents the A D fragment of gambieric acid A, would be ac 
cessed from diol 290 (Scheme 3.3). The key secondary alcohol would be derived from
89the corresponding ketone 291. Coupling between iodide 292 and dithiane 293 would
give the complete skeleton of the A D fragment. The advantage of this strategy is that
by making the two diﬀerent enantiomers of the A ring, all four potential diastereomers
of the A D fragment would be accessible and available for spectroscopic comparison
with the natural product.
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Scheme 3.3: Retrosynthetic approach of the A-D fragment of gambieric acid A
Finally, the retrosynthesis of the B D fragment is described in Scheme 3.4. Dithiane
293 would be obtained from terminal alkene 294 after oxidative cleavage and dithiane
formation. The alkyl side chain would be introduced by alkylation of enone 295 via
an intermediate hydrazone. Retro RCM gave diene 296, which can be obtained by
nucleophilic substitution from alcohol 297. Alcohol 297 can result from opening on an
epoxide derived from enol ether 298. The C ring can be formed by RCM of the vinyl
ether 299. Epoxidation and epoxide opening of glucal 301 would give the required
alcohol 300. The starting material of this synthesis would be tri O acetyl D glucal
302, a derivative of D glucose, which is commercially available and reasonably priced.
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Scheme 3.4: Retrosynthetic analysis of B-D fragment.
Previous work in our group had realised the synthesis of the tricyclic enone 295 in
22 steps.182 However, some of the steps were quite low yielding especially towards the
end of the synthesis. The goals of this project were to prepare this enone, optimise the
problematic steps and investigate the coupling strategy with the A ring fragment.
3.2 Results and Discussion
3.2.1 Synthesis of Functionalised D Ring
Initial strategy
The synthesis started with commercially available tri O acetoxy D glucal 302. Com 
plete deacetylation using sodium methoxide followed by protection of the 1,2 diol with
a di tert butylsilyl group gave alcohol 303 (Scheme 3.5). The third hydroxyl group was
then protected as a triethylsilyl ether in very good overall yield. The enol ether 301
was then epoxidised stereoselectively using in situ generated DMDO and subsequent
91addition of allylmagnesium chloride opened the epoxide at the anomeric position to
deliver the alcohol 304.170 Using Swern conditions, the alcohol was oxidised to the cor 
responding ketone and the triethylsilyl ether was removed under oxidative conditions
(DDQ) to yield alcohol 305.191 The hydroxyl group was then removed in a two step
sequence: substitution by iodine using standard conditions then radical mediated re 
duction promoted by tri n butyltinhydride. This sequence aﬀorded ketone 306 in a
reasonable overall yield (47% over two steps). Nucleophilic addition of methylmagne 
sium iodide to ketone 306 gave both possible isomers in a 4:1 ratio in favour of the
desired isomer 300.
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Scheme 3.5: Preparation of alcohol 300. Conditions: a) MeONa, MeOH, rt; b) (tBu)2Si(OTf)2, DMF,
0 ◦C; c) TESCl, imidazole, DMF, rt, 86% (3 steps); d) Oxone, acetone, NaHCO3, CH2Cl2, H2O, 0 ◦C
to rt; e) allylmagnesium chloride, THF, 0 ◦C, 81% (2 steps); f) (COCl)2, DMSO, Et3N, CH2Cl2,
−78 ◦C, 87%; g) DDQ, THF, H2O, rt, 84%; h) PPh3, I2, imidazole, THF, rt; i) Bu3SnH, AIBN,
toluene, reﬂux, 47% (2 steps); j) MeMgI, toluene, −78 ◦C.
Assignment of the exact conﬁguration of the newly created tertiary alcohol was
originally accomplished by obtaining a crystal structure of the para nitrobenzoic ester
of the undesired isomer 307.182 Ester 308 was prepared by deprotonation of the alcohol
with n butyllithium followed by addition of para nitrobenzoyl chloride, aﬀording the
desired product in a modest 40% yield (Scheme 3.6).
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Scheme 3.6: Formation of ester 308. Conditions: a) nBuLi, pNO2-benzoyl chloride, THF, rt, 40%.
Revised route to ketone 306
The main problem with this ﬁrst strategy to obtain ketone 306 was the three step
sequence (TES deprotection, iodide formation and abstraction) necessary to remove the
hydroxyl group that is present in the starting material but not in the natural product.
The yield over the last two steps was moderate at best and involved the use of large
amount of highly toxic tin reagent. Furthermore, from a practical point of view, it was
quite diﬃcult to process large quantities of material. Due to reduction in molecular
weight during these three steps and the average yields, the mass of compound was
reduced to a quarter within three steps. Consequently, another strategy was envisioned
where the hydroxyl group would be removed at the beginning of the synthesis to avoid
the problems encountered above. The starting glucal 302 would be transformed into a
similar enol ether 309 without the additional hydroxyl group. Then the same sequence
as earlier (epoxidation, allylmagnesium chloride and Swern oxidation) would be applied
to give ketone 311. It was anticipated that the epoxidation would not be selective, but
epimerisation after the Swern oxidation would give only the desired isomer 306.
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Scheme 3.7: Revised synthetic approach towards ketone 306.
93Diol 309 was prepared in two steps according to a literature procedure.192 The tri 
O acetyl D glucal 302 was treated with methanol in the presence of boron triﬂuoride
diethyl etherate to aﬀord the mixed acetal 312 in high yield. Acetal 312 was then
treated with lithium aluminium hydride, which displaced the allylic methoxy group
and simultaneously deprotected the two acetate groups, to deliver diol 309 in excellent
yield (Scheme 3.8).
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Scheme 3.8: Preparation of diol 309. Conditions: a) BF3·Et2O, MeOH, CH2Cl2, rt, 88%; b) LiAlH4,
dioxane, reﬂux, 93%.
Two diﬀerent protecting groups were then used. First, two TBDMS groups were
installed in 64% yield (Scheme 3.9). The cyclic enol ether 313 was epoxidised using
in situ generated DMDO and a 7:3 mixture of the epoxides 314 was obtained. The
mixture was directly treated with allylmagnesium chloride and only one product 315
was isolated in very poor yield (9%). As the yield was so low, the conﬁguration of the
two stereocentres was not investigated.
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Scheme 3.9: Conditions: a) TBSCl, imidazole, DMF, rt, 64%; b) Oxone, acetone, NaHCO3 aq, CH2Cl2,
0 ◦C to rt, quant; c) allylmagnesium chloride, THF, 0 ◦C, 9%.
Diol 309 was also protected as the di tert butylsiloxane using the same conditions
as described previously (Scheme 3.10). It was also possible to use di tert butyldichloro 
silane, which is less expensive than the bis triﬂate, in presence of silver (I) nitrate. The
94dichlorosilane itself is not very reactive, so adding the silver complex creates the bis 
nitrate silane which is much more reactive. The enol ether 316 was then epoxidised
under the usual conditions to deliver a 55:45 mixture of both epoxides 317. Treatment
with allylmagnesium chloride gave a mixture of several diastereomers, from which one
alcohol 318 was isolated after column chromatography in 32% yield. After Swern
oxidation, the ketone 311 was conﬁrmed as having the undesired conﬁguration, so an
isomerisation step was necessary to yield the desired diastereomer. Reﬂuxing the ketone
311 in toluene with one drop of DBU for ﬁve hours led to signiﬁcant decomposition of
the starting material. Switching from DBU to proton sponge gave no reaction at all.
Finally, using a sub stoechiometric amount of DBU in toluene at room temperature
gave the desired ketone 306 in 61% yield.
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Scheme 3.10: Synthetic eﬀorts towards ketone 306. Conditions: a) (tBu)2SiOTf2, DMF, rt, 73% or
(tBu)2SiCl2, AgNO3, DMF, 0 ◦C, 67%; b) Oxone, acetone, NaHCO3 aq, CH2Cl2, 0 ◦C to rt, quant;
c) allylmagnesium chloride, THF, 0 ◦C, 32%; d) (COCl)2, DMSO, Et3N, CH2Cl2, −78 ◦C, 84%; e)
DBU, toluene, rt, 61%.
It was then decided to carry out the Swern oxidation directly on the crude mixture
obtained from the Grignard step. A 7:3 mixture of ketone 306 and 311 was obtained
in favour of the undesired diastereomer in an excellent 71% yield over three steps
(Scheme 3.11). The two diastereomers were separated by column chromatography, and
the undesired isomer 311 was then treated with DBU to obtain the isomer with the
correct conﬁguration.
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Scheme 3.11: Optimised route for the synthesis of ketone 306. Conditions: a) Oxone, acetone,
NaHCO3 aq, CH2Cl2, 0 ◦C to rt; b) allylmagnesium chloride, THF, 0 ◦C; c) (COCl)2, DMSO, Et3N,
CH2Cl2, −78 ◦C, 71% (3 steps), (306-311; 3:7); d) DBU, toluene, rt, 61%.
3.2.2 Formation of the C Ring
The introduction of the enol ether moiety required for the RCM was investigated. The
ﬁrst route used a three step sequence to functionalise the alcohol: formation of the
dichloroenol ether, then treatment with nBuLi to obtain the alkyne 320 and partial
hydrogenation with Lindlar’s catalyst to reduce it to the alkene 299 (Scheme 3.12).
The hydrogenation reaction had to be monitored carefully by NMR spectroscopy to
avoid any over hydrogenation of the allyl side chain.
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Scheme 3.12: Enol ether formation. Conditions: a) KH, Cl2CCHCl, THF, rt; b) nBuLi, Et2O, −78 ◦C
to −45 ◦C, 90% (2 steps); c) Lindlar’s catalyst, quinoline, EtOAc, H2, rt, 96%.
Even though this route worked very well (yields over 90% for each step), it was
time consuming and so shorter alternatives were explored.
A one step protocol developed by Bosch and Schlaf, using a vinyl ether transfer cata 
lysed by palladium bis(triﬂuoroacetate) in the presence of 4,7 diphenyl 1,10 phenan 
throline (DPP) was investigated.193 The authors reported some excellent results on
96primary and secondary alcohols, and good yields on tertiary alcohols. Since this re 
action is a thermodynamic equilibrium, a large excess of butylvinyl ether has to be
employed to drive the conversion of the starting material. Despite using butylvinyl
ether as the solvent in the reaction, the best yield obtained was 45%, along with 46%
of recovered starting material (Scheme 3.13). There were also some reproductibility
issues, as the yield would drop to 20% sometimes. Even though the starting material
was always recovered from this vinylation procedure, it was not considered to be a
viable alternative to the original route.
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Scheme 3.13: Palladium-catalysed vinyl ether transfer. Conditions: a) Pd(CF3CO2), DPP, butylvinyl
ether, reﬂux, 45% (84% BRSM).
Diene 299 was then treated with Grubbs’ second generation catalyst 92 to deliver
the cyclic enol ether 298 in excellent yield (Scheme 3.14).
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Scheme 3.14: Formation of C-D system. Conditions: Grubbs II catalyst 92, toluene, 80 ◦C, 95%.
3.2.3 Formation of Tricyclic Enone
Functionalisation of enol ether 298
The next steps involved the epoxidation of the enol ether moiety followed by nucle 
ophilic attack to introduce the two carbon unit necessary for the second RCM step.
Epoxidation was realised using DMDO, either using the in situ protocol or by prepar 
ing a DMDO solution in acetone. In this case, it was found that preparing the DMDO
solution then adding it onto the enol ether was preferable. Indeed, the epoxide gener 
ated seemed to be rather unstable, so shorter reaction times and cleaner reactions were
preferable. However, the DMDO solution had to be used as soon as the distillation was
ﬁnished and could not be kept in the freezer overnight.
97Based on the crude NMR, it was clear that the epoxidation was highly stereoselective
(d.r>9:1). It was postulated that the attack of the oxidising agent from the upper
face of the enol ether would lead to a unstable boat like transition state (pathway a),
whereas an approach from the lower face of the double bond (pathway b) would give a
much more stable chair like transition state (Scheme 3.15).
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Scheme 3.15: Epoxidation of enol ether 321. Conditions: DMDO, CH2Cl2, 0 ◦C, quant.
As a consequence of the stereoselective outcome of the epoxidation reaction, stan 
dard SN2 nucleophilic attack onto the epoxide would introduce the carbon chain with
the wrong conﬁguration at the ring junction. The initial protocol chosen to introduce
the two carbon unit was based on a report by van Boom and co workers.194 They de 
scribed the addition of various alkyne nucleophiles onto 1,2 anhydrosugar derivatives
mediated by ZnCl2 and obtained exclusively the cis product. They proposed a mech 
anism where an alkynylzinc 322 would activate an epoxide 323, which would then be
opened by a chlorine anion to give intermediate 324 (Scheme 3.16). This would be in
equilibrium with the oxonium cation 325 and intramolecular delivery would give the
α product 326.
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Scheme 3.16: Zinc-mediated syn-addition onto epoxides.
These conditions described above were applied to epoxide 321 using sodium acetylide
98as the nucleophile. After some reaction optimisation, the desired secondary alcohol 327
was obtained in 55% yield (Scheme 3.17). The alkyne was then partially hydrogenated
using Lindlar catalyst, to deliver alkene 328.
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Scheme 3.17: Synthesis of alcohol 328. Conditions: a) ZnCl2, NaCCH, Et2O, CH2Cl2, 0 ◦C to rt,
55%; b) Lindlar’s catalyst, quinoline, EtOAc, H2, rt, 84%.
It turned out that the reaction was very sensitive to the reaction conditions employed
and it was particurlarly important to warm the solution of epoxide and alkynylzinc very
slowly to room temperature, otherwise formation of a by product was observed. It is
believed that this by product was ketone 329, resulting from a 1,2 hydride shift as
previously observed by Rainier in related reactions (Scheme 3.18).195
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Scheme 3.18: Byproduct formation.
Although the yield of alcohol 328 was acceptable, other possible methods for intro 
duction of the desired side chain were considered. The direct zinc catalysed addition of
a vinyl Grignard reagent onto a glycal epoxide had been reported to give good yields by
Wei and co workers.196 However, when applied to our system, the product was obtained
in just 27% yield as a 1:1 mixture of α and β isomers (Scheme 3.19).
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Scheme 3.19: Conditions: a) ZnCl2, vinylmagnesium bromide, THF, 0 ◦C to rt, 27%.
99Wipf and co workers have reported the syn addition of vinylzirconocenes onto glycal
epoxides.197 For our system, the simple 1 hexyne was chosen as the reagent. Although
an extra four carbon chain would be introduced, it would be lost during the RCM
step. Upon submission of the epoxide to the literature procedure, none of the required
product was isolated (Scheme 3.20).
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Scheme 3.20: Conditions: a) AgClO4/Celite, CH2Cl2, 0 ◦C to rt .
Enyne RCM strategy
Another strategy to obtain alcohol 328, involving an enyne metathesis reaction, was
explored. It was envisaged that alcohol 328 would be obtained from diene 331 by a
sequence of chemoselective epoxidation and reductive opening (Scheme 3.21). Diene
331 would be formed by ring closing metathesis of enyne 320.
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Scheme 3.21: Enyne RCM approach towards alcohol 328
The previously synthesised alkynyl ether 320 was treated with Grubbs II catalyst in
toluene under an atmosphere of ethylene to deliver diene 331 in excellent yield. Treat 
ment of diene 331 with DMDO solution gave the crude epoxide 332, which was treated
with a variety of reductive agents (Super Hydride, Et3SiH, NaBH3CN). Unfortunately,
all of these reagents led to the decomposition of the starting material. Even though this
type of reaction has been described several times in the literature, the allylic character
of the reactive site might be problematic in this case.
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Scheme 3.22: Synthetic eﬀorts towards alcohol 328. Conditions: a) Grubbs II, toluene, ethylene,
80 ◦C, 90%; b) DMDO, CH2Cl2, 0 ◦C, quant; c) Super-Hydride or Et3SiH or NaBH3CN.
Enone metathesis
The synthesis continued from alcohol 328 (Scheme 3.23). The conﬁguration of the sec 
ondary alcohol was corrected using a two step sequence: oxidation to give the ketone
using Dess Martin periodinane198 and subsequent sodium borohydride reduction deliv 
ered the desired alcohol 297 in excellent yield over two steps. The trans conﬁguration
was conﬁrmed by analysis of the coupling constants (3J = 9.2 Hz).
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Scheme 3.23: Progress towards the B ring. Conditions: a) DMP, CH2Cl2, rt; b) NaBH4, MeOH,
CH2Cl2, 90% (2 steps).
The enone side chain required for the construction of the seven membered B ring was
introduced using a procedure developed by Cossy and co workers.199 Alcohol 297 was
ﬁrst alkylated with chlorophosphorane 333,200 then treated with an aqueous solution
of formaldehyde to deliver bicyclic enone 296 (Scheme 3.24). Exposure of the diene to
Grubbs II catalyst in reﬂuxing dichloromethane aﬀorded the tricyclic B D system 295
in 84%.
101O
H
H
O
Si
O O
H
Me
HO
H
H
297
O
333
O
H
H
O
Si
O O
H
Me
O
H
H
296
O
H
H
O
Si
O O
H
Me H
H
295
O
O
a, b
c
O
PPh3 Cl +
Scheme 3.24: Formation of tricyclic enone 295. Conditions: a) phosphorane 333, NaH, (nBu)4NI,
THF, reﬂux; b) CH2Oaq, Et2O, buﬀer pH=7, rt, 63%; c) Grubbs II catalyst 92, CH2Cl2, reﬂux, 84%.
A shorter alternative for the introduction of the enone moiety required for the RCM
step was investigated. Minehan and co workers reported the formation of α alkoxy
ketones by alkylation of alcohols with α diazoketones mediated by In(OTf)3. Two
diﬀerent diazoketones 335 and 337 were prepared from 3 bromopropanoic acid 334
according to literature procedures (Scheme 3.25).201 These diazoketones were then
reacted in the presence of alcohol 297 and In(OTf)3 or RuCl2(PPh3)3.202 None of the
desired alkylated products 336 and 296 were isolated for these reactions.
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Scheme 3.25: Conditions: a) (COCl)2, PhH, 38 ◦C, then CH2N2, Et2O, 0 ◦C to rt, 18%; b)
DBN polymer-bound, hydroquinone, 0 ◦C; c) alcohol 297, In(OTf)3, toluene, rt; d) alcohol 297,
RuCl2(PPh3)3, benzene, rt.
Enone 295 was a white solid, which could be recrystallised from EtOAc and gave
crystals suitable for X ray crystallography. The X ray structure conﬁrmed the exact
102conﬁguration of all the stereocentres created during the synthesis (Figure 3.2).
Figure 3.2: X-ray structure of enone 295
3.2.4 Functionalisation of B-D System
Alkylation of enone 295
Direct alkylation of 3 oxo α,β unsaturated ketones is not very common but has been re 
ported once by Cossy and co workers with methyl iodide as an electrophile.203 However,
direct application of their conditions (LDA, allyl bromide, HMPA) led to decomposition
of the starting material (Scheme 3.26) and so alternative strategies were investigated.
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Scheme 3.26: Attempt of direct alkylation of enone 295. Conditions: LDA, allyl bromide, HMPA,
THF, −78 ◦C.
• Hydrazone pathway
The ﬁrst strategy for the introduction of the required allyl side chain onto the seven 
membered ring that was explored relied on formation and alkylation of a hydrazone.
This strategy had already been used in our group with great success.204,205 Transfor 
ming the unsaturated ketone moiety into the corresponding hydrazone reduces the
risk of 1,4 addition of the base during the deprotonation step. First, enone 295 was
heated in toluene with an excess of 1 aminopiperidine using a Dean Stark apparatus
(Scheme 3.27). The resulting hydrazone 339 was then treated with t butyllithium at
low temperature, followed by an addition of excess allyl bromide. The crude product
was reacted with copper(II) chloride in aqueous THF to cleave the hydrazone and
aﬀord the alkylated enone 338 in low yield (19% over 2 steps). The enone was isolated
103as a 5:1 mixture in favour of the undesired isomer and so the epimerisation of the
newly created centre was investigated. It was discovered that DBU was suitable for
this reaction and gave an 8:1 mixture favouring the desired cis product.
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Scheme 3.27: Hydrazone pathway. Conditions: a) 1-aminopiperidine, toluene, 100 ◦C; b) tBuLi,
allylbromide, THF, −100 ◦C to −78 ◦C; c) CuCl2, THF, H2O, 19% (dr = 1:5) (3 steps); d) DBU,
CH2Cl2, rt, 68% (dr = 8:1).
The absolute conﬁguration at the new stereocentre was initially assigned based on
previous results obtained in our group concerning this type of compound.204,205 It has
been noted that the chemical shifts of the alkene protons of the trans product 338b
are always higher than the chemical shifts of the cis product 338a (Scheme 3.28). This
was consistent with the epimerisation step where the cis product 338a is expected to
be the thermodynamic product.
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Scheme 3.28: NMR characteristics of epimers 338a and 338b.
104• Tsuji allylation
Clearly, this sequence of hydrazone formation and alkylation was not eﬃcient enough
to pursue the synthesis. Consequently, a second approach was investigated, using the
Tsuji allylation reaction.
In 1983, Tsuji and co workers reported the α allylation of ketone via a decarboxyla 
tive palladium catalysed rearrangement (Scheme 3.29).206 Cyclohexanone 340 was ﬁrst
deprotonated and treated with allylchloroformate to furnish the allyl enol carbonate
341. When the carbonate was reacted with a source of Pd0, the palladium inserted
into the C O bond to generate a π allyl palladium complex 342, which was followed
by decarboxylation to give intermediate 343. Nucleophilic attack of the enolate onto
the electrophilic π allyl complex delivered the alkylated product 344.
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Scheme 3.29: Mechanism of the decarboxylative Tsuji rearrangement. Conditions: a) tBuOK, al-
lylchloroformate, DMF, rt; b) Pd2dba3·CHCl3, PPh3, DME, rt, 91%.
This reaction has several advantages: it is very regioselective and alkylation will only
occur where the ketone has been originally deprotonated. There is no isomerisation
of the enolate, even though the reaction is conducted at room temperature. Only one
alkylation will occur per reaction. This reaction requires Pd2(dba)3, which is fairly
stable and widely available. Finally, it is a very powerful reaction for the construction
of quaternary centers.
However, its use in organic chemistry has been limited until two groups recently rein 
vestigated this reaction and developed enantioselective versions. Stoltz and co workers
105reported the ﬁrst enantioselective Tsuji allylation reaction,207 using the phosphino 
oxazoline ligand (S) tBu PHOX 345, a P/N ligand previously used in other enantio 
selective palladium catalysed reactions.208–210 They reported the formation of quater 
nary stereogenic centers with excellent stereocontrol (ee = 82 92%) and very high yields
(85 96%) (Scheme 3.30).
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Scheme 3.30: Tsuji enantioselective version by Stoltz and co-workers. Conditions: a) Pd2dba3, ligand
345, THF, rt.
They also investigated the use of TMS enol ethers as starting materials and obtained
the desired alkylated ketones in high yield and enantioselectivity. The allyl side chain
was introduced from diallylcarbonate and tetrabutylammonium diﬂuorotriphenylsili 
cate (TBAT) was used as an initiator to generate a reactive enolate (Scheme 3.31).
The TMS enol ethers are usually easier to prepare than corresponding enol allyl car 
bonate, so this represented a useful alternative.
OTMS O
a
Scheme 3.31: Allylation of TMS enol ethers. Conditions: a) diallylcarbonate, TBAT, Pd2(dba)3,
ligand 345, THF, rt, 95%, 87 % ee.
A few months later, Trost and co workers reported another enantioselective ver 
sion of the Tsuji allylation reaction.211 The reaction conditions were very similar
to Stoltz’s except that Trost used the C2 symmetrical bis phosphine 346, a ligand
he had developed previously for his palladium catalysed allylic alkylation reactions
(Scheme 3.32).212
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Scheme 3.32: Enantioselective Tsuji reaction developed by Trost and co-workers. Conditions: a)
Pd2(dba)3, ligand 346, toluene, rt.
Even though there were few examples of application of this method to α,β unsaturated
ketones or seven membered rings, this methodology appeared to be a potentially eﬃ 
cient method for the introduction of the desired side chain.
First, formation of the allyl enol carbonate was investigated (Scheme 3.33). The
original conditions developed by Trost involved the use of NaHMDS to deprotonate
the ketone and TMEDA to favour the O alkylation against the C alkylation. After
15 to 30 min at −78 ◦C, allylchloroformate was added and the reaction was complete
within 15 min. Where Trost and Stoltz reported very high yields using these reaction
conditions (> 80%), the average yield obtained was 55% along with 20% of starting
material. Although the products are supposedly fairly stable on silica gel, it was found
that the isolated yield was variable even though the analysis of the crude mixture by
TLC was consistent. This problem was solved by drying the silica gel overnight in an
oven to remove traces of water.
Some optimisation studies were performed to improve the yield of this reaction and it
was found that Barbier type conditions, in which the enone 295 and allylchloroformate
were cooled down to −78 ◦C and then the base was added, were better and increased the
yield of the required enol allyl carbonate 347 to 80%. It was also found that TMEDA
was not necessary for our substrate. Because of the presence of the oxygen atom at the
β position and the alkene which is conjugated with the enolate, the O enolate form is
probably more reactive than the C enolate and so no additive is required to achieve
complete O allylation.
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Scheme 3.33: Formation of allyl enol carbonate 347. Conditions: a) allylchloroformate, NaHMDS,
THF, −78 ◦C, 80%, 95% BRSM.
Following identiﬁcation of optimised reaction conditions to form the carbonate 347,
the palladium catalysed rearrangement reaction was explored. The reaction was per 
formed initially without a chiral ligand: Pd2(dba)3·CHCl3, PPh3 in toluene. After 3
h at room temperature, the desired alkylated enone 338 was isolated in 67% as a 3:2
mixture in favour of the required isomer (Scheme 3.34). Low stereoselectivity of the
reaction can be explained by the planar conﬁguration of the diene 347, which oﬀers
little conformational preference for the attack at either face. An important by product
348 was also isolated in 27% yield and was assigned as the allyl enol ether resulting
from the O alkylation product.
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Scheme 3.34: Tsuji rearrangement reaction of carbonate 346 with a non-chiral ligand. Conditions: a)
Pd2(dba)3·CHCl3, PPh3, toluene, rt.
Although it was known that the mixture of products could be epimerised to give
the desired isomer exclusively, chiral ligands were probed in order to obtain a single di 
astereomer from the rearrangement reaction. Based on the original studies, it appeared
that the chiral ligand should possess S conﬁguration in order to deliver the desired cis
isomer 338a. Both the Trost and Stoltz ligand systems were tested. Initially, the
Trost bis phosphine ligand 346 was screened in oxygenated solvents (dioxane, DME),
108but the substrate 347 was completely unreactive under these conditions. Switching
to toluene gave the rearranged product in 81% 6.1:1 ratio in favour of the desired
isomer 338a and none of the O alkylated product as observed (Scheme 3.35). Al 
ternatively, the carbonate 347 was treated with the conditions developed by Stoltz
and co workers: Pd2(dba)3 and the phosphino oxazoline ligand 345. NMR analysis of
the crude product indicated an excellent diastereomeric ratio (95:5) and after column
chromatography, only the desired isomer 338a was obtained in 87% yield. However,
free dibenzylideneacetone from the original palladium complex eluted at the same Rf
as the product and it was impossible to separate it from the product, so it was decided
to carry onto the next step with this mixture.
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Scheme 3.35: Stereoselective Tsuji rearrangement of carbonate 347. Conditions: a) Pd2(dba)3, ligand
346, toluene, rt, 81% (338a-338b = 6.1:1); b) Pd2(dba)3, ligand 345, toluene, rt, 87% (pure 338a).
Rearrangement via the TMS enol ether was also investigated. Treatment of enone
295 with TMSOTf and triethylamine gave the desired TMS enol ether 349 in excellent
yield (Scheme 3.36). However, application of the literature reaction conditions failed
to deliver any of the desired alkylated product 338a, but led to the cleavage of the
TMS enol ether and recovery the enone 295.
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Scheme 3.36: Conditions: a) TMSOTf, Et3N, THF, rt, 94%; b) Pd2(dba)3, ligand 345, diallylcarbon-
ate, TBAT, THF, rt.
• Preparation of chiral ligand 345
The (S) tBu PHOX ligand 345 appeared as the best ligand for this reaction. Even
though the ligand is commercially available, this reaction would be expensive if it
were to be repeated on larger scale. Stoltz and co workers reported a short and
practical preparation of this ligand. The synthesis starts with the chiral pool ma 
terial, the (S) tert leucinol 350, which is coupled with 2 bromobenzoyl chloride 351
to give the corresponding amide (Scheme 3.37). Formation of the primary tosylate
followed by cyclisation gave the oxazoline ring 352. Finally, copper mediated arylation
of diphenylphosphine gave the desired chiral ligand 345.
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Scheme 3.37: Conditions: a) Na2CO3, CH2Cl2, H2O, rt, 94%; b) TsCl, Et3N, CH2Cl2, rt, then H2O,
75%; c) CuI, DMEDA, Ph2PH, CsCO3, toluene, 110 ◦C, 62%.
110Completion of B D fragment
With the side chain in place, only a few steps involving functional group manip 
ulation were required to complete the synthesis of the B D fragment. First, the
enone was reduced under Luche conditions to deliver alcohol 353 as a single diastere 
omer (Scheme 3.38). The exact conﬁguration of the new stereogenic center could
not be veriﬁed by NMR analysis (coupling constant or NOE studies) at this stage,
but based on numerous literature precedents, it was consistent with the required R 
conﬁguration.205,213,214 The secondary alcohol was then protected as the TBS ether 354
in high yield. At this stage, analysis of the coupling constants at the newly created
stereocenter revealed a trans conﬁguration (3J = 8.6 Hz). Chemoselective dihydroxyla 
tion of the terminal double bond was then carried out using OsO4 and NMO. To avoid
the disubstituted endocyclic alkene reacting, only 1.05 equivalent of NMO was used
and the reaction was not pushed to completion. The desired diol 355 was obtained in
reasonable yield (54%) and most of the rest of the starting material was recovered. The
diol was subsequently cleaved under oxidative conditions and the resulting aldehyde
was immediately treated with 1,3 propanedithiol and BF3·Et2O to deliver the dithiane
356. The latter reaction was carried out at low temperature −30 ◦C to avoid any
cleavage of the TBS ether.215 The dithiane 356 represents the complete B D fragment
of gambieric acid A.
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Scheme 3.38: Completion of the B-D fragment. Conditions: a) CeCl3·7H2O, NaBH4, MeOH, CH2Cl2,
rt, 95%; b) TBSOTf, 2,6-lutidine, CH2Cl2, rt, 82%; c) OsO4, NMO, THF, H2O, rt, 54%, 78% BRSM;
d) NaIO4, THF, H2O, rt; e) 1,3-propanedithiol, BF3·Et2O, CH2Cl2, −30 ◦C, 53% (2 steps).
The A ring fragment had been previously prepared within the group (see 1.4.3).167,216
The synthesis used (L) malic acid 357 as the starting material and the desired iodide
358 was obtained in 15 steps (Scheme 3.39). The advantage of the synthesis was that
both isomers of malic acid are commercially available, so both enantiomers of iodide
358 would be accessible.
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Scheme 3.39: Preparation of iodide 358 by Dr S. Chaudhury.
The coupling reaction of the dithiane 356 and the iodide 358 was then tested. The
112dithiane 356 was cooled down to −78 ◦C in THF, before t butyllithium was added.
Unfortunately, no colour change was observed and it is known that dithiane anions are
usually brown. HMPA and iodide 358 were added to the reaction mixture anyway, but
none of the coupled product 359 was obtained after two hours (Scheme 3.40).
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Scheme 3.40: Coupling reaction between dithiane 356 and iodide 358. Conditions: a) tBuLi, HMPA,
THF, −78 ◦C.
3.2.5 Revised Approach to the A-D Fragment
The new strategy
The failure of the coupling reaction led to the design of a new strategy for the coupling
of both units. The development of the previous strategy showed that the Tsuji reaction
is a very powerful tool to create the stereocentre on the seven membered B ring while
introducing a side chain. This time, it was imagined that the Tsuji reaction would
be used to introduce the whole A ring fragment in one step instead of a simple allyl
unit (Scheme 3.41). Carbonate 361 should rearrange in presence of Pd0 to deliver the
enone 362. This intermediate would possess the complete carbon skeleton of the A D
fragment and the corresponding protected alcohol 363 would be obtained in two steps.
Selective dihydroxylation followed by oxidative cleavage and hydrogenation would then
give the ketone 364. At this point, the ﬁrst possibility would be to deprotect the
secondary alcohol and then perform hydroxy directed reduction of the ketone to obtain
alcohol 365. It would also be possible to perform the reduction ﬁrst to obtain the
other diastereomer in high selectivity and then deprotect the alcohol to give the other
diastereomer 366.
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Scheme 3.41: Second-generation synthesis of the A-D fragment.
Model studies
The formation of carbonate 361 is the ﬁrst challenging step of this new synthetic se 
quence. There is a limited number of ways in the literature to generate enol carbonates
from functionalised allylic alcohols. To start with, the alcohol must be transformed
into an activated carbonate which will later react with an enolate anion. The ﬁrst
option is to treat the allylic alcohol with trisphosgene and pyridine to generate the
chlorocarbonate (Scheme 3.42).217 The other possibility is to react the allylic alcohol
with CDI to form an allyl 1H imidazole 1 carboxylate .218
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Scheme 3.42: Various options to generate carbonate 361.
These sets of conditions were ﬁrst explored using a model system. The model allylic
alcohol was prepared in two steps from valeraldehyde 367. First, a Mannich reaction
was used to introduce the exocyclic alkene219 and subsequent Luche reduction delivered
allylic alcohol 368 in excellent yield (Scheme 3.43).
O
H a, b OH
367 368
Scheme 3.43: Synthesis of alcohol 368. Conditions: a) Me2NH·HCl, CH2Oaq, 70 ◦C; b) CeCl3·7H2O,
NaBH4, MeOH, CH2Cl2, rt, 89% (2 steps).
The formation of the corresponding chlorocarbonate was then attempted following
the literature conditions, but the expected product was not obtained (Scheme 3.44).
Considering the high toxicity of triphosgene, this route was not pursued further.
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Scheme 3.44: Conditions: a) Triphosgene, pyridine, toluene, 0 ◦C.
The other method required much milder reagents. When treated with an excess
of CDI, alcohol 368 aﬀorded the allyl 1H imidazole 1 carboxylate 370 in good yield
(Scheme 3.45). The success of the reaction meant it could be utilised for the required
coupling sequence.
115OH
368
a
O
370 O
N
N
Scheme 3.45: Formation of carboxylate 370. Conditions: a) CDI, THF, rt, 88%.
With the carboxylate in hand, the formation of the enol allyl carbonate was explored.
A model enone system was also employed for the purposes of preliminary studies.
Enone 371 had already been described in the literature by our group and has been
prepared in large amounts by another member of the group.204 The original conditions
described by Trost and co workers were applied to the model system: ketone 371 was
ﬁrst deprotonated with NaHMDS, then a solution of carboxylate 370 and BF3·Et2O in
THF was added to the reaction mixture (Scheme 3.46).218 The desired carbonate 372
was obtained initially in a modest 30% yield.
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Scheme 3.46: First attempt to synthesise the carbonate 372. Conditions: a) BF3·Et2O, NaHMDS,
THF, −78 ◦C, 30%.
Optimisation studies were performed in order to increase the yield. It was found
that minor changes in the reaction protocol had an important eﬀect on the yield. Pre 
mixing the enone 371 and the carboxylate 370 together in THF at −78 ◦C before
adding the NaHMDS and the BF3·Et2O gave an improved 55% yield. It was also
possible to pre mix the carboxylate 370 and BF3·Et2O for 1 h in THF before adding
it onto the enolate solution; again a 55% yield was obtained.
The nature of the Lewis acid was also investigated. During alkylation reactions,
it is known that the enolate will react with a soft electrophile to give a C acylated
product, whereas hard electrophiles will give an O acylated product. According to
Trost and co workers, a Lewis acid is required to coordinate the imidazole ring and
increase its electrophilic character, hence turning the 1H imidazole 1 carboxylate into
an hard electrophile. The reaction was ﬁrst tested in the absence of a Lewis acid, and,
as expected, a mixture of C  and O acylation products was obtained in very poor yield
(Scheme 3.47).
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Scheme 3.47: Conditions: a) NaHMDS, THF, −78 ◦C, 11%.
Addition of various Lewis acids to the reaction was then explored. Because of
the presence of various functional groups capable of binding a Lewis acid (e.g. car 
bonyl, ethers), a Lewis acid possessing a high aﬃnity of nitrogen atoms was required.
Kobayashi and co workers recently screened a variety of metal chlorides on aldehydes
and aldimines and classiﬁed them depending on their selectivity.220 Several of these
azaphilic Lewis acids were then tested on our model system. Sc(OTf)3, FeCl3 and
CuCl2 gave very low yield (Table 3.1). In the presence of InCl3, carbonate 372 was
isolated in 22% yield. The results of this study were disappointing and so it was decided
to continue using BF3·Et2O as the Lewis acid.
O O
O O
H H
H
+ O
O
N
N NaHMDS
Lewis acid O O
O O
H H
H
O
O
371 372
370
THF
-78 °C
Entry Lewis acid Yield Entry Lewis acid Yield
1 Sc(OTf)3 0% 3 CuCl2 6%
2 FeCl3 3% 4 InCl3 22%
Table 3.1: Screening of Lewis acids for the preparation of carbonate 372.
The second reaction parameter to be probed was the nature of the base used to
deprotonate the enone. For alkylation reactions, it is known that large counter cations
favour the O alkylation, so KHMDS was the logical choice. The potassium enolate
of enone 371 had been shown to be highly reactive and unstable. Therefore, the two
previous sets of conditions developed for NaHMDS were combined: the carboxylate
117370 was pre mixed with BF3·Et2O for 1 h, then cooled down to −78 ◦C. The enone
371 in THF was then added and ﬁnally the KHMDS was introduced in the reaction
mixture. This procedure allowed the isolation of carbonate 372 in an isolated yield of
69% (Scheme 3.48). The puriﬁcation of carbonate 372 had to be done using dry silica
gel to avoid any decomposition.
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Scheme 3.48: Conditions: a) BF3·Et2O, KHMDS, THF, −78 ◦C, 69%.
The carbonate 372 was then submitted to the standard conditions used for palladium 
catalysed rearrangement. However, on this occasion there was no reaction and the
starting material was recovered. The Pd2(dba)3 was changed for another source of
Pd0: Pd(PPh3)4. There were some concerns about potential loss of selectivity because
Pd(PPh3)4 is itself capable of promoting the rearrangement reaction. However, con 
sidering that the chiral ligand is bidentate, and therefore better ligand than PPh3, it
was envisioned that by pre mixing the catalyst and an excess of ligand for a prolonged
period of time, this problem should be avoided. Using this new palladium catalyst, the
rearrangement reaction proceeded very well, and after 2 h at room temperature, the
desired alkylated enone 374 was isolated in 69% yield as a 7:1 mixture favouring the
desired diastereomer (Scheme 3.49).
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Scheme 3.49: Palladium-catalysed rearrangement of carbonate 372. Conditions: a) Pd(PPh3)4, ligand
345, THF, rt, 69%.
Towards the synthesis of the A D fragment
The optimised conditions for the key coupling steps were then applied to the target
system. Carboxylate 377 was prepared following a similar strategy as for compound
371 by a member of our group (Scheme 3.50).
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Scheme 3.50: Preparation of coupling partner 377 by Dr S. Chaudhury.
The formation of the carbonate 361 was then carried out. Despite using the op 
timum conditions for either NaHMDS or KHMDS, the best yield achieved was only
31% (Scheme 3.51). Signiﬁcant amounts of both starting materials were recovered,
meaning that enone 295 and carboxylate 377 did not decompose but failed to react.
It is possible that the amount of BF3·Et2O should be increased because of the presence
of many more chelating groups than in the model system. At this point, it was not
possible to separate the product 361 from the strating material enone 295 by column
chromatography and so it was decided to perform the next step using this mixture
because the enone 295 should be unreactive towards the reaction conditions.
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Scheme 3.51: Conditions: a) BF3·Et2O, KHMDS, THF, −78 ◦C, 31%.
The carbonate 361 was then treated with Pd(PPh3)4 and the chiral phosphino 
oxazoline 345 (Scheme 3.52). NMR analysis of the crude mixture revealed a complete
diastereoselectivity (> 95:5). The desired enone 362 was isolated in 57% yield. Some
non alkylated enone 295 was also isolated, half of it came from the starting mixture but
the other half came from the rearrangement reaction: once the π allyl enolate palladium
119is formed, the enolate can be quenched by a proton to return the non alkylated enone
295 back.
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Scheme 3.52: Conditions: a) Pd(PPh3)4, ligand 345, THF, rt, 57%.
With the whole carbon skeleton of the A D fragment in hand, the synthesis was con 
tinued. First, a Luche reduction gave the corresponding allylic alcohol (Scheme 3.53).
The conﬁguration of the stereocentre was assigned based on previous observations (see
chap. 3.2.4). Tha alcohol was protected as the TBS ether 363 under the same con 
ditions as before. Chemoselective dihydroxylation of the 1,1 disubstituted alkene was
then performed using the conditions employed previously because it was known that
the 1,2 disubstituted endocyclic alkene would not be reactive under these conditions.
Conversion only reached 50%, but extended reaction times or additional NMO could
further increase the consumption of starting material. The diol 378 was then treated
with Pd/C under H2 atmosphere to hydrogenate the alkene, and the diol was cleaved
with sodium periodate to deliver ketone 364.
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Scheme 3.53: Conditions: a) CeCl3·7H2O, NaBH4, MeOH, CH2Cl2, rt, 98%; b) TBSOTf, 2,6-lutidine,
CH2Cl2, rt, 85%; c) OsO4, NMO, THF, H2O, rt, 49%; d) Pd/C, EtOH, H2, rt; e) NaIO4, EtOH, H2O,
rt, 55% (2 steps).
The ﬁnal steps of the synthesis consisted in the reduction of the ketone to the
secondary alcohol and the removal of the TBS ether in the presence of the bis tBu silyl
ether. It was decided to reduce the ketone 364 with sodium borohydride to obtain the
two possible diastereomers and compare their spectroscopic data to that of Sasaki’s
products.152 The reduction was quantitative, although it was not possible to determine
the ratio of the two diastereomers (Scheme 3.54). For the selective deprotection step,
a procedure by Mori and co workers was used.221 Wet TsOH failed to remove the TBS
ether, but another sulfonic acid, (+) CSA, in a mixture of MeOH and CH2Cl2 was
found to be eﬃcient for this reaction. After the reaction, it was possible to observe
two distinct spots on TLC: due to intramolecular hydrogen bonds, the two diols 365
and 366 have quite diﬀerent polarities. Unfortunately, it was not possible to isolate
enough material to obtain satisfactory NMR spectra.
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Scheme 3.54: Final steps of the A-D fragment synthesis. Conditions: a) NaBH4, MeOH, CH2Cl2, rt;
b) (+)-CSA, MeOH, CH2Cl2, rt.
3.3 Future Work
The synthesis needs to be repeated on larger scale to obtain signiﬁcant amounts of
alcohols 365 and 366. After comparison with the original spectroscopic data and with
Sasaki’s work, it should be possible to determine the absolute conﬁguration of the nat 
ural product. Once this is done, some work remains to be done on the eastern part
of the fragment to prepare it for coupling with the G J system, especially the intro 
duction the second angular methyl group (379→380), which could be done following
Sasaki’s procedure (Scheme 3.55).222 After one carbon homologation of alcohol 380
and iodination, the iodide 381 should be ready for coupling with the G J unit.
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Scheme 3.55: Future work.
123Chapter 4
Experimental Part
4.1 General conditions
NMR spectra were recorded on a Bruker 400 MHz Spectrospin spectrometer (1H NMR
at 400 MHz and 13C NMR at 100 MHz). Chemical shifts are reported in ppm. 1H NMR
spectra were recorded with CDCl3 as solvent using (δ = 7.26) as internal standard, and
for 13C NMR spectra, the chemical shifts are reported relative to the central resonance
of CDCl3 (δ = 77.16). Signals in NMR spectra are described as singlet (s), doublet (d),
triplet (t), quartet (q), multiplet (m), broad (br) or a combination of these, which refers
to the spin spin coupling pattern observed. DEPT 135 and two dimensional (COSY,
HSQC) NMR spectroscopy were used where appropriate to assist the assignment of
signals in the 1H and 13C NMR spectra.
IR spectra were recorded using a JASCO FT/IR 4100 using NaCl plates or a
Shimadzu FTIR 8400 without any preparation. High resolution mass spectra were
recorded under EI, CI and FAB conditions by the analytical services at the University
of Glasgow. Elemental analyses were carried out using an Exeter Analytical Elemen 
tal Analyser EA 440. Melting points were recorded with an Electrothermal IA 9100
apparatus. Optical rotations were determined on solutions of samples and irradiating
with the sodium D line (λ = 589 nm) using an Autopol V polarimeter. [α]D values are
given in units 10−1 deg cm2 g−1.
Column chromatography was performed under pressure using silica gel (Fluorochem
LC60A, 35−70 µ) as solid support and HPLC grade solvents as eluent. Reactions
were monitored by thin layer chromatography (TLC) on Merck silica gel 60 covered
aluminium plates F254. TLC plates were developed under UV light and/or with a
KMnO4 solution (3 g of KMnO4, 20 g K2CO3, 5 mL 5% NaOH(aq) and 300 mL H2O)
or acidic ethanolic anisaldehyde solution (formed by dissolving 15 g of anisaldehyde in
250 mL ethanol and 2.5 mL conc. sulfuric acid). Liquid reagents were distilled prior
124to use if necessary. All reagents were purchased from commercial suppliers and used
without further puriﬁcation unless otherwise stated. Reactions involving air sensitive
agents and dry solvents were performed in glassware that had been ﬂame dried prior
to use and were carried out under an argon atmosphere.
4.2 Experimental details
(2R,3S,4R)-3,4-Bis(benzyloxy)-2-(benzyloxymethyl)-3,4-dihydro-2H-pyran :
260
5 5
4 4 3 3
2 2
1 1 O
OBn
BnO
6 6
O
7 7
8 8
11 11
10 10
9 9
C27H28O4
Molecular weight: 416.5 g.mol−1
To a solution of tri O acetyl α D glucal (10.0 g, 36.8 mmol) in MeOH (40 mL) was
added sodium methoxide (104 mg, 1.80 mmol). The reaction mixture was stirred at rt
for 45 min and concentrated under reduced pressure to aﬀord the crude triol (5.50 g,
36.8 mmol, quant.) which was used without further puriﬁcation.
To a suspension of degreased NaH (5.88 g, 147 mmol) in THF (140 mL) was added
a solution of crude triol (5.50 g, 36.8 mmol) in DMF (40 mL). The solution was stirred
for 30 min at rt, then cooled to 0 ◦C and BnBr (15.4 mL, 129 mmol) was added. The
solution was allowed to warm to rt and stirred for 2 h. The reaction was quenched by
the addition of MeOH (5 mL) and H2O (50 mL). The aqueous phase was extracted
with Et2O (2 × 150 mL) and the combined organic phases were washed with brine
(2 × 100 mL), dried (MgSO4) and concentrated under reduced pressure. The residue
was puriﬁed by ﬂash column chromatography (PE Et2O; 100:1→85:15) to give the pro 
tected triol 260 (14.8 g, 35.5 mmol, 96%) as a white solid.
Rf = 0.45 (PE Et2O; 1:1)
m.p. = 56−57 ◦C, lit.223 m.p. = 56−57 ◦C
[α]D (23.5 ◦C, CHCl3) = −1.8 (c = 1.04), lit.223 [α]D (21 ◦C, CHCl3) = −2.9 (c = 1.2)
IR : νmax 3063, 3030, 2866, 1647, 1497, 1453, 1238 cm−1.
1H NMR : δ 7.34−7.22 (15H, m, CH C Arom), 6.43 (1H, dd, J = 6.1, 0.8 Hz, CH C1),
4.88 (1H, dd, J = 6.1, 2.6 Hz, CH C2), 4.84 (1H, d, J = 7.2 Hz, CH2 C7a), 4.64 (2H,
d, J = 7.2 Hz, CH2 C7b and CH2 C7’a), 4.57 (3H, m, CH2 C7’b and CH2 C7”), 4.21
(1H, ddd, J = 6.2, 2.6, 0.8 Hz, CH C3), 4.06 (1H, ddd, J = 8.6, 4.9, 2.9 Hz, CH C5),
3.86 (1H, dd, J = 8.6, 6.2 Hz, CH C4), 3.81 (1H, dd, J 10.7, 4.9 Hz, CH2 C6a), 3.76
(1H, dd, J = 10.7, 2.9 Hz, CH2 C6b).
12513C NMR : δ 144.8 (CH C1), 138.4 (C C8), 138.2 (C C8’), 138.0 (C C8”), 128.5 (2
CH Arom), 128.4 (2 CH Arom), 128.4 (3 CH Arom), 128.0 (2 CH Arom), 127.9 (2
CH Arom), 127.8 (2 CH Arom), 127.7 (2 CH Arom), 100.0 (CH C2), 76.8 (CH C5),
75.8 (CH C3), 74.4 (CH C4), 73.8 (CH2 C7), 73.6 (CH2 C7’), 70.5 (CH2 C7”), 68.6
(CH2 C6).
MS (EI) : m/z (Int) 253 (100), 163 (80), 91 (100).
(2S,3S,4R,5R,6R)-4,5-Bis(benzyloxy)-6-(benzyloxymethyl)-2-(but-3-enyl)
tetrahydro-2H-pyran-3-ol : 261
5 5
4 4 3 3
2 2
1 1 O
OBn
BnO
6 6
O
7 7
OH
8 8
11 11
10 10
9 9
12 12
13 13
14 14
15 15 C31H36O5
Molecular weight: 488.6 g.mol−1
To a vigorously stirred biphasic solution of tri O benzyl D glucal 260 (2.6 g, 6.2
mmol) in CH2Cl2 (20 mL), acetone (2 mL) and a saturated aqueous solution of NaHCO3
(50 mL) at 0 ◦C, was added a solution of Oxone (11 g, 18 mmol) in H2O (35 mL). The
mixture was stirred vigorously at 0 ◦C for 30 min and then at rt for an additional 2
h. The aqueous phase was extracted with CH2Cl2 (2 × 30 mL). The combined organic
phases were dried (Na2SO4) and concentrated under reduced pressure to the crude
aﬀord epoxide (2.7 g, quant.) as a white solid.
To a solution of epoxide (2.7 g, 6.2 mmol) in THF (53 mL), cooled to −20 ◦C, was
added a solution of butenylmagnesiumbromide (25 mL, 12 mmol) in THF. The solu 
tion was stirred for 2 h at −20 ◦C. The solution of butenylmagnesiumbromide (12 mL)
was added and the solution was stirred for another 1 h at −20 ◦C. The reaction was
quenched with a saturated aqueous solution of NH4Cl (12 mL) and the mixture was
extracted with Et2O (3 × 20 mL). The combined organic phases were dried (MgSO4)
and concentrated under reduced pressure. The residue was puriﬁed by ﬂash column
chromatography (PE Et2O; 3:1) to give the alcohol 261 (1.0 g, 2.1 mmol, 34%) as a
colourless oil.
Rf = 0.44 (PE Et2O; 1:2)
[α]D (23.8 ◦C, CHCl3) = +25.4 (c = 0.99)
IR : νmax 3477, 2932, 2867, 1496, 1454, 1324, 1206, 1075 cm−1.
1H NMR : δ 7.30−7.14 (15H, m, CH Arom), 5.83 (1H, dddd, J = 17.0, 10.2, 6.6,
6.6 Hz, CH C14), 5.03 (1H, dddd, J = 17.0, 1.6, 1.6, 1.6 Hz, CH2 C15a), 4.95 (1H,
dd, J = 10.2, 1.6 Hz, CH2 C15b), 4.68 (1H, d, J = 11.8 Hz, CH2 C7a), 4.63 (1H,
126d, J = 11.4 Hz, CH2 C7’a), 4.57 (1H, d, J = 11.8 Hz, CH2 C7b), 4.57 (1H, d, J =
12.1 Hz, CH2 C7”a), 4.56 (1H, d, J = 11.4 Hz, CH2 C7’b), 4.51 (1H, d, J = 12.1 Hz,
CH2 C7”b), 3.98 (1H, ddd, J = 5.0, 5.0, 5.0 Hz, CH C5), 3.89 (1H, ddd, J = 9.6, 4.0,
4.0 Hz, CH C1), 3.82−3.78 (1H, m, CH C4), 3.75−3.69 (2H, m, CH C3 and CH2 C6a),
3.66−3.62 (2H, m, CH C2 and CH2 C6b), 2.82 (1H, d, J = 7.9 Hz, OH), 2.31−2.23
(1H, m, CH2 C13a), 2.21−2.11 (1H, m, CH2 C13b), 1.90−1.80 (1H, m, CH2 C12a),
1.76−1.68 (1H, m, CH2 C12b).
13C NMR : δ 138.3 (CH C14), 138.2 (C C8), 138.1 (C C8’), 137.5 (C C8”) 128.6 (2
CH Arom), 128.5 (3 CH Arom), 128.4 (2 CH Arom), 127.9 (3 CH Arom), 127.8 (3 CH
Arom), 127.6 (2 CH Arom), 114.8 (CH2 C15), 78.1 (CH), 75.2 (CH), 73.5 (CH2 C7),
73.3 (CH2 C7’), 73.2 (CH), 73.0 (CH2 C7”), 71.1 (CH), 69.7 (CH), 68.2 (CH2 C6), 29.7
(CH2 C13), 27.4 (CH2 C12).
MS (EI) : m/z (Int) 489 (79), 293 (12), 257 (10), 209 (9), 154 (100), 107 (45). HRMS
(C31H36O5
+) : calculated : 489.2641; obtained : 489.2640, (  = 0.2 ppm).
(2R,3R,4S,5S,6S)-3,4-Bis(benzyloxy)-2-(benzyloxymethyl)-6-(but-3-enyl)-
5-ethynyloxytetrahydro-2H-pyran : 262
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C33H36O5
Molecular weight: 512.6 g.mol−1
To a suspension of KH (0.27 g, 2.0 mmol) in Et2O (3.5 mL) was added a solution of
alcohol 261 (0.40 g, 0.82 mmol) in Et2O (2.9 mL). The reaction mixture was stirred for
10 min at rt, then cooled to 0 ◦C. After the addition of a solution of trichloroethylene
(89 µL, 1.0 mmol) in Et2O (1 mL), the reaction mixture was warmed to rt and stirred
for 1 h. The reaction mixture was cooled to −78 ◦C and a solution of n butyllithium
(1.7 mL, 2.7 mmol) in pentane was added dropwise. The reaction mixture was stirred
30 min at −78 ◦C, allowed to warm to −45 ◦C and stirred for another 45 min. The
reaction was quenched with MeOH (1 mL) and a satured aqueous solution of NH4Cl
(10 mL). The aqueous layer was extracted with Et2O (3 × 10 mL) and the combined
organic phases were washed with brine (10 mL), dried (MgSO4) and concentrated under
reduced pressure. The residue was puriﬁed by ﬂash column chromatography (PE Et2O;
10:1, 1% Et3N) to give the alkynylether 262 (0.29 g, 0.57 mmol, 69%) as a colourless
oil.
Rf = 0.59 (PE Et2O; 1:1)
127[α]D (22.4 ◦C, CHCl3) = +21.2 (c = 1.05)
IR : νmax 3321, 2931, 2856, 2150, 1497, 1453, 1356, 1095, 914, 735 cm−1.
1H NMR : δ 7.40−7.24 (15H, m, CH Arom), 5.84 (1H, dddd, J = 17.0, 10.3, 6.6, 6.6
Hz, CH C14), 5.07 (1H, dddd, J = 17.0, 1.5, 1.5, 1.5 Hz, CH2 C15a), 5.00 (1H, dd, J
= 10.3, 1.5 Hz, CH2 C15b), 4.89 (1H, d, J = 10.8 Hz, CH2 C7a), 4.79 (1H, d, J = 10.8
Hz, CH2 C7’a), 4.72 (1H, d, J = 10.8 Hz, CH2 C7b), 4.60 (1H, d, J = 12.0 Hz, CH2 
C7”a), 4.48 (1H, d, J = 12.0 Hz, CH2 C7”b), 4.47 (1H, d, J = 10.8 Hz, CH2 C7’b),
4.32−4.28 (2H, m, CH C1 and CH C5), 3.84 (1H, t, J = 8.4 Hz, CH), 3.70−3.58 (4H,
m, CH and CH2 C6), 2.28−2.20 (1H, m, CH2 C13a), 2.19−2.06 (1H, m, CH2 C13b),
1.84−1.66 (2H, m, CH2 C12), 1.59 (1H, s, CH C17).
13C NMR : δ 138.2 (C C8), 138.1 (C C8’), 138.1 (C C8”), 137.7 (CH C14), 128.8 (2
CH Arom), 128.7 (3 CH Arom), 128.6 (2 CH Arom), 128.1 (3 CH Arom), 128.0 (3
CH Arom), 127.8 (2 CH Arom), 115.6 (CH2 C15), 90.0 (C C16), 87.8 (CH C1 or C5),
80.7 (CH), 77.7 (CH), 75.5 (CH2 C7), 75.3 (CH2 C7’), 73.7 (CH2 C7”), 72.3 (CH C5
or C1), 71.6 (CH), 68.9 (CH2 C6), 29.3 (CH2 C13), 27.3 (CH C17), 24.3 (CH2 C12).
MS (CI) : m/z (Int) 513 (32), 471 (47), 363 (95), 255 (54), 147 (100), 107 (100), 91
(83). HRMS (C33H37O5
+) : calculated : 513.2641; obtained : 513.2634, (  = 1.4 ppm).
(3-Bromobut-3-enyloxy)dimethylphenylsilane : 264
Br 3 3
2 2
4 4
1 1
O
Si
6 6
5 5
9 9
8 8
7 7
C12H17BrOSi
Molecular weight: 285.3 g.mol−1
To a solution of 3 bromo 3 buten 1 ol 263 (1.0 g, 6.6 mmol) in CH2Cl2 (20 mL)
cooled to 0 ◦C was added DMAP (80 mg, 0.66 mmol), Et3N (2.7 mL, 20 mmol)
and chlorodimethylphenylsilane (1.2 mL, 6.9 mmol). The mixture was stirred at rt
overnight. The reaction was quenched by the addition of H2O (10 mL). The organic
phase was washed with brine (10 mL), dried (MgSO4) and concentrated under reduced
pressure. The residue was puriﬁed by ﬂash column chromatography (PE Et2O; 99:1)
to give the silylether 264 (1.6 g, 5.8 mmol, 87%) as a colourless oil.
Rf = 0.72 (PE Et2O; 1:1)
IR : νmax 2956, 1631, 1428, 1253, 1098 cm−1.
1H NMR : δ 7.52−7.48 (2H, m, CH Arom), 7.34−7.28 (3H, m, CH Arom), 5.54 (1H,
dt, J = 1.6, 1.0 Hz, CH2 C4a), 5.38 (1H, d, J = 1.6 Hz, CH2 C4b), 3.71 (2H, t, J =
6.4 Hz, CH2 C1), 2.55 (2H, td, J = 6.4, 1.0 Hz, CH2 C2), 0.32 (6H, s, CH3 C5).
12813C NMR : δ 139.4 (C), 135.3 (CH Arom), 132.4 (C), 131.5 (CH Arom), 129.7 (CH
Arom), 120.4 (CH2 C4), 62.6 (CH2 C1), 46.3 (CH2 C2), 0.0 (CH3 C5).
MS (CI) : m/z (Int) 287 (77), 285 (77), 271 (10), 269 (10), 209 (18), 207 (18), 165
(100), 135 (15), 130 (9). HRMS (C12H18BrOSi+) : calculated : 285.0310; obtained :
285.0313, (  = 1.1 ppm).
3-(Dimethylphenylsilyl)but-3-en-1-ol : 265
Si 3 3
2 2
4 4
1 1
OH 6 6
5 5
7 7
8 8
9 9
C12H18OSi
Molecular weight: 206.4 g.mol−1
From vinyl bromide 264: To a solution of vinylbromide 264 (2.0 g, 7.0 mmol) in
THF (9 mL) cooled to −78 ◦C was added a solution of t butyllithium (8.8 mL, 14
mmol) in pentane (1.6 M). The solution was stirred for 30 min at −78 ◦C, then was
allowed to warm to −45 ◦C and was stirred for another hour at this temperature.
The reaction was quenched with a saturated aqueous solution of NH4Cl (10 mL) and
extracted with Et2O (10 mL). The organic phase was washed with brine (2 × 10 mL),
dried (MgSO4) and concentrated under reduced pressure. The residue was puriﬁed by
ﬂash column chromatography (PE Et2O; 2:1) to give the alcohol 265 (1.1 g, 5.3 mmol,
76%) as a colourless oil.
From 3 butyn 1 ol: To a solution of NaI (4.3 g, 29 mmol) in MeCN (20 mL) was
added TMSCl (3.6 mL, 29 mmol) and H2O (260 µL, 14 mmol). The reaction mixture
was stirred for 10 min and a solution of 3 butyn 1 ol (1.0 g, 14 mmol) in MeCN (5
mL) was added. After 1 h at rt, H2O (15 mL) was added and the aqueous layer was
extracted with EtOAc (3 × 20 mL). The combined organic phases were dried (Na2SO4)
and concentrated under reduced pressure. The residue was puriﬁed by ﬂash column
chromatography (PE Et2O; 5:1→3:1) to give the vinyl iodide 270 (1.4 g, 7.1 mmol,
51%) as a brown oil, which was used directly into the next step.
To a solution of vinyl iodide 270 (450 mg, 2.3 mmol), DMAP (28 mg, 0.23 mmol) and
Et3N (0.94 mL, 6.8 mmol) in CH2Cl2 (7 mL) cooled to 0 ◦C was added chlorodimethylphe 
nylsilane (380 µL, 2.3 mmol) dropwise. The reaction was stirred at rt overnight and the
reaction mixture was concentrated under reduced pressure. The residue was ﬁltered on
a small plug of silica gel (PE Et2O; 99:1) to give the corresponding silylether (0.76 g,
2.3 mmol), as a colourless oil, which was used directly into the next step.
To a solution of vinyliodide (0.76 g, 2.3 mmol) in THF (12 mL) cooled to −78 ◦C
129was added a solution of t butyllithium (2.8 mL, 4.5 mmol) in hexane. The solution was
stirred for 30 min at −78 ◦C, then allowed to warm to −45 ◦C and stirred for another
1 h at this temperature. The reaction was quenched by the addition of a saturated
aqueous solution of NH4Cl (10 mL) and extracted with Et2O (3 × 20 mL). The or 
ganic phase was washed with brine (20 mL), dried (MgSO4) and concentrated under
reduced pressure. The residue was puriﬁed by ﬂash column chromatography (PE Et2O;
5:1;→3:1) to give the alcohol 265 (280 mg, 1.4 mmol, 61% over 2 steps) as a colourless
oil.
Rf = 0.31 (PE Et2O; 1:1)
IR : νmax 3336, 2955, 1427, 1249, 1111, 1046 cm−1.
1H NMR : δ 7.54−7.50 (2H, m, CH Arom), 7.39−7.35 (3H, m, CH Arom), 5.79 (1H,
dt, J = 2.8, 1.4 Hz, CH2 C4a), 5.57 (1H, dt, J = 2.8, 0.7 Hz, CH2 C4b), 3.56 (2H, t, J
= 6.6 Hz, CH2 C1), 2.41 (2H, tdd, J = 6.6, 1.4, 0.7 Hz, CH2 C2), 1.39 (1H, br s, OH),
0.41 (6H, s, CH3 C5).
13C NMR : δ 146.8 (C C3), 137.8 (C C6), 133.8 (CH Arom), 129.2 (CH C9), 128.9
(CH2 C4), 127.9 (CH Arom), 61.4 (CH2 C1), 39.3 (CH2 C2),  3.0 (CH3 C5).
MS (EI) : m/z (Int) 191 (22), 152 (6), 137 (100), 135 (63), 84 (42), 75 (32). HRMS
(C11H15OSi+) : calculated : 191.0892; obtained : 191.0896, (  = 2.1 ppm).
(4-Bromobut-1-en-2-yl)dimethylphenylsilane : 266
Si 3 3
2 2
4 4
1 1
Br 6 6
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9 9
C12H17BrSi
Molecular weight: 269.3 g.mol−1
To a solution of alcohol 265 (0.87 g, 4.2 mmol) and CBr4 (2.1 g, 6.3 mmol) in
CH2Cl2 (42 mL) cooled to 0 ◦C was added triphenylphosphine (3.3 g, 13 mmol). The
solution was stirred for 1 h at rt. Silica gel was added directly to the reaction mixture
and the solvent removed under reduced pressure. The residue was puriﬁed by ﬂash
column chromatography (PE Et2O; 250:1) to give the bromide 266 (1.1 g, 4.0 mmol,
95%) as a colourless oil.
Rf = 0.71 (PE Et2O; 1:1)
IR : νmax 2957, 1428, 1250, 1112 cm−1.
1H NMR : δ 7.53−7.48 (2H, m, CH Arom), 7.39−7.35 (3H, m, CH Arom), 5.77 (1H,
dt, J = 2.3, 1.3 Hz, CH2 C4a), 5.55 (1H, dt, J = 2.3, 1.3 Hz, CH2 C4b), 3.31 (2H,
t, J = 8.0 Hz, CH2 C1), 2.66 (2H, tdd, J = 8.0, 1.3, 1.3 Hz, CH2 C2), 0.40 (6H, s,
130CH3 C5).
13C NMR : δ 147.4 (C C3), 137.4 (C C6), 133.9 (CH Arom), 129.3 (CH C9), 128.5
(CH2 C4), 127.9 (CH Arom), 39.2 (CH2 C2), 31.8 (CH2 C1),  3.1 (CH3 C5).
MS (EI) : m/z (Int) 255 (11), 253 (11), 201 (18), 199 (18), 135 (35), 84 (100), 77 (31),
49 (80).
(But-3-ynyloxy)dimethyl(phenyl)silane : 268a
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C12H16OSi
Molecular weight: 204.3 g.mol−1
To a solution of 3 butyn 1 ol (0.40 g, 5.7 mmol) in CH2Cl2 (17 mL) cooled to 0 ◦C was
added DMAP (70 mg, 0.57 mmol), Et3N (2.4 mL, 17 mmol) and chlorodimethylphenyl 
silane (1.0 mL, 6.0 mmol). The reaction was stirred at rt for 3 days and then quenched
with H2O (10 mL). The organic phase was washed with brine (2 × 10 mL), dried
(MgSO4) and concentrated under reduced pressure. The residue was puriﬁed by ﬂash
column chromatography (PE Et2O; 99:1) to give the silylether 268a (0.94 g, 4.6 mmol,
81%) as a colourless oil.
Rf = 0.66 (PE Et2O; 1:1)
IR : νmax 3296, 2959, 1429, 1253, 1096, 828, 789 cm−1.
1H NMR : δ 7.60−7.57 (2H, m, CH Arom), 7.42−7.36 (3H, m, CH Arom), 3.72 (2H,
t, J = 7.1 Hz, CH2 C1), 2.41 (2H, td, J = 7.1, 2.6 Hz, CH2 C2), 1.96 (1H, t, J = 2.6
Hz, CH C4), 0.40 (6H, s, CH3 C5).
13C NMR : δ 139.3 (C C6), 135.3 (CH Arom), 131.6 (CH C9), 129.7 (CH Arom), 83.2
(C C3), 71.3 (CH C4), 63.3 (CH2 C1), 24.4 (CH2 C2), 0.0 (CH3 C5).
MS (CI) : m/z (Int) 205 (100), 165 (31), 153 (11), 127 (18). HRMS (C12H17OSi+) :
calculated : 205.1049; obtained : 205.1048, (  = 0.5 ppm).
1-((But-3-ynyloxy)methyl)-4-methoxybenzene : 268b
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C12H14O2
Molecular weight: 190.2 g.mol−1
To a suspension of degreased NaH (0.22 g, 5.6 mmol) and nBu4NI (63 mg, 0.17
mmol) in THF (17 mL) at 0 ◦C was added 3 butyn 1 ol (0.30 mg, 4.3 mmol). The so 
131lution was stirred for 20 min at 0 ◦C and p methoxybenzylchloride (1.4 mL, 10 mmol)
was added. The reaction mixture was stirred for 24 h at rt, then quenched with MeOH
(0.5 mL) and diluted with water (40 mL). The aqueous phase was extracted with Et2O
(3 × 20 mL) and the combined organic phases were washed with brine (20 mL), dried
(MgSO4) and concentrated under reduced pressure. The residue was puriﬁed by ﬂash
column chromatography (PE Et2O; 95:5) to give the protected alcohol 268b (0.51 g,
2.6 mmol, 61%) as a colourless oil.
Rf = 0.63 (PE Et2O; 1:1)
IR : νmax 3292, 2863, 1613, 1512, 1244, 1173, 1093, 1033, 820 cm−1.
1H NMR : δ 7.26 (2H, d, J = 8.6 Hz, CH Arom), 6.87 (2H, d, J = 8.6 Hz, CH Arom),
4.49 (2H, s, CH2 C5), 3.80 (3H, s, CH3 C10, 3.57 (2H, t, J = 7.0 Hz, CH2 C1), 2.48
(2H, td, J = 7.0, 2.5 Hz, CH2 C2), 1.98 (1H, t, J = 2.5 Hz, CH C4).
13C NMR : δ 159.3 (C C9), 130.1 (C C6), 129.4 (CH C7), 113.8 (CH C8), 81.4 (C 
C3), 72.7 (CH2 C5), 69.3 (CH3 C10), 67.8 (CH2 C1), 55.3 (CH C4), 19.9 (CH2 C2).
MS (EI) : m/z (Int) 190 (38), 159 (43), 135 (71), 121 (100), 77 (40).
(But-3-ynyloxy)(tert-butyl)diphenylsilane : 268c
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C20H24OSi
Molecular weight: 308.5 g.mol−1
To a solution of 3 butyn 1 ol (0.60 mL, 7.9 mmol) and DMAP (90 mg, 0.72 mmol)
in CH2Cl2 (9 mL) cooled to 0 ◦C was added Et3N (1.5 mL, 11 mmol) and chloro 
tert butyldiphenylsilane (1.9 mL, 7.3 mmol) dropwise. The reaction was stirred at rt
overnight and then ﬁltrated on a small pad of silica gel (PE Et2O; 9:1) to give the silyl
ether 268c (2.3 g, 7.3 mmol, quant.) as a colourless oil.
Rf = 0.67 (PE Et2O; 1:1)
IR : νmax 3006, 2931, 2858, 1473, 1428, 1105, 823, 700 cm−1.
1H NMR : δ 7.70−7.67 (4H, m, CH Arom), 7.42−7.36 (6H, m, CH Arom), 3.79 (2H,
t, J = 7.1 Hz, CH2 C1), 2.46 (2H, td, J = 7.1, 2.5 Hz, CH2 C2), 1.95 (1H, t, J = 2.5
Hz, CH C4), 1.06 (9H, s, CH3 C11).
13C NMR : δ 135.6 (CH Arom), 133.6 (C C6), 129.7 (CH C9), 127.7 (CH Arom), 81.5
(C C3), 69.4 (CH C4), 62.3 (CH2 C1), 26.8 (CH3 C11), 22.6 (CH2 C2), 19.2 (C C10).
MS (FAB) : m/z (Int) 309 (29), 251 (100), 221 (100), 197 (65), 159 (53), 136 (83),
106 (53). HRMS (C20H25OSi+) : calculated : 309.1675; obtained : 309.1665, (  = 3.2
132ppm).
(3-Bromobut-3-enyloxy)(tert-butyl)diphenylsilane : 269
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Br C20H25BrOSi
Molecular weight: 389.4 g.mol−1
To a solution of silylether 268c (1.1 g, 3.7 mmol) in CH2Cl2 (30 mL) at 0 ◦C was
added a freshly prepared solution of 9 Br 9 BBN (5.6 mL, 5.6 mmol) in CH2Cl2.224
The reaction mixture was stirred at rt for 3 days, then cooled to 0 ◦C and acetic acid
(5 mL) was added. The mixture was stirred for 1 h at 0 ◦C before a saturated aque 
ous solution of NaOH (10 mL) and a solution of H2O2 (30 %wt in water, 5 mL) were
added. The reaction mixture was stirred for another 1.5 h at rt. The aqueous phase
was extracted with CH2Cl2 (2 × 20 mL), and the combined organic phases were dried
(MgSO4) and concentrated under reduced pressure. The residue was puriﬁed by ﬂash
column chromatography (PE Et2O; 9:1) to give a mixture of the vinyl bromide 269
(0.59 g) and TBDPSOH.
3-Bromo-3-buten-1-ol : 263
4 4
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OH Br
C4H7BrO
Molecular weight: 151.0 g.mol−1
To a solution of silylether 269 (0.59 g, 1.5 mmol) in THF at 0 ◦C was added a solu 
tion of TBAF (2.3 mL, 2.3 mmol) in THF (1 M). The reaction mixture was stirred at rt
for 30 min and then diluted with H2O (10 mL). The aqueous phase was extracted with
Et2O (2 × 10 mL) and the combined organic phases were washed with brine (20 mL),
dried (MgSO4) and concentrated under reduced pressure. The residue was puriﬁed by
ﬂash column chromatography (PE Et2O; 1:1) to give the bromo alcohol 263 (75 mg,
0.5 mmol, 14% over two steps) as an orange oil.
Rf = 0.21 (PE Et2O; 1:1)
IR : νmax 3338, 2948, 2885, 1629, 1420, 1204, 1127, 1046, 888 cm−1.
1H NMR : δ 5.71 (1H, s, CH2 C4a), 5.54 (1H, s, CH2 C4b), 3.82 (2H, br s, CH2 C1),
2.67 (2H, t, J = 5.8 Hz, CH2 C2), 1.56 (1H, br s, OH).
13313C NMR : δ 130.6 (C C3), 119.6 (CH2 C4), 60.2 (CH2 C1), 44.5 (CH2 C2).
MS (EI) : m/z (Int) 152 (31), 150 (32), 135 (67), 133 (71), 122 (98), 120 (100), 82
(60), 53 (63).
5-[(2S,3S,4S,5R,6R)-4,5-Bis(benzyloxy)-6-(benzyloxymethyl)-2-(but-3-
enyl)-tetrahydro-2H-pyran-3-yloxy]hexa-1,5-dien-2-yldimethyl(phenyl)silane
: 253
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Molecular weight: 703.0 g.mol−1
CuBr (0.10 g, 0.71 mmol) and LiBr (62 mg, 0.71 mmol) were dried at 60 ◦C for 4
h under high vacuum. THF (4.6 mL) was added and the solution cooled to −90 ◦C.
To this was added a solution (0.5 M in THF) of the Grignard reagent prepared from
bromide 266 (1.4 mL, 0.71 mmol) and the reaction mixture was stirred for 10 min
at −90 ◦C. Alkyne 263 (0.24 g, 0.47 mmol) in THF (4.7 mL) was then added and
the solution was warmed to −78 ◦C then stirred at this temperature for 45 min. The
reaction was quenched by the addition of a solution of NH4OH (10% in a saturated
aqueous solution of NH4Cl) (3 mL) and the aqueous phase was extracted with Et2O (2
× 15 mL). The combined organic phases were dried (Na2SO4) and concentrated under
reduced pressure. The residue was puriﬁed by ﬂash column chromatography (PE Et2O;
100:0.5, 1% Et3N) to give the enol ether 253 (200 mg, 0.29 mmol, 61%) as a colourless
oil.
Rf = 0.38 (PE Et2O; 4:1)
[α]D (25.1 ◦C, CHCl3) = +33.6 (c = 1.51)
IR : νmax 2947, 2864, 1453, 1248, 1098, 816 cm−1.
1H NMR : δ 7.46−7.06 (20H, m, CH Arom), 5.84 (1H, dddd, J = 17.0, 10.3, 6.6, 6.6
Hz, CH C9), 5.65 (1H, d, J = 2.3 Hz, CH2 C16a), 5.38 (1H, d, J = 2.3 Hz, CH2 C16b),
4.98 (1H, dddd, J = 17.0, 1.5, 1.5, 1.5 Hz, CH2 C10a), 4.92 (1H, dddd, J = 10.3, 1.5,
1.5, 1.5 Hz, CH2 C10b), 4.75 (2H, d, J = 10.7 Hz, CH2 C22), 4.63 (1H, d, J = 11.0
Hz, CH2 C22’a), 4.60 (1H, d, J = 12.1 Hz, CH2 C22”a), 4.47 (1H, d, J = 12.1 Hz,
CH2 C22”b), 4.40 (1H, d, J = 11.0 Hz, CH2 C22’b), 4.28−4.19 (2H, m, 2 CH), 4.01
(1H, d, J = 2.2 Hz, CH2 C12a), 3.87 (1H, d, J = 2.2 Hz, CH2 C12b), 3.78 (1H, t, J
= 8.6 Hz, CH), 3.70−3.54 (4H, m, 2 CH and CH2 C1), 2.30−2.26 (2H, m, CH2 C8a),
2.16−2.07 (3H, m, CH2 and CH2 C8b), 2.02−1.94 (1H, m, CH2), 1.78−1.68 (1H, m,
134CH2 C13a), 1.45−1.31 (1H, m, CH2 C13b), 0.29 (6H, s, CH3 C17).
13C NMR : δ 161.2 (C C11), 149.6 (C C15), 138.8 (C C23), 138.6 (CH C9), 138.3
(C C23’), 138.2 (C C23”), 138.2 (C C18), 134.0 (CH Arom), 133.8 (CH Arom), 129.1
(CH Arom), 128.6 (2 CH Arom), 128.5 (2 CH Arom), 128.5 (2 CH Arom), 128.3 (2
CH Arom), 128.1 (2 CH Arom), 128.0 (2 CH Arom), 127.9 (CH Arom), 127.9 (2 CH
Arom), 127.8 (CH Arom), 127.7 (CH Arom), 126.0 (CH2 C16), 114.9 (CH2 C10), 82.6
(CH2 C12), 81.7 (CH), 77.9 (CH), 76.8 (CH), 75.4 (CH2 C22), 75.2 (CH2 C22’), 73.7
(CH2 C22”), 72.1 (CH), 71.1 (CH), 69.2 (CH2 C1), 35.0 (CH2), 33.7 (CH2), 33.6 (CH2),
24.3 (CH2),  2.9 (CH3 C17).
MS (FAB) : m/z (Int) 725 (16), 363 (14), 271 (9), 181 (100), 136 (99), 93 (95), 92
(95). HRMS (C45H54O5SiNa+) : calculated : 725.3638; obtained : 725.3637, (  = 0.1
ppm).
4-[(4aS,6R,7R,8S,8aS)-7,8-Bis(benzyloxy)-6-(benzyloxymethyl)-4,4a,6,7,
8,8a-hexahydropyrano[3,2-b]pyran-2-yl]but-1-en-2-yldimethyl(phenyl)silane
: 255
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Molecular weight: 660.9 g.mol−1
To a solution of enol ether 253 (65 mg, 93 µmol) in benzene (2 mL) was added
RuCl(CO)H(PPh3)3 (1.0 mg, 1.0 µmol). The solution was stirred at reﬂux for 10 min,
then benzene (18 mL) and Grubbs second generation catalyst (7.9 mg, 9.0 µmol) were
added. The reaction mixture was stirred for 2 h at reﬂux, then concentrated under
reduced pressure. The residue was puriﬁed by ﬂash column chromatography (PE Et2O;
98:2, 1% Et3N) to give the cyclic enol ether 255 (35 mg, 53 µmol, 57%) as a colourless
oil.
Rf = 0.24 (PE Et2O; 4:1)
[α]D (25.8 ◦C, CHCl3) = +49.1 (c = 1.41)
IR : νmax 2917, 2859, 1681, 1453, 1248, 1065, 815, 775, 731, 695 cm−1.
1H NMR : δ 7.40−7.02 (20H, m, CH Arom), 5.60 (1H, s, CH2 C13a), 5.34 (1H, s,
CH2 C13b), 4.71 (2H, d, J = 12.0 Hz, CH2 C19a and 19’a), 4.57−4.52 (2H, m, CH2 
C19b and CH2 C19”a), 4.43 (1H, d, J = 12.0 Hz, CH2 C19’b), 4.36 (1H, d, J = 10.8
Hz, CH2 C19”b), 4.28 (1H, br s, CH C8), 4.25−4.20 (1H, m, CH C6), 4.07 (1H, dd, J
= 8.7, 5.3 Hz, CH C5), 3.71 (1H, t, J = 8.7 Hz, CH C4), 3.69 (1H, m, CH), 3.63−3.50
135(3H, m, CH and CH2 C1), 2.33−2.16 (3H, m, CH2), 2.01−1.94 (3H, m, CH2), 0.27 (6H,
s, CH3 C14).
13C NMR : δ 151.1 (C C9), 149.3 (C C12), 138.4 (C C20), 138.1 (C C20’), 138.0 (C 
C20”), 137.8 (C C15), 133.8 (2 CH Arom), 128.9 (3 CH Arom), 128.3 (2 CH Arom),
128.6 (CH Arom), 128.2 (2 CH Arom), 128.0 (3 CH Arom), 127.9 (CH Arom), 127.8
(CH Arom), 127.7 (3 CH Arom), 127.6 (2 CH Arom), 125.9 (CH2 C13), 91.5 (CH C8),
79.6 (CH C4), 77.7 (CH C2 or C3), 75.1 (CH C5), 74.9 (CH2 C19), 74.7 (CH2 C19’),
73.5 (CH2 C19”), 72.0 (CH C3 or C2), 69.1 (CH2 C1), 67.5 (CH C6), 33.1 (CH2 C10
or C11), 33.0 (CH2 C11 or C10), 20.6 (CH2 C7),  2.9 (CH3 C14).
MS (EI) : m/z (Int) 660 (11), 569 (10), 269 (26), 181 (19), 135 (87), 91 (100). HRMS
(C42H48O5Si+) : calculated : 660.3271; obtained : 660.3273, (  = 0.3 ppm).
(2S,3S,4R,5R,6R)-4,5-Bis(benzyloxy)-6-(benzyloxymethyl)-2-(4-methyl
pent-3-enyl)tetrahydro-2H-pyran-3-ol: 279
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Molecular weight: 516.7 g.mol−1
To a vigorously stirred biphasic solution of tri O benzyl D glucal 260 (1.0 g, 2.4
mmol) in CH2Cl2 (10 mL), acetone (1 mL) and a saturated aqueous solution of NaHCO3
(25 mL) at 0 ◦C, was added a solution of Oxone (4.5 g, 7.2 mmol) in H2O (20 mL). The
mixture was stirred vigorously at 0 ◦C for 30 min and then at rt for an additional 2
h. The aqueous phase was extracted with CH2Cl2 (2 × 30 mL). The combined organic
phases were dried (Na2SO4) and concentrated under reduced pressure to aﬀord epoxide
(1.1 g, quant.) as a white solid.
To a solution of epoxide (1.1 g, 2.4 mmol) in THF (24 mL), cooled to −35 ◦C, was
added a solution of (4 methylpent 3 enyl)magnesium bromide (9.6 mL, 4.8 mmol) in
THF (0.5 M) and the solution was stirred for 2 h at −30 ◦C. To the reaction mixture
was added a solution of (4 methylpent 3 enyl)magnesium bromide (4.8 mL, 2.4 mmol)
in THF (0.5 M) and the mixture was allowed to warm to 0 ◦C over 1 h. The reaction
was quenched with a saturated aqueous solution of NH4Cl (15 mL) and extracted with
Et2O (3 × 20 mL). The combined organic phases were washed with brine (20 mL),
dried (MgSO4) and concentrated under reduced pressure. The residue was puriﬁed by
ﬂash column chromatography (PE Et2O; 3:1) to give the alcohol 279 (310 mg, 0.60
mmol, 25%) as a colourless oil.
Rf = 0.43 (PE Et2O; 1:1)
136[α]D (24.1 ◦C, CHCl3) = +22.7 (c = 1.17)
IR : νmax 3445, 2928, 2865, 1453, 1074, 1027, 734, 696 cm−1.
1H NMR : δ 7.37−7.21 (15H, CH Arom), 5.12 (1H, ddd, J = 10.2, 7.2, 2.7 Hz, CH 
C9), 4.71 (1H, d, J = 11.6 Hz, CH2 C12a), 4.65 (1H, d, J = 11.3 Hz, CH2 C12’a), 4.59
(1H, d, J = 11.6 Hz, CH2 C12b), 4.59 (1H, d, J = 12.0 Hz, CH2 C12”a), 4.56 (1H, d,
J = 11.3 Hz, CH2 C12’b), 4.51 (1H, d, J = 12.0 Hz, CH2 C12”b), 3.95 (1H, ddd, J =
5.6, 5.3, 5.1 Hz, CH C2), 3.90 (1H, ddd, J = 9.6, 9.6, 4.1 Hz, CH C6), 3.78 (1H, dd, J
= 10.2, 5.3 Hz, CH2 C1a), 3.74−3.70 (2H, m, CH C4 and CH2 C1b), 3.69−3.66 (1H,
m, CH C5), 3.63 (1H, dd, J = 5.6, 5.6 Hz, CH C3), 2.72 (1H, d, J = 7.2 Hz, OH),
2.17−1.97 (2H, m, CH2 C8), 1.75−1.67 (1H, m, CH2 C7a), 1.67 (3H, s, CH3 C11),
1.63−1.59 (1H, m, CH2 C7b), 1.60 (3H, s, CH3 C11’).
13C NMR : δ 138.3 (C Arom), 138.2 (C Arom), 137.7 (C Arom), 132.0 (C C10), 128.7
(2 CH Arom), 128.6 (2 CH Arom), 128.5 (CH Arom), 128.1 (2 CH Arom), 128.1 (3 CH
Arom), 127.9 (2 CH Arom), 127.8 (2 CH Arom), 127.8 (CH Arom), 124.1 (CH C9),
78.8 (CH C4), 75.8 (CH C3), 73.8 (CH2 C12), 73.5 (CH2 C12’), 73.3 (CH2 C12”), 73.1
(CH C2), 71.8 (CH C6), 70.0 (CH C5), 68.5 (CH2 C1), 27.9 (CH2 C7), 25.9 (CH3 C11),
24.0 (CH2 C8), 17.9 (CH3 C11’).
MS (EI): m/z (Int) 516 (61), 425 (100), 408 (100), 391 (100), 317 (97), 211 (95),
181 (100), 163 (100), 133 (100). HRMS (C33H40O5
+): calculated: 516.2876; obtained:
516.2874, (  = 0.4 ppm).
(2R,3R,4S,5S,6S)-3,4-Bis(benzyloxy)-2-(benzyloxymethyl)-5-(ethynyloxy)-
6-(4-methylpent-3-enyl)tetrahydro-2H-pyran: 280
2 2
3 3 4 4
5 5
6 6 O
OBn
BnO
1 1
O
14 14
O
15 15
18 18
17 17
16 16
7 7
8 8
9 9
10 10
11 11
12
13
C35H40O5
Molecular weight: 540.7 g.mol−1
To a suspension of KH (0.25 g, 1.9 mmol) in Et2O (6 mL) was added a solution of
alcohol 279 (0.38 g, 0.74 mmol) in Et2O (5 mL). The reaction mixture was stirred for
10 min at rt, then cooled to 0 ◦C. Trichloroethylene (80 µL, 0.89 mmol) was added
to the solution, which was then warmed to rt and stirred for 3 h. The reaction was
quenched with MeOH (1 mL) and H2O (5 mL), and the aqueous phase was extracted
with Et2O (3 × 10 mL). The combined organic phases were washed with brine (10
mL), dried (MgSO4) and concentrated under reduced pressure. Puriﬁcation by ﬂash
chromatography on a small plug of silica gel gave the dichloroenol ether (0.38 g, 0.62
137mmol), which was used directly into the next step.
To a solution of dichloroenol ether (0.38 g, 0.62 mmol) in Et2O (6.2 mL) cooled to
−78 ◦C was added a solution of n butyllithium (0.74 mL, 1.9 mmol) in pentane (2.5 M)
dropwise. The reaction was stirred for 30 min at −78 ◦C, allowed to warm to −45 ◦C
and stirred for another 45 min. The reaction was quenched by addition of MeOH (1
mL) and H2O (10 mL) then extracted with Et2O (3 × 10 mL). The combined organic
phases were washed with brine (10 mL), dried (MgSO4) and concentrated under re 
duced pressure. The residue was puriﬁed by ﬂash column chromatography (PE Et2O;
10:1, 1% Et3N) to give the alkynylether 280 (0.28 g, 0.51 mmol, 70% over 2 steps) as
a colourless oil.
Rf = 0.33 (PE Et2O; 9:1)
[α]D (23.6 ◦C, CHCl3) = +30.0 (c = 1.08)
IR : νmax 3317, 2930, 2863, 2150, 1453, 1356, 1093, 1028, 734, 696 cm−1.
1H NMR : δ 7.40−7.28 (13H, m, CH Arom), 7.16−7.13 (2H, m, CH Arom), 5.14
(1H, ddd, J = 9.7, 7.2, 2.5 Hz, CH C9), 4.90 (1H, d, J = 10.7 Hz, CH2 C14a), 4.79
(1H, d, J = 10.8 Hz, CH2 C14’a), 4.72 (1H, d, J = 10.7 Hz, CH2 C14b), 4.61 (1H, d,
J = 12.1 Hz, CH2 C14”a), 4.50 (1H, d, J = 12.1 Hz, CH2 C14”b), 4.47 (1H, d, J =
10.8 Hz, CH2 C14’b), 4.33−4.27 (2H, m, CH C6 and CH C5), 3.84 (1H, dd, J = 8.0,
8.0 Hz, CH C4), 3.71−3.59 (4H, m, CH C2 and CH C3 and CH2 C1), 2.21−2.12 (1H,
m, CH2 C8a), 2.09−2.00 (1H, m, CH2 C8b), 1.75−1.63 (2H, m, CH2 C7), 1.69 (3H, s,
CH3 C11), 1.61 (3H, s, CH3 C11’), 1.59 (1H, s, CH C13).
13C NMR : δ 138.2 (C C15), 138.1 (C C15’), 138.1 (C C15”), 132.7 (C C10), 128.6 (2
CH Arom), 128.5 (3 CH Arom), 128.3 (2 CH Arom), 128.1 (3 CH Arom), 128.0 (3 CH
Arom), 127.8 (2 CH Arom), 123.3 (CH C9), 89.0 (C C12), 87.8 (CH), 80.7 (CH C4),
77.8 (CH), 75.4 (CH2 C14), 75.2 (CH2 C14’), 73.7 (CH2 C14”), 72.4 (CH), 71.5 (CH),
68.9 (CH2 C1), 27.0 (CH C13), 25.9 (CH3 C11), 25.0 (CH2 C7), 23.6 (CH2 C8), 17.8
(CH3 C11’).
MS (EI): m/z (Int) 540 (5), 467 (40), 253 (42), 181 (91), 91 (100), 69 (52). HRMS
(C35H40O5
+): calculated: 540.2876; obtained: 540.2878, (  = 0.4 ppm).
(2R,3R,4S,5S,6S)-3,4-Bis(benzyloxy)-2-(benzyloxymethyl)-5-(hept-1-en-2-
yloxy)-6-(4-methylpent-3-enyl)tetrahydro-2H-pyran: 281
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Molecular weight: 612.8 g.mol−1
138CuBr (0.11 g, 0.72 mmol) and LiBr (63 mg, 0.72 mmol) were dried at 60 ◦C for
4 h under high vacuum. THF (5 mL) was added and the solution cooled to −90 ◦C.
To this was added a solution of the Grignard reagent generated from bromopentane
(0.72 mL, 0.72 mmol) in THF (1 M) and the reaction mixture was stirred for 10 min
at −90 ◦C. Alkyne 280 (0.26 g, 0.48 mmol) in THF (5 mL) was then added, the
solution was warmed to −78 ◦C and stirred for 45 min. The reaction was quenched by
the addition of a solution of NH4OH (10% in a saturated solution of NH4Cl) (4 mL)
and the aqueous phase was extracted with Et2O (3 × 15 mL). The combined organic
phases were dried (Na2SO4) and concentrated under reduced pressure. The residue was
puriﬁed by ﬂash column chromatography (PE Et2O; 95:5→9:1, 1% Et3N) to give the
enol ether 281 (76 mg, 0.12 mmol, 25%) as a colourless oil.
Rf = 0.55 (PE Et2O; 4:1)
[α]D (23.9 ◦C, CHCl3) = +47.6 (c = 1.07)
IR : νmax 2929, 2860, 1655, 1453, 1358, 1257, 1095, 1047, 733, 696 cm−1.
1H NMR : δ 7.36−7.25 (13H, m, CH Arom), 7.14−7.11 (2H, m, CH Arom), 5.11
(1H, ddd, J = 9.9, 7.2, 2.7 Hz, CH C9), 4.86 (1H, d, J = 10.9 Hz, CH2 C19a), 4.81
(1H, d, J = 10.7 Hz, CH2 C19’a), 4.71 (1H, d, J = 10.9 Hz, CH2 C19b), 4.64 (1H,
d, J = 12.1 Hz, CH2 C19”a), 4.51 (1H, d, J = 12.1 Hz, CH2 C19”b), 4.46 (1H, d, J
= 10.7 Hz, CH2 C19’b), 4.33−4.23 (2H, m, CH C5 and CH C6), 4.08 (1H, d, J = 2.1
Hz, CH2 C18a), 3.96 (1H, d, J = 2.1 Hz, CH2 C18b), 3.84 (1H, dd, J = 8.6, 8.6 Hz,
CH C4), 3.73−3.61 (4H, m, CH C2 and CH C3 and CH2 C1), 2.19−2.02 (3H, m, CH2 
C8a and CH2 C13), 2.01−1.91 (1H, m, CH2 C8b), 1.78−1.68 (1H, m, CH2 C7a), 1.67
(3H, s, CH3 C11), 1.60 (3H, s, CH3 C11’), 1.53−1.46 (3H, m, CH2 C7b and CH2 C14),
1.31−1.25 (4H, m, CH2 C15 and CH2 C16), 0.90−0.83 (3H, m, CH3 C17).
13C NMR : δ 161.5 (C C12), 138.9 (C Arom), 138.4 (C Arom), 138.2 (C Arom), 132.3
(C C10), 128.5 (2 CH Arom), 128.5 (3 CH Arom), 128.1 (2 CH Arom), 128.1 (2 CH
Arom), 127.8 (3 CH Arom), 127.8 (2 CH Arom), 127.7 (CH Arom), 123.8 (CH C9),
82.5 (CH2 C18), 81.7 (CH C4), 78.0 (CH), 76.8 (CH C5), 75.3 (CH2 C19), 75.2 (CH2 
C19’), 73.7 (CH2 C19”), 72.0 (CH C6), 71.2 (CH), 69.2 (CH2 C1), 35.5 (CH2 C13), 31.4
(CH2), 27.1 (CH2 C14), 25.9 (CH3 C11), 25.2 (CH2 C7), 23.9 (CH2 C8), 22.6 (CH2),
17.8 (CH3 C11’), 14.2 (CH3 C17).
MS (EI): m/z (Int) 612 (5), 498 (12), 407 (25), 299 (14), 253 (19), 181 (82), 91 (100).
HRMS (C40H52O5
+): calculated: 612.3815; obtained: 612.3818, (  = 0.5 ppm).
139(4aR,8R,8aR)-2,2-Di-tert-butyl-8-(triethylsilyloxy)-4,4a,8,8a-tetrahydro-
pyrano[3,2-d][1,3,2]dioxasiline : 301
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Molecular weight: 400.7 g.mol−1
To a solution of tri O acetyl D glucal (10.0 g, 36.8 mmol) in MeOH (40 mL) was
added sodium methoxide (104 mg, 1.84 mmol) portionwise. The reaction mixture was
sitrred for 45 min before being concentrated under reduced pressure to give the triol
(5.40 g, 36.8 mmol, quant.) as a brown oil.
To a solution of triol (5.40 g, 36.8 mmol) in DMF (86 mL) at −40 ◦C was added
di tert butylsiyl bis(triﬂuoromethanesulfonate) (11.0 mL, 40.4 mmol) with a syringe
pump over 1 h. The solution was then stirred for 2 h at −40 ◦C. The reaction was
quenched by addition of pyridine (3.8 mL) and diluted with Et2O (100 mL) and H2O
(100 mL). The aqueous phase was extracted with Et2O (100 mL). The combined organic
phases were washed with a saturated aqueous solution of NaHCO3 (100 mL) and brine
(100 mL), dried (MgSO4) and concentrated under reduced pressure to give the alcohol
303 (10.5 g, 36.8 mmol, quant.) as a yellow oil.
To a solution of alcohol 303 (10.5 g, 36.8 mmol) in DMF (100 mL) was added
imidazole (6.28 g, 92.4 mmol) and triethylsilylchloride (10.0 mL, 60.0 mmol). The re 
action was stirred at rt overnight and diluted with Et2O (400 mL). The organic phase
was washed with H2O (4 × 400 mL), dried (MgSO4) and concentrated under reduced
pressure. The crude product was puriﬁed by ﬂash column chromatography (PE Et2O;
99:1→95:5) to give the protected triol 301 (12.7 g, 31.8 mmol, 86% over 3 steps) as a
colourless oil.
Rf = 0.72 (PE Et2O; 4:1)
[α]D (22.4 ◦C, CHCl3) = −42.6 (c = 2.35)
IR : νmax 2957, 2878, 1649, 1473, 1364, 1234, 1162, 1123 cm−1.
1H NMR : δ 6.23 (1H, d, J = 6.0 Hz, CH C6), 4.61 (1H, dd, J = 6.0, 1.6 Hz, CH 
C5), 4.27 (1H, ddd, J = 7.0, 1.6, 1.6 Hz, CH C4), 4.15 (1H, dd, J = 10.2, 4.9 Hz,
CH2 C1a), 3.98−3.92 (2H, m, CH2 C1b and CH C3), 3.81 (1H, ddd, J = 10.2, 10.2,
4.9 Hz, CH C2), 1.06 (9H, s, CH3 C10), 1.00 (9H, s, CH3 C10’), 0.99 (9H, t, J = 7.9
Hz, CH3 C8), 0.66 (6H, q, J = 7.9 Hz, CH2 C7).
13C NMR : δ 143.0 (CH C6), 105.2 (CH C5), 77.3 (CH C3), 76.7 (CH C2), 72.9 (CH 
140C4), 65.9 (CH2 C1), 27.5 (CH3 C10), 27.0 (CH3 C10’), 22.8 (C C9), 19.9 (C C9’), 6.9
(CH3 C8), 4.9 (CH2 C7).
MS (CI) : m/z (Int) 401 (29), 371 (27), 269 (100), 225 (58), 187 (32), 81 (44). HRMS
(C20H41O4Si2
+) : calculated : 401.2543; obtained : 401.2541, (  = 0.5 ppm).
(4aR,6S,7S,8R,8aR)-2,2-Di-tert-butyl-8-(triethylsilyloxy)-6-vinyl-hexa-
hydropyrano[3,2-d][1,3,2]dioxasilin-7-ol : 304
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Molecular weight: 458.8 g.mol−1
To a solution of glucal 301 (12.7 g, 31.8 mmol) in a mixture of acetone (30 mL),
CH2Cl2 (127 mL) and a saturated aqueous solution of NaHCO3 (317 mL) at 0 ◦C was
slowly added a solution of Oxone (58.3 g, 94.8 mmol) in H2O (228 mL). After 30 min
at 0 ◦C, the solution was stirred for an additional 3 h at rt. The aqueous phase was
extracted with CH2Cl2 (2 × 150 mL) and the organic phase was dried (Na2SO4) and
concentrated under reduced pressure to give the epoxide (13.0 g, 31.3 mmol, 98 %) as
a colourless oil, which was used directly into the next step.
To a solution of the epoxide (13.0 g, 31.3 mmol) in THF at 0 ◦C was added a solution
of allylmagnesium chloride (31.3 mL, 62.6 mmol) in THF with a syringe pump over 30
min. The reaction mixture was stirred for 2 h at 0 ◦C and quenched with a saturated
aqueous solution of NH4Cl (150 mL). The aqueous phase was extracted with Et2O
(2 × 150 mL), the combined organic phases were washed with brine (150 mL), dried
(MgSO4) and concentrated under reduced pressure. The crude product was puriﬁed
by ﬂash column chromatography (PE Et2O; 98:2→9:1) to give the alcohol 304 (11.7
g, 25.4 mmol, 81%) as a colourless oil.
Rf = 0.55 (PE Et2O; 10:1)
[α]D (23.2 ◦C, CHCl3) = −19.8 (c = 1.02)
IR : νmax 3601, 2957, 2878, 1643, 1473, 1387, 1165, 1095 cm−1.
1H NMR : δ 5.80 (1H, dddd, J = 17.1, 10.2, 7.0, 7.0 Hz, CH C8), 5.04 (1H, dddd,
J = 17.1, 1.4, 1.0, 1.0 Hz, CH2 C9a), 4.99 (1H, dddd, J = 10.2, 1.4, 1.0, 1.0 Hz,
CH2 C9b), 4.06 (1H, dd, J = 10.1, 5.0 Hz, CH2 C1a), 3.74 (1H, dd, J = 10.1, 10.1
Hz, CH2 C1b), 3.57 (1H, dd, J = 8.9, 8.9 Hz, CH C3), 3.41 (1H, dd, J = 8.9, 8.9 Hz,
CH C4), 3.30−3.24 (2H, m, CH C2 and CH C6), 3.17 (1H, ddd, J = 9.4, 8.9, 2.5 Hz,
141CH C5), 2.49 (1H, m, CH2 C7a), 2.18 (1H, dddd, J = 7.3, 7.0, 1.0, 1.0 Hz, CH2 C7b),
2.14 (1H, d, J = 2.5 Hz, OH), 0.98 (9H, s, CH3 C13), 0.93 (9H, s, CH3 C13’), 0.92
(9H, t, J = 7.8 Hz, CH3 C11), 0.64 (6H, q, J = 7.8 Hz, CH2 C10).
13C NMR : δ 134.4 (CH C8), 117.2 (CH2 C9), 80.0 (CH C4), 78.6 (CH C6), 77.5 (CH 
C3), 74.9 (CH C2), 74.5 (CH C5), 66.5 (CH2 C1), 36.2 (CH2 C7), 27.6 (CH3 C13), 27.0
(CH3 C13’), 22.8 (C C12), 20.0 (C C12’), 7.0 (CH3 C11), 5.2 (CH2 C10).
MS (CI) : m/z (Int) 459 (100), 429 (8), 327 (9). HRMS (C23H47O5Si2
+) : calculated :
459.2962; obtained : 459.2959, (  = 0.7 ppm).
Elemental analysis: calculated for C23H46O5Si2: C 60.21, H 10.11; obtained: C 60.10,
H 10.28.
(4aR,6S,8S,8aR)-6-Allyl-2,2-di-tert-butyl-8-(triethylsilyloxy)-tetrahydro-
pyrano[3,2-d][1,3,2]dioxasilin-7(6H)-one : 366
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Molecular weight: 456.8 g.mol−1
To a solution of oxalyl chloride (4.31 mL, 47.8 mmol) in CH2Cl2 (132 mL) at −78 ◦C
was slowly added a solution of DMSO (6.80 mL, 95.9 mmol) in CH2Cl2 (31 mL). The
solution was stirred for 30 min at −78 ◦C before a solution of alcohol 304 (11.6 g, 25.3
mmol) in CH2Cl2 (81 mL) was slowly added. The reaction mixture was stirred for 2
h at −78 ◦C and Et3N (17.5 mL, 127 mmol) was added. The solution was allowed
to warm to rt and diluted with CH2Cl2 (300 mL) and H2O (300 mL). The aqueous
phase was extracted with CH2Cl2 (2 × 300 mL) and the combined organic phases were
washed with brine (300 mL), dried (MgSO4) and concentrated under reduced pressure.
The crude product was puriﬁed by ﬂash column chromatography (PE Et2O; 5%) to
give the ketone 366 (10.0 g, 22 mmol, 87 %) as a colourless oil.
Rf = 0.78 (PE Et2O; 10:1)
[α]D (22.7 ◦C, CHCl3) = −52.4 (c = 1.00)
IR : νmax 2936, 2878, 1744, 1180, 1152, 1105 cm−1.
1H NMR : δ 5.75 (1H, dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, CH C8), 5.04 (1H, dd, J =
17.1, 1.4 Hz, CH2 C9a), 4.98 (1H, dd, J = 10.2, 1.4 Hz, CH2 C9b), 4.18 (1H, dd, J =
10.2, 5.0 Hz, CH2 C1a), 4.07 (1H, d, J = 9.2 Hz, CH C4), 3.92 (1H, dd, J = 9.2, 9.2
Hz, CH C3), 3.85−3.78 (2H, m, CH2 C1b and CH C6), 3.62 (1H, ddd, J = 9.2, 9.2, 5.0
142Hz, CH C2), 2.58−2.51 (1H, m, CH2 C7a), 2.26−2.19 (1H, m, CH2 C7b), 0.98 (9H, s,
CH3 C13), 0.96 (9H, s, CH3 C13’), 0.93 (9H, t, J = 7.8 Hz, CH3 C11), 0.61 (6H, q, J
= 7.8 Hz, CH2 C10).
13C NMR : δ 202.3 (C C5), 133.7 (CH C8), 117.5 (CH2 C9), 81.3 (CH C6), 80.8 (CH 
C4), 80.2 (CH C3), 74.7 (CH C2), 66.4 (CH2 C1), 33.1 (CH2 C7), 27.4 (CH3 C13), 27.0
(CH3 C13’), 22.7 (C C12), 19.9 (C C12’), 6.8 (CH3 C11), 4.8 (CH2 C10).
MS (CI) : m/z (Int) 457 (13), 325 (100), 133 (22). HRMS (C23H45O5Si2
+) : calculated
: 457.2806; obtained : 457.2808, (  = 0.4 ppm).
(4aR,6S,8S,8aS)-6-Allyl-2,2-di-tert-butyl-8-hydroxy-tetrahydropyrano[3,2-
d][1,3,2]dioxasilin-7(6H)-one: 305
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Molecular weight: 342.5 g.mol−1
To a solution of silyl ether 366 (3.0 g, 6.6 mmol) in a mixture of THF (42 mL) and
H2O (4 mL) was added DDQ (0.15 g, 0.66 mmol). The reaction mixture was stirred for
4 h before being concentrated under reduced pressure. The crude product was puriﬁed
by ﬂash column chromatography (PE Et2O; 3:1) to give the hydroxy ketone 305 (1.9
g, 5.5 mmol, 84%) as a colourless oil.
Rf = 0.28 (PE Et2O; 4:1)
[α]D (24.1 ◦C, CHCl3) = −46.5 (c = 1.02)
IR : νmax 3514, 2934, 2859, 1732, 1646, 1475, 1364, 1265, 1144 cm−1.
1H NMR : δ 5.84 (1H, dddd, J = 17.1, 10.2, 6.9, 6.9 Hz, CH C8), 5.18 (1H, dddd, J =
17.1, 1.5, 1.5, 1.5 Hz, CH2 C9a), 5.12 (1H, dddd, J = 10.2, 1.5, 1.5, 1.5 Hz, CH2 C9b),
4.30 (1H, dd, J = 10.2, 5.0 Hz, CH2 C1a), 4.26 (1H, ddd, J = 9.3, 2.8, 1.0 Hz, CH C4),
4.02−3.96 (2H, m, CH C6 and CH C3), 3.94 (1H, dd, J = 10.2, 10.2 Hz, CH2 C1b),
3.80 (1H, ddd, J = 10.2, 9.7, 5.0 Hz, CH C2), 3.55 (1H, d, J = 2.8 Hz, OH), 2.70−2.63
(1H, m, CH2 C7a), 2.41−2.34 (1H, m, CH2 C7b), 1.10 (9H, s, CH3 C11), 1.07 (9H, s,
CH3 C11’).
13C NMR : δ 203.0 (C C5), 133.0 (CH C8), 118.0 (CH2 C9), 80.8 (CH C3 or CH C6),
80.4 (CH C6 or CH C3), 79.7 (CH C4), 74.3 (CH C2), 66.1 (CH2 C1), 32.9 (CH2 C7),
27.5 (CH3 C11), 27.0 (CH3 C11’), 22.7 (C C10), 20.0 (C C10’).
MS (FAB) : m/z (Int) 343 (30), 325 (18), 285 (54), 243 (24), 201 (24), 146 (38), 104
(33), 77 (100), 75 (70). HRMS (C17H31O5Si+) : calculated : 343.1941; obtained :
143343.1945, (  = 1.2 ppm).
Elemental analysis: calculated for C17H30O5Si: C 59.61, H 8.83; obtained: C 59.49,
H 9.01.
(4aR,6S,8R,8aR)-6-Allyl-2,2-di-tert-butyl-8-iodo-tetrahydropyrano[3,2-d]
dioxasilin-7(6H)-one : 380
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Molecular weight: 452.4 g.mol−1
To a solution of alcohol 305 (1.85 g, 5.40 mmol) in THF (53 mL) was added imida 
zole (734 mg, 10.8 mmol), PPh3 (2.12 g, 8.10 mmol) and I2 (2.19 g, 8.64 mmol). The
solution was stirred overnight at rt, then quenched with a saturated aqueous solution of
Na2SO3 (50 mL). The aqueous phase was extracted with EtOAc (100 mL), the organic
phase was washed with brine (50 mL), dried (MgSO4) and concentrated under reduced
pressure. The crude product was ﬁltrated on silica (PE Et2O; 4:1) to give the iodide
367 (1.59 g, 3.50 mmol, 65%) as a white solid.
(4aR,6S,8aS)-6-Allyl-2,2-di-tert-butyl-tetrahydropyrano[3,2-d][1,3,2]di-
oxasilin-7(6H)-one : 306
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Molecular weight: 326.5 g.mol−1
From iodide 367: To a solution of iodine 367 (1.6 g, 3.5 mmol) in toluene (53 mL)
was added tri n butyltin hydride (2.8 mL, 10 mmol) and AIBN (30 mg, cat.). The
reaction was stirred at reﬂux for 2 h. The mixture was concentrated under reduced
pressure and the crude product was puriﬁed by ﬂash column chromatography (PE 
Et2O; 99:1→9:1) to give the ketone 306 (840 mg, 2.6 mmol, 73%) as a white solid.
From enol ether 316: To a solution of enol ether 309 (9.30 g, 34.4 mmol) in a
mixture of acetone (60 mL), CH2Cl2 (155 mL) and a saturated aqueous solution of
NaHCO3 (330 mL) at 0 ◦C, was added a solution of Oxone (63.4 g, 103 mmol) in H2O
(250 mL). The mixture was stirred vigorously at 0 ◦C for 30 min and then at rt for
an additional 2 h. The aqueous phase was extracted with CH2Cl2 (2 × 200 mL). The
144organic phase was dried (Na2SO4) and concentrated under reduced pressure to aﬀord
the corresponding epoxide (9.80 g, 34.4 mmol, quant) as a white solid, which was used
directly into the next step.
To a solution of epoxide (9.80 g, 34.4 mmol) in THF (435 mL) at 0 ◦C was added a
solution of allymagnesium chloride (34.4 mL, 68.8 mmol) in THF (2 M) with a syringe 
pump over 30 min. After the addition, the reaction mixture was stirred for another 2 h
at 0 ◦C and a saturated aqueous solution of NH4Cl (100 mL) was added. The aqueous
layer was extracted with Et2O (2 × 200 mL) and the combined organic phases were
washed with brine (200 mL), dried (MgSO4) and concentrated under reduced pressure
to give the alcohol (11.3 g, 34.4 mmol, quant) as a mixture of 4 possible diastereomers.
To a solution of oxalyl chloride (5.89 mL, 65.4 mmol) in CH2Cl2 (175 mL) at −78 ◦C
was slowly added a solution of DMSO (9.29 mL, 131 mmol) in CH2Cl2 (44 mL). The
solution was stirred for 30 min at −78 ◦C before a solution of alcohol (11.3 g, 34.4
mmol) in CH2Cl2 (106 mL) was slowly added. The reaction mixture was stirred for
2 h at −78 ◦C and Et3N (23.8 mL, 172 mmol) was added. The solution was allowed
to warm to rt and diluted with CH2Cl2 (300 mL) and H2O (150 mL). The aqueous
phase was extracted with CH2Cl2 (2 × 200 mL) and the combined organic phases
were washed with brine (200 mL), dried (MgSO4) and concentrated under reduced
pressure. The crude product was puriﬁed by ﬂash column chromatography (PE Et2O;
99:1→98:2→95:5) to give the ketone 306 (1.11 g, 3.40 mmol, 10 %) as a white solid.
Further elution gave a 9:1 mixture of ketones 311 and 306 (5.16 g, 16.0 mmol, 46%)
in favour of the wrong diastereomer.
To a solution of the ketones (5.2 g, 16 mmol) in toluene (160 mL) was added DBU
(0.72 mL, 4.8 mmol). The solution was stirred at rt overnight and more DBU (0.36 mL,
2.4 mmol) was added. After another 7 h at rt, the reaction was quenched by addition
of a saturated aqueous solution of NH4Cl (50 mL). The aqueous phase was extracted
with EtOAc (2 × 75 mL) and the combined organic phases were washed with brine
(50 mL), dried (MgSO4) and concentrated under reduced pressure. The crude product
was puriﬁed by ﬂash column chromatography (PE Et2O; 99:1→98:2→9:1) to give the
ketone 306 (3.2 g, 9.8 mmol, 61 %) as a white solid.
Rf = 0.76 (PE Et2O; 1:1)
m.p. = 86−88 ◦C
[α]D (24.5 ◦C, CHCl3) = −24.1 (c = 1.07)
IR : νmax 2934, 2860, 1728, 1643, 1473, 1266, 1115 cm−1.
1H NMR : δ 5.73 (1H, dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, CH C8), 5.04 (1H, dddd, J
= 17.1, 1.5, 1.5, 1.5 Hz, CH2 C9a), 4.99 (1H, dddd, J = 10.2, 1.5, 1.1, 1.1 Hz, CH2 
145C9b), 4.19 (1H, dd, J = 10.3, 5.0 Hz, CH2 C1a), 4.06 (1H, ddd, J = 11.0, 9.3, 5.7 Hz,
CH C3), 3.83 (1H, dd, J = 10.3, 10.3 Hz, CH2 C1b), 3.78 (1H, dd, J = 7.7, 4.3 Hz,
CH C6), 3.55 (1H, ddd, J = 10.3, 9.3, 5.0 Hz, CH C2), 2.95 (1H, dd, J = 15.7, 5.7 Hz,
CH2 C4a), 2.58−2.51 (1H, m, CH2 C7a), 2.38 (1H, dd, J = 15.7, 11.0 Hz, CH2 C4b),
2.28−2.19 (1H, m, CH2 C7b), 0.98 (9H, s, CH3 C11), 0.94 (9H, s, CH3 C11’).
13C NMR : δ 204.7 (C C5), 133.7 (CH C8), 117.6 (CH2 C9), 82.6 (CH C6), 76.4 (CH 
C2), 73.2 (CH C3), 66.6 (CH2 C1), 48.3 (CH2 C4), 33.5 (CH2 C7), 27.4 (CH3 C11),
27.0 (CH3 C11’), 22.6 (C C10), 19.9 (C C10’).
MS (FAB) : m/z (Int) 327 (55), 269 (100), 227 (93), 171 (98), 129 (95), 101 (93).
HRMS (C17H31O4Si+) : calculated : 327.1992; obtained : 327.1991, (  = 0.3 ppm).
Elemental analysis: calculated for C17H30O4Si: C 62.54, H 9.26; obtained: C 62.53,
H 9.31.
(4aR,6S,7R,8aS)-6-Allyl-2,2-di-tert-butyl-7-methyl-hexahydropyrano[3,2-
d][1,3,2]dioxasilin-7-ol : 300
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Molecular weight: 342.6 g.mol−1
To a solution of ketone 306 (0.80 g, 2.5 mmol) in toluene (245 mL) at −78 ◦C was
added a solution of methylmagnesium iodide (4.0 mL, 12 mmol) in THF. The reaction
was stirred at −78 ◦C for 40 min and quenched by addition of MeOH (5 mL). The
solution was diluted with EtOAc (30 mL) and a saturated aqueous solution of NH4Cl
(30 mL) was added. The aqueous phase was extracted with EtOAc (3 × 30 mL), the
combined organic phases were washed with brine (30 mL), dried (MgSO4) and con 
centrated under reduced pressure. The crude product was puriﬁed by ﬂash column
chromatography (PE Et2O; 9:1) to give the tertiary alcohol 300 (0.62 g, 1.8 mmol,
74%) as a colourless oil.
Rf = 0.20 (PE Et2O; 5:1)
[α]D (23.0 ◦C, CHCl3) = −24.1 (c = 1.07)
IR : νmax 3364, 2934, 2859, 1474, 1094, 826 cm−1.
1H NMR : δ 5.90 (1H, dddd, J = 17.2, 10.2, 6.8, 6.8 Hz, CH C8), 5.12 (1H, dddd, J =
17.2, 1.6, 1.6, 1.6 Hz, CH2 C9a), 5.06 (1H, dddd, J = 10.2, 1.6, 1.1, 1.1 Hz, CH2 C9b),
4.14 (1H, dd, J = 10.1, 4.9 Hz, CH2 C1a), 3.81 (1H, dd, J = 10.1, 10.1 Hz, CH2 C1b),
3.76 (1H, ddd, J = 11.4, 9.4, 4.6 Hz, CH C3), 3.29 (1H, ddd, J = 10.1, 9.4, 4.9 Hz,
146CH C2), 3.25 (1H, dd, J = 9.3, 3.6 Hz, CH C6), 2.45−2.37 (1H, m, CH2 C7a), 2.22
(1H, dd, J = 11.9, 4.6 Hz, CH2 C4a), 2.16−2.07 (1H, m, CH2 C7b), 1.60 (1H, dd,
J = 11.9, 11.4 Hz, CH2 C4b), 1.40 (1H, s, OH), 1.23 (3H, s, CH3 C10), 1.04 (9H, s,
CH3 C12), 0.98 (9H, s, CH3 C12’).
13C NMR : δ 136.0 (CH C8), 116.9 (CH2 C9), 84.3 (CH C6), 78.5 (CH C2), 72.5
(CH C3), 71.4 (C C5), 67.2 (CH2 C1), 48.9 (CH2 C4), 33.6 (CH2 C7), 27.7 (CH3 C12),
27.3 (CH3 C12’), 22.9 (C C11), 21.9 (CH3 C10), 20.2 (C C11’).
MS (CI) : m/z (Int) 343 (90), 325 (100), 285 (34). HRMS (C18H35O4Si+) : calculated
: 343.2305; obtained : 343.2309, (  = 1.2 ppm).
(4R,6S,7S,8aS)-6-Allyl-2,2-di-tert-butyl-7-methyl-hexahydropyrano[3,2-d]
[1,3,2]di-oxasilin-7-ol: 307
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Molecular weight: 342.6 g.mol−1
Further elution (PE Et2O; 1:1) gave the other diastereomer 307 (151 mg, 0.44 mmol,
74%) as a colourless oil.
Rf = 0.18 (PE Et2O; 9:1)
m.p = 71−73 ◦C
[α]D (23.0 ◦C, CHCl3) = −32.8 (c = 1.01)
IR : νmax 3480, 2932, 2859, 1643, 1474, 1092 cm−1.
1H NMR : δ 5.89 (1H, dddd, J = 17.0, 10.0, 6.8, 6.8 Hz, CH C8), 5.09 (1H, d, J
= 17.0 Hz, CH2 C9a), 5.05 (1H, d, J = 10.0 Hz, CH2 C9b), 4.13 (1H, dd, J = 10.0,
4.9 Hz, CH2 C1a), 4.01 (1H, ddd, J = 10.2, 10.2, 4.7 Hz, CH C3), 3.87 (1H, dd, J =
10.2, 10.0 Hz, CH2 C1b), 3.32−3.25 (2H, m, CH C2 and CH C6), 2.37−2.24 (2H, m,
CH2 C7), 2.20 (1H, dd, J = 13.2, 4.7 Hz, CH2 C4a), 1.89 (1H, br s, OH), 1.50 (1H,
dd, J = 13.2, 10.2 Hz, CH2 C4b), 1.19 (3H, s, CH3 C10), 1.03 (9H, s, CH3 C12), 0.98
(9H, s, CH3 C12’).
13C NMR : δ 135.6 (CH C8), 116.6 (CH2 C9), 84.0 (CH C6), 78.3 (CH C2), 72.1 (C 
C5), 71.1 (CH C3), 66.8 (CH2 C1), 46.6 (CH2 C4), 32.9 (CH2 C7), 27.5 (CH3 C12),
27.1 (CH3 C12’), 25.3 (CH3 C10), 22.6 (C C11), 20.0 (C C11’).
MS (FAB) : m/z (Int) 365 (90), 325 (84), 285 (100), 227 (81), 77 (100). HRMS
(C18H34NaO4Si+) : calculated : 365.2124; found : 365.2121, (  = 0.8 ppm).
Elemental Analysis: calculated : C 63.11, H 10.00; found : C 63.18, H 10.20.
147(4aR,6S,7S,8aS)-6-Allyl-2,2-di-tert-butyl-7-methyl-hexahydropyrano[3,2-
d][1,3,2]di oxasilin-7-yl-4-nitrobenzoate : 308
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Molecular weight: 491.7 g.mol−1
To a solution of alcohol 307 (227 mg, 0.664 mmol) in THF (1.1 mL) at −78 ◦C
was added a solution of n BuLi (0.32 mL, 0.81 mmol) in hexane. The solution was
warmed to rt and stirred for 1 h. A solution of p nitrobenzoylchloride (245 mg, 1.32
mmol) in THF (2.6 mL) was added and the reaction mixture was stirred for 4 h at
rt. The reaction mixture was diluted with Et2O (10 mL), washed with an aqueous 1N
HCl solution (5 mL), a saturated aqueous solution of NaHCO3 (5 mL) and brine (5
mL). The organic phase was dried (MgSO4) and concentrated under reduced pressure.
Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 95:5) delivered
the ester 308 (130 mg, 0.264 mmol, 40%) as a white solid.
Rf = 0.65 (PE Et2O; 2:1)
m.p = 135−136 ◦C
[α]D (23.2 ◦C, CHCl3) = −46.0 (c = 1.01)
IR : νmax 2929, 2861, 1724, 1531, 1292, 1260, 1098, 847, 827, 720 cm−1.
1H NMR : δ 8.30 (2H, d, J = 8.1 Hz, CH C13), 8.17 (2H, d, J = 8.1 Hz, CH C12),
5.95 (1H, dddd, J = 16.9, 9.8, 6.8, 6.8 Hz, CH C8), 5.15 (1H, d, J = 16.9 Hz, CH2 
C9a), 5.10 (1H, d, J = 9.8 Hz, CH2 C9b), 4.16 (1H, dd, J= 9.8, 4.6 Hz, CH2 C1a), 3.86
(1H, dd, J = 9.8, 9.8 Hz, CH2 C1b), 3.86−3.78 (1H, m, CH C3), 3.40−3.30 (3H, m,
CH C2 and CH C6 and CH2 C4a), 2.51−2.41 (2H, m, CH2 C7), 1.64 (3H, s, CH3 C15),
1.58−1.53 (1H, m, CH2 C4b), 0.98 (9H, s, CH3 C17), 0.94 (9H, s, CH3 C17’).
13C NMR : δ 163.6 (C C10), 150.6 (C C14), 136.7 (C C11), 135.2 (CH C8), 130.6
(CH C12), 123.7 (CH C13), 116.9 (CH2 C9), 84.7 (CH C6), 83.5 (C C5), 78.2 (CH 
C2), 70.5 (CH C3), 66.8 (CH2 C1), 41.1 (CH2 C4), 31.0 (CH2 C7), 27.4 (CH3 C17),
27.1 (CH3 C17’), 22.7 (C C16), 22.5 (CH3 C15), 19.9 (C C16’).
MS (CI) : m/z (Int) 492 (8), 462 (17), 325 (47), 97 (48), 71 (100). HRMS (C25H38NO7Si+)
: calculated : 492.2418; found : 492.2405, (  = 2.6 ppm).
Acetic acid (2R,3S)-3-acetoxy-6-methoxy-3,6-dihydro-2H-pyran-2-ylmethyl
ester : 312
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Molecular weight: 244.2 g.mol−1
To a solution of tri O acetyl D glucal (32.0 g, 118 mmol) in CH2Cl2 (150 mL) was
added methanol (5.20 mL, 128 mmol) and boron triﬂuoride diethyl etherate (6.40 mL,
52.0 mmol) dropwise. The reaction mixture was stirred for 1h 15min at rt. A satu 
rated aqueous solution of NaHCO3 (200 mL) was added and the reaction mixture was
diluted with H2O (400 mL) and CH2Cl2 (400 mL). The aqueous phase was extracted
with CH2Cl2 (2 × 400 mL) and the combined organic phases were washed with brine
(400 mL), dried (MgSO4) and concentrated under reduced pressure. The brown oil
was ﬁltered through a small plug of silica (PE Et2O; 1:1) to give the mixed acetal 312
(25.2 g, 103 mmol, 88%) as a colourless oil, which was used directly to the next step.
(2R,3S)-2-(Hydroxymethyl)-3,4-dihydro-2H-pyran-3-ol : 309
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Molecular weight: 130.1 g.mol−1
To a solution of the mixed acetal 312 (25.2 g, 103 mmol) in dioxane (690 mL) was
added lithium aluminium hydride (8.24 g, 206 mmol) portionwise. The solution was
stirred at reﬂux for 5 h and then cooled to 0 ◦C. H2O (8.2 mL) was added slowly,
followed by a 6N aqueous solution of NaOH (8.2 mL) and H2O (24.6 mL). The mixture
was then stirred for 45 min at rt, ﬁltered through a Celite plug and concentrated under
reduced pressure to aﬀord diol 309 (12.5 g, 96.2 mmol, 93%) as a colourless oil, which
was used directly to the next step.
tert-Butyl{[(2R,3S)-3-(tert-butyldimethylsilyloxy)-3,4-dihydro-2H-pyran-
2-yl]methoxy}dimethylsilane : 313
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Molecular weight: 358.7 g.mol−1
149To a solution of diol 309 (0.81 g, 6.3 mmol) in DMF (17.4 mL) were added imidazole
(2.1 g, 31 mmol) and tert butyldimethylsilylchloride (3.0 g, 20 mmol). The reaction
mixture was stirred for 2 h and Et2O (50 mL) was added to it. The organic phase
was washed with H2O (5 × 50 mL), dried (MgSO4) and concentrated under reduced
pressure. Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 99:1)
delivered the bis protected diol 313 (1.4 g, 4.0 mmol, 64%) as a colourless oil.
Rf = 0.75 (PE Et2O; 1:1)
[α]D (22.6 ◦C, CHCl3) = +75.3 (c = 1.015)
IR : νmax 2928, 2657, 1655, 1474, 1252, 1088 cm−1.
1H NMR : δ 6.32 (1H, d, J = 5.8 Hz, CH C6), 4.57 (1H, ddd, J = 5.8, 5.6, 2.2 Hz,
CH C5), 3.87−3.80 (2H, m, CH2 C1a and CH C3), 3.77 (1H, ddd, J = 11.3, 11.3, 4.8
Hz, CH2 C1b), 3.49 (1H, ddd, J = 11.3, 4.8, 2.4 Hz, CH C2), 2.15 (1H, ddd, J = 16.3,
5.6, 5.4 Hz, CH2 C4a), 1.95 (1H, dddd, J = 16.3, 8.8, 2.5, 2.2 Hz, CH2 C4b), 0.83 (9H,
s, CH3 C9), 0.82 (9H, s, CH3 C9’), 0.07 (12H, s, CH3 C7 and CH3 C7’).
13C NMR : δ 143.2 (CH C6), 97.5 (CH C5), 79.8 (CH C2), 64.3 (CH C3), 62.6 (CH2 
C1), 30.4 (CH2 C4), 26.0 (CH3 C9), 25.7 (CH3 C9’), 18.5 (C C8), 18.0 (C C8’),  4.2
(CH3 C7a),  4.9 (CH3 C7a’),  5.10 (CH3 C7b),  5.3 (CH3 C7b’).
MS (CI) : m/z (Int) 359 (34), 97 (28), 86 (75), 82 (75), 69 (100). HRMS (C18H39O3Si2
+)
: calculated : 359.2438; obtained : 359.2440, (  = 0.6 ppm).
(4aR,8aS)-2,2-Di-tert-butyl-4,4a,8,8a-tetrahydropyrano[3,2-d][1,3,2]di-
oxasiline: 316
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Molecular weight: 270.4 g.mol−1
Method A: To a solution of diol 309 (5.26 g, 40.5 mmol) in DMF (101 mL)
at −45 ◦C was added di tert butylsilyl bis(triﬂuoromethanesulfonate) (14.4 mL, 44.6
mmol) dropwise. The reaction mixture was stirred at −45 ◦C for 1 h and pyridine (4.5
mL) was added. The solution was diluted with Et2O (200 mL). The organic phase
was washed with H2O (5 × 200 mL), dried (MgSO4) and concentrated under reduced
pressure. Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 99:1)
delivered the bis protected diol 316 (7.94 g, 29.4 mmol, 73%) as a white solid.
Method B: To a solution of di tert butyldichlorosilane (22.5 mL, 106 mmol) in
DMF (160 mL) at 0 ◦C was added silver nitrate (35.6 g, 211 mmol). The solution was
150stirred for 5 min at 0 ◦C and a solution of diol 309 (12.5 g, 96.2 mmol) in DMF (81
mL) was added to the reaction mixture. The reaction mixture was stirred at 0 ◦C for
1h15 and Et3N (66.4 mL, 480 mmol) was added. The solution was diluted with Et2O
(400 mL). The organic phase was washed with H2O (4 × 400 mL), dried (MgSO4) and
concentrated under reduced pressure. Puriﬁcation by ﬂash column chromatography
on silica gel (PE Et2O; 99:1) delivered the bis protected diol 315 (18.0 g, 66.7 mmol,
67%) as a white solid.
Rf = 0.75 (PE Et2O; 1:1)
m.p = 38−40 ◦C
IR: νmax 2931, 2859, 1645, 1472, 1238, 1126, 1076 cm−1.
[α]D (20.4 ◦C, CHCl3) = +40.1 (c = 1.00)
1H NMR: δ 6.26 (1H, ddd, J = 5.9, 2.3, 1.4 Hz, CH C6), 4.69 (1H, ddd, J = 5.9, 5.9,
2.0 Hz, CH C5), 4.18 (1H, dd, J = 10.3, 4.8 Hz, CH2 C1a), 4.11 (1H, ddd, J = 9.5,
9.5, 6.0 Hz, CH C3), 3.92 (1H, dd, J = 10.3, 10.3 Hz, CH2 C1b), 3.68 (1H, ddd, J =
10.3, 9.5, 4.8 Hz, CH C2), 2.38 (1H, dddd, J = 16.5, 6.0, 5.9, 1.4 Hz, CH2 C4a), 2.07
(1H, dddd, J = 16.5, 9.5, 2.3, 2.0 Hz, CH2 C4b), 1.06 (9H, s, CH3 C8), 0.99 (9H, s,
CH3 C8’).
13C NMR: δ 142.6 (CH C6), 98.9 (CH C5), 73.9 (CH C2), 71.4 (CH C3), 66.4 (CH2 
C1), 30.2 (CH2 C4), 27.5 (CH3 C8), 27.0 (CH3 C8’), 22.7 (C C7), 19.9 (C C7’).
MS (CI): m/z (Int) 271 (100), 213 (13). HRMS (C14H27O3Si+): calculated: 271.1729;
obtained: 271.1733, (  = 1.5 ppm).
Elemental analysis: calculated for C14H26O3Si: C 62.18, H 9.69; obtained: C 62.15,
H 9.79.
(4aR,6S,7R,8aS)-6-allyl-2,2-di-tert-butyl-7-(ethynyloxy)-7-methylhexa-
hydropyrano[3,2-d][1,3,2]dioxasiline: 320
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Molecular weight: 366.6 g.mol−1
To a suspension of KH (6.64 g, 49.8 mmol) in THF (70 mL) was added a solution of
alcohol 300 (8.50 g, 24.9 mmol) in THF (100 mL). The reaction mixture was stirred for
10 min at rt, then cooled to 0 ◦C. Trichloroethylene (2.68 mL, 29.9 mmol) was added
to the solution, and it was then subsequently warmed to rt and stirred for 3 h. The
reaction was quenched with MeOH (10 mL) and H2O (150 mL), and the aqueous phase
151was extracted with Et2O (2 × 200 mL). The combined organic phases were washed with
brine (200 mL), dried (MgSO4) and concentrated under reduced pressure. Puriﬁcation
by ﬂash chromatography on a small plug of silica gel gave the dichloroenol ether (10.8
g, 24.7 mmol), which was used directly in the next step.
To a solution of dichloroenol ether (10.8 g, 24.7 mmol) in Et2O (370 mL) cooled
to −78 ◦C was added dropwise a solution of n butyllithium (29.6 mL, 74.1 mmol) in
hexane (2.6M). The reaction was stirred 30 min at −78 ◦C, allowed to warm to −45 ◦C
and stirred for another 45 min. The reaction was quenched by addition of MeOH (10
mL) and H2O (150 mL) then extracted with Et2O (2 × 200 mL). The combined organic
phases were washed with brine (200 mL), dried (MgSO4) and concentrated under re 
duced pressure. The residue was puriﬁed by ﬂash column chromatography (PE Et2O;
99:1) to give the alkynylether 320 (8.17 g, 22.3 mmol, 90% over 2 steps) as a colourless
oil.
Rf = 0.63 (PE Et2O; 9:1)
[α]D (22.6 ◦C, CHCl3) = −53.0 (c = 1.02)
IR : νmax 3329, 2934, 2861, 2141, 1474, 1387, 1113 cm−1.
1H NMR : δ 5.84 (1H, dddd, J = 17.0, 10.2, 6.8, 6.8 Hz, CH C8), 5.11 (1H, d, J
= 17.0 Hz, CH2 C9a), 5.06 (1H, d, J = 10.2 Hz, CH2 C9b), 4.14 (1H, dd, J = 10.1,
4.9 Hz, CH2 C1a), 3.80 (1H, dd, J = 10.1, 10.1 Hz, CH2 C1b), 3.81−3.74 (1H, m,
CH C3), 3.50 (1H, dd, J = 10.1, 1.7 Hz, CH C6), 3.30 (1H, ddd, J = 10.1, 10.1, 4.9
Hz, CH C2), 2.50 (1H, dd, J = 11.8, 4.5 Hz, CH2 C4a), 2.38 (1H, ddd, J = 14.6, 6.8,
1.7 Hz, CH2 C7a), 2.11−2.02 (1H, m, CH2 C7b), 1.94 (1H, dd, J = 11.8, 11.8 Hz,
CH2 C4b), 1.62 (1H, s, CH C11), 1.40 (3H, s, CH3 C12), 1.03 (9H, s, CH3 C14), 0.98
(9H, s, CH3 C14’).
13C NMR : δ 134.8 (CH C8), 117.0 (CH2 C9), 85.8 (CH C11), 84.8 (C C5), 81.1 (CH 
C6), 78.1 (CH C2), 72.3 (CH C3), 66.7 (CH2 C1), 43.7 (CH2 C4), 33.0 (CH2 C7), 30.3
(C C10), 27.4 (CH3 C14), 27.1 (CH3 C14’), 22.7 (C C13), 20.0 (C C13’), 18.1 (CH3 
C12).
MS (FAB) : m/z (Int) 367 (22), 326 (100), 325 (100), 267 (100), 227 (100), 211 (91),
102 (93). HRMS (C20H35O4Si+) : calculated : 367.2305; obtained : 367.2302, (  =
0.8 ppm).
152(4aR,6S,7R,8aS)-6-Allyl-2,2-di-tert-butyl-7-methyl-7-(vinyloxy)-hexa-
hydropyrano[3,2-d][1,3,2]dioxasiline : 299
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Molecular weight: 368.6 g.mol−1
From alcohol 300: To a solution of alcohol 300 (0.26 g, 0.76 mmol) in butylvinylether
(3.9 mL) was added Et3N (31 µL, 0.22 mmol), 4,7 diphenyl 1,10 phenanthroline (12.5
mg, 0.038 mmol) and Pd(CF3CO2)2 (13 mg, 38 µmol). The reaction was stirred at
reﬂux for 24 h, ﬁltrated on activated carbon and concentrated under reduced pressure.
The crude product was puriﬁed by ﬂash chromatography (PE Et2O; 99:1→1:1) to give
the vinyl ether 299 (130 mg, 0.34 mmol, 45%) as a colourless oil and some starting
material (120 mg, yield = 84% BRSM).
From alkynyl ether 320: To a solution of alkyne 320 (8.17 g, 22.3 mmol) in EtOAc
(450 mL) was added quinoline (130 µL) and Lindlar catalyst (475 mg, 0.223 mmol).
The solution was purged with Ar three times then saturated with H2 three times. The
reaction was stirred for 45 min, then ﬁltered on Celite and concentrated under reduced
pressure. Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 99:1)
delivered the alkene 299 (7.84 g, 21.3 mmol, 96%) as a colourless oil.
Rf = 0.75 (PE Et2O; 4:1)
[α]D (24.1 ◦C, CHCl3) = −34.0 (c = 0.98)
IR : νmax 2934, 2961, 1634, 1474, 1180, 1096 cm−1.
1H NMR : δ 6.46 (1H, dd, J = 13.6, 6.2 Hz, CH C10), 5.87 (1H, dddd, J = 17.0,
10.4, 6.7, 6.7 Hz, CH C8), 5.10 (1H, dddd, J = 17.0, 1.8, 1.1, 1.1 Hz, CH2 C9a), 5.04
(1H, dddd, J = 10.4, 1.8, 1.1, 1.1 Hz, CH2 C9b), 4.48 (1H, dd, J = 13.6, 0.8 Hz,
CH2 C11a), 4.14 (1H, dd, J = 10.2, 4.9 Hz, CH2 C1a), 4.12 (1H, dd, J = 6.2, 0.8 Hz,
CH2 C11b), 3.81 (1H, dd, J = 10.2, 10.2 Hz, CH2 C1b), 3.76 (1H, ddd, J = 11.4, 9.3,
4.6 Hz, CH C3), 3.36 (1H, dd, J = 10.3, 2.2 Hz, CH C6), 3.29 (1H, ddd, J = 10.2, 9.3,
4.9 Hz, CH C2), 2.43 (1H, dddt, J = 14.8, 6.7, 2.2, 1.1 Hz, CH2 C7a), 2.36 (1H, dd,J
= 11.9, 4.6 Hz, CH2 C4a), 2.05−1.97 (1H, m, CH2 C7b), 1.68 (1H, dd, J = 11.9, 11.4
Hz, CH2 C4b), 1.27 (3H, s, CH3 C12), 1.03 (9H, s, CH3 C14), 0.98 (9H, s, CH3 C14’).
13C NMR : δ 114.7 (CH C10), 135.7 (CH C8), 116.5 (CH2 C9), 92.6 (CH2 C11), 82.6
(CH C6), 78.2 (CH C2), 72.2 (CH C3), 66.7 (CH2 C1), 65.0 (CH C5), 44.7 (CH2 C4),
32.9 (CH2 C7), 27.5 (CH3 C14), 27.1 (CH3 C14’), 22.7 (C C13), 20.0 (C C13’), 18.7
(CH3 C12).
153MS (CI) : m/z (Int) 369 (18), 325 (60), 85 (52), 71 (70), 69 (100). HRMS (C20H37O4Si+)
: calculated : 369.2461; obtained : 369.2462, (  = 0.3 ppm).
(4aR,8aR,9aS,10aS)-2,2-Di-tert-butyl-8a-methyl-4a,5,8a,9,9a,10a-hexa-
hydro-4H-1,3,8,10-tetraoxa-2-silaanthracene : 298
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Molecular weight: 340.5 g.mol−1
To a solution of diene 299 (120 mg, 0.33 mmol) in toluene (33 mL) was added
Grubbs’ second generation catalyst 3 (14 mg, 17 µmol). The reaction was stirred for 1
h at reﬂux and then concentrated under reduced pressure. Puriﬁcation by ﬂash column
chromatography (PE Et2O; 99:1, 1% Et3N) gave the cyclic enol ether 298 (110 mg,
0.31 mmol, 95%) as a white solid.
m.p = 110−112 ◦C
[α]D (23.8 ◦C, CHCl3) = −7.0 (c = 0.96)
IR : νmax 2934, 2857, 1645, 1474, 1240, 1173 cm−1.
1H NMR : δ 6.08 (1H, ddd, J = 6.1, 2.5, 1.3 Hz, CH C9), 4.55 (1H, ddd, J = 6.1,
5.8, 1.3 Hz, CH C8), 4.10 (1H, dd, J = 10.2, 4.9 Hz, CH2 C1a), 3.83 (1H, ddd, J =
11.4, 9.4, 4.7 Hz, CH C3), 3.77 (1H, dd, J = 10.2, 10.2 Hz, CH2 C1b), 3.40 (1H, dd,
J = 10.8, 5.8 Hz, CH C6), 3.33 (1H, ddd, J = 10.2, 9.4, 4.9 Hz, CH C2), 2.24 (1H,
dd, J = 11.7, 4.7 Hz, CH2 C4a), 2.10 (1H, dddd, J = 16.3, 5.8, 5.8, 1.3 Hz, CH2 C7a),
1.96−1.78 (1H, m, CH2 C7b), 1.61 (1H, dd, J = 11.7, 11.4 Hz, CH2 C4b), 1.48 (3H, s,
CH3 C10), 0.98 (9H, s, CH3 C12), 0.92 (9H, s, CH3 C12’).
13C NMR : δ 141.0 (CH C9), 97.8 (CH C8), 78.7 (CH C2), 77.2 (CH C6), 73.8 (C 
C5), 72.2 (CH C3), 67.0 (CH2 C1),45.5 (CH2 C4), 27.5 (CH3 C12), 27.1 (CH3 C12’),
23.7 (CH2 C7), 22.7 (C C11), 20.0 (C C11’), 16.7 (CH3 C10).
MS (CI) : m/z (Int) 341 (100), 283 (9), 97 (10). HRMS (C18H33O4Si+) : calculated :
341.2148; obtained : 341.2152, (  = 1.2 ppm).
Elemental analysis: calculated for C18H32O4Si: C 63.49, H 9.47; obtained: C 63.27,
H 9.48.
154(4aR,6S,7S,8aR,9aS,10aS)-2,2-Di-tert-butyl-7-ethynyl-8a-methyl-octahy-
dro-1,3,8,10-tetraoxa-2-sila-anthracen-6-ol: 327
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Molecular weight: 382.6 g.mol−1
To a solution of enol ether 298 (500 mg, 1.48 mmol) in CH2Cl2 (6.6 mL) at 0 ◦C was
added a solution of DMDO (21.0 mL, 1.78 mmol) in acetone. After 5 min at 0 ◦C, the
solution was concentrated under reduced pressure, diluted with CH2Cl2 (10 mL), dried
(Na2SO4) and concentrated under reduced pressure to give the crude epoxide (524 mg,
1.48 mmol, quant.) which was used without further puriﬁcation.
To a solution of sodium acetylide (1.74 mL, 5.92 mmol) at 0 ◦C was added a solution
of ZnCl2 (790 mg, 5.92 mmol) in Et2O (12 mL). The reaction mixture was stirred for
15 min at 0 ◦C, then a solution of epoxide (524 mg, 1.48 mmol) in CH2Cl2 (15 mL)
was added. The reaction mixture was allowed to warm slowly to 14 ◦C over 2.5 h.
The reaction was quenched with a saturated aqueous solution of NH4Cl (20 mL). The
aqueous phase was extracted with CH2Cl2 (3 × 20 mL), the combined organic phases
were washed with brine (20 mL), dried (MgSO4) and concentrated under reduced pres 
sure. Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 4:1→2:1)
delivered the alcohol 327 (310 mg, 0.811 mmol, 55%) as a white solid.
Rf = 0.34 (PE Et2O; 1:2)
m.p. = 176−178 ◦C
[α]D (22.4 ◦C, CHCl3) = −22.8 (c = 1.00)
IR : νmax 3486, 3277, 2934, 2861, 1474, 1101 cm−1.
1H NMR : δ 4.56 (1H, br s, CH C9), 4.15 (1H, dd, J = 9.6, 4.9 Hz, CH2 C1a), 4.00
(1H, br s, CH C8), 3.96−3.90 (1H, m, CH C3), 3.80 (1H, dd, J = 10.1, 9.6 Hz, CH2 
C1b), 3.74 (1H, dd, J = 12.5, 3.8 Hz, CH C6), 3.49−3.43 (1H, m, CH C2), 2.58 (1H, d,
J = 1.9 Hz, CH C11), 2.32 (1H, br s, OH), 2.24 (1H, dd, J = 11.6, 4.9 Hz, CH2 C4a),
2.12−2.07 (1H, m, CH2 C7a), 1.76−1.68 (2H, m, CH2 C4b and CH2 C7b), 1.25 (3H, s,
CH3 C12), 1.03 (9H, s, CH3 C14), 0.98 (9H, s, CH3 C14’).
13C NMR : δ 78.5 (CH C2), 76.2 (C C10), 74.6 (CH C11), 74.0 (CH C6), 73.1 (C C5),
71.5 (CH C3), 67.7 (CH C8), 65.9 (CH2 C1), 63.6 (CH C9), 45.0 (CH2 C4), 29.2 (CH2 
C7), 26.4 (CH3 C14), 26.1 (CH3 C14’), 21.6 (C C13), 18.9 (C C13’), 13.6 (CH3 C12).
MS (CI) : m/z (Int) 383 (73), 365 (41), 320 (40), 302 (100), 157 (72), 69 (53). HRMS
(C20H35O5Si+) : calculated : 383.2254; found : 383.2252, (  = 0.5 ppm).
155Elemental analysis: calculated for C20H34O5Si: C 62.79, H 8.96; obtained: C 62.74,
H 9.12.
(4aR,8aR,9aS,10aS)-2,2-Di-tert-butyl-8a-methyl-7-vinyl-4a,5,8a,9,9a,10a-
hexahydro-4H-1,3,8,10-tetraoxa-2-sila-anthracene: 331
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Molecular weight: 366.6 g.mol−1
To a stirred solution of Grubbs second generation catalyst (46 mg, 5.0 µmol) in
toluene (78 mL) was bubbled ethylene gas for 10 min. A solution of enyne 320 (0.40
g, 1.1 mmol) in toluene (31 mL) was added to the reaction mixture, which was heated
at 80 ◦C for 1.5 h under an atmosphere of ethylene. The reaction mixture was con 
centrated under reduced pressure and puriﬁcation by ﬂash column chromatography on
silica gel (PE Et2O; 99:1) delivered the diene 331 (360 mg, 0.98 mmol, 90%) as a white
solid.
Rf = 0.59 (PE Et2O; 4:1)
m.p = 110−111 ◦C
[α]D (23.4 ◦C, CHCl3) = −1.95 (c = 1.02)
IR : νmax 2934, 2859, 1603, 1472, 1377, 1350, 1101, 1040 cm−1.
1H NMR : δ 6.06 (1H, dd, J = 17.1, 10.8 Hz, CH C10), 5.45 (1H, d, J = 17.1 Hz,
CH2 C11a), 5.01 (1H, d, J = 10.8 Hz, CH2 C11b), 4.73 (1H, d, J = 5.7 Hz, CH C8),
4.17 (1H, dd, J = 10.0, 4.8 Hz, CH2 C1a), 3.92 (1H, ddd, J = 11.4, 11.4, 4.6 Hz,
CH C3), 3.84 (1H, dd, J = 10.2, 10.0 Hz, CH2 C1b), 3.49 (1H, dd, J = 10.7, 5.9 Hz,
CH C6), 3.40 (1H, ddd, J = 11.4, 10.2, 4.8 Hz, CH C2), 2.38 (1H, dd, J = 11.9, 4.6
Hz, CH2 C4a), 2.27 (1H, ddd, J = 17.2, 5.9, 5.7 Hz, CH2 C7a), 1.99 (1H, dd, J = 17.2,
10.7 Hz, CH2 C7b), 1.78 (1H, dd, J = 11.9, 11.4 Hz, CH2 C4b), 1.18 (3H, s, CH3 C12),
1.05 (9H, s, CH3 C14), 0.99 (9H, s, CH3 C14’).
13C NMR : δ 148.2 (C C9), 132.2 (CH C10), 112.8 (CH2 C11), 99.6 (CH C8), 78.7
(CH C2), 77.0 (CH C6), 73.6 (C C5), 72.2 (CH C3), 67.0 (CH2 C1), 45.6 (CH2 C4),
27.5 (CH3 C14), 27.1 (CH3 C14’), 24.6 (CH2 C7), 22.7 (C C13), 20.0 (C C13’), 16.6
(CH3 C12).
MS (FAB+) : m/z (Int) 367 (56), 309 (100), 271 (20), 227 (35), 122 (49), 77 (68).
HRMS (C20H35O4Si+) : calculated : 367.2305; found : 367.2306, (  = 0.3 ppm).
156(4aR,6S,7S,8aR,9aS,10aS)-2,2-Di-tert-butyl-8a-methyl-7-vinyl-octahydro-
1,3,8,10-tetraoxa-2-sila-anthracen-6-ol: 328
O
Si
O
3 3
2 2
1 1
4 4
5 5
6 6
O
O
9 9
8 8
7 7
10 10
H
Me
12 12
13 13
14 14
HO
H
H
11 C20H36O5Si
Molecular weight: 384.6 g.mol−1
To a solution of alkyne 327 (130 mg, 0.35 mmol) in EtOAc (7 mL) was added quino 
line (1 drop) and Lindlar catalyst (7.5 mg, 3.5 µmol). The solution was purged with
Ar three times then saturated with H2 three times. The reaction was stirred for 1 h,
then ﬁltered on Celite and concentrated under reduced pressure. Puriﬁcation by ﬂash
column chromatography on silica gel (PE Et2O; 3:1) delivered the alkene 328 (110 mg,
0.29 mmol, 84%) as a white solid.
Rf = 0.45 (PE Et2O; 1:2)
m.p. = 159−160 ◦C
[α]D (22.9 ◦C, CHCl3) = −37.6 (c = 0.87)
IR : νmax 3460, 2934, 2861, 1474, 1101, 1051, 826 cm−1.
1H NMR : δ 5.85 (1H, ddd, J = 17.4, 10.8, 4.4 Hz, CH C10), 5.46 (1H, ddd, J =
17.4, 1.7, 1.7 Hz, CH2 C11a), 5.34 (1H, ddd, J = 10.8, 1.7, 1.7 Hz, CH2 C11b), 4.32
(1H, dddd, J = 4.4, 1.7, 1.7, 1.7 Hz, CH C9), 4.17 (1H, dd, J = 9.9, 4.9 Hz, CH2 C1a),
4.00−3.91 (2H, m, CH C3 and CH C8), 3.82 (1H, dd, J= 10.1, 9.9 Hz, CH2 C1b), 3.68
(1H, dd, J = 12.7, 4.1 Hz, CH C6), 3.46 (1H, ddd, J = 10.1, 10.1, 4.9 Hz, CH C2), 2.24
(1H, dd, J = 11.7, 4.9 Hz, CH2 C4a), 2.07 (1H, ddd, J = 13.1, 4.1, 3.6 Hz, CH2 C7a),
1.81−1.68 (3H, m, CH2 C4b and CH2 C7b and OH), 1.26 (3H, s, CH3 C12), 1.04 (9H,
s, CH3 C14), 0.99 (9H, s, CH3 C14’).
13C NMR : δ 134.8 (CH C10), 117.8 (CH2 C11), 79.6 (CH C2), 76.0 (CH C6), 73.3
(C C5), 72.6 (CH C3), 71.9 (CH C9), 68.6 (CH C8), 67.1 (CH2 C1), 46.4 (CH2 C4),
31.2 (CH2 C7), 27.5 (CH3 C14), 27.1 (CH3 C14’), 22.7 (C C13), 22.0 (C C13’), 15.0
(CH3 C12).
MS (CI) : m/z (Int) 385 (84), 367 (19), 89 (100). HRMS (C20H37O5Si+) : calculated
: 385.2410; found : 385.2407, (  = 0.8 ppm).
Elemental analysis: calculated for C20H36O5Si: C 62.46, H 9.44; obtained: C 62.50,
H 9.63.
157(4aR,7S,8aR,9aS,10aS)-2,2-Di-tert-butyl-8a-methyl-7-vinyl-hexahydro-1,3,
8,10-tetraoxa-2-sila-anthracen-6-one: 381
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Molecular weight: 382.6 g.mol−1
To a solution of alcohol 328 (94 mg, 0.24 mmol) in CH2Cl2 (3.7 mL) was added
Dess Martin periodinane (0.14 g, 0.32 mmol). The reaction was stirred for 1.5 h, then
quenched by the addition of a saturated aqueous solution of Na2S2O3 (10 mL) and the
reaction mixture was stirred for 30 min at rt. The aqueous phase was extracted with
Et2O (2 × 7 mL), the combined organic phases were dried (MgSO4) and concentrated
under reduced pressure to deliver the ketone 368 (93 mg, 0.24 mmol) which was used
without further puriﬁcation.
(4aR,6R,7S,8aR,9aS,10aS)-2,2-Di-tert-butyl-8a-methyl-7-vinyl-octahydro-
1,3,8,10-tetraoxa-2-sila-anthracen-6-ol: 297
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Molecular weight: 384.6 g.mol−1
To a solution of ketone 368 (93 mg, 0.24 mmol) in a mixture of MeOH (3.6 mL)
and CH2Cl2 (3.6 mL) was added sodium borohydride (9.1 mg, 0.24 mmol). After 10
min, another portion of sodium borohydride (14 mg, 0.24 mmol) was added and the
reaction mixture was stirred for another 10 min. The reaction was quenched by the
addition of a saturated aqueous solution of NH4Cl (3 mL). The aqueous phase was ex 
tracted with Et2O (3 × 8 mL), the combined organic phases were dried (MgSO4) and
concentrated under reduced pressure. Puriﬁcation by ﬂash column chromatography on
silica gel (PE Et2O; 2:1 → 1:1) delivered the alcohol 297 (85 mg, 0.22 mmol, 90% (2
steps)) as a white solid.
Rf = 0.45 (PE Et2O; 1:2)
m.p. = 135−137 ◦C
[α]D (19 ◦C, CHCl3) = −42.6 (c = 1.05)
IR : νmax 3439, 2934, 2859, 1474, 1103, 1053, 826 cm−1.
1H NMR : δ 5.80 (1H, ddd, J = 17.3, 10.1, 7.2 Hz, CH 10), 5.40 (1H, d, J = 17.3
158Hz, CH2 C11a), 5.34 (1H, d, J = 10.1 Hz, CH2 C11b), 4.17 (1H, dd, J = 10.9, 4.8
Hz, CH2 C1a), 3.95 (1H, ddd, J = 9.6, 9.6, 4.9 Hz, CH C3), 3.88−3.84 (1H, dd, J =
9.2, 7.2 Hz, CH C9), 3.83 (1H, dd, J = 10.9, 10.9 Hz, CH2 C1b), 3.45−3.36 (2H, m,
CH C2 and CH C8), 3.25 (1H, dd, J = 12.5, 3.7 Hz, CH C6), 2.25 (1H, dd, J = 9.6,
4.8 Hz, CH2 C4a), 2.22−2.16 (1H, m, CH2 C7a), 1.74 (1H, br s, OH), 1.65−1.52 (2H,
m, CH2 C4b and CH2 C7b), 1.28 (3H, s, CH3 C12), 1.04 (9H, s, CH3 C14), 0.98 (9H,
s, CH3 C14’).
13C NMR : δ 136.2 (CH C10), 119.6 (CH2 C11), 79.5 (CH C2), 79.0 (CH C6), 76.2
(CH C9), 72.8 (C C5), 72.5 (CH C3), 69.9 (CH C8), 67.1 (CH2 C1), 46.3 (CH2 C4),
32.3 (CH2 C7), 27.5 (CH3 C14), 27.1 (CH3 C14’), 22.7 (C C13), 20.0 (C C13’), 15.9
(CH3 C12).
MS (CI) : m/z (Int) 385 (100), 367 (26), 327 (8). HRMS (C20H37O5Si+) : calculated
: 383.2410; found : 383.2404, (  = 1.6 ppm).
Elemental analysis: calculated for C20H36O5Si: C 62.46, H 9.44; obtained: C 61.96,
H 9.37.
1-[(4aR,6R,7S,8aR,9aS,10aS)-2,2-Di-tert-butyl-8a-methyl-7-vinyl-octa-
hydro-1,3,8,10-tetraoxa-2-sila-anthracen-6-yloxy]-3-(triphenyl-λ5-phospha-
nylidene)-propan-2-one: 382
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Molecular weight: 700.9 g.mol−1
To a solution of alcohol 297 (2.05 mg, 5.34 mmol) in THF (113 mL) was added
sodium hydride (848 mg, 21.2 mmol). The reaction mixture was stirred for 10 min and
TBAI (98 mg, 0.27 mmol) and phosphorane 333 (2.24 g, 6.36 mmol) were added. The
reaction mixture was stirred for 3 h at reﬂux, then cooled to 0 ◦C and H2O (20 mL)
was added carefully. The aqueous phase was extracted with Et2O (3 × 40 mL), the
combined organic phases were washed with brine (50 mL), dried (MgSO4) and concen 
trated under reduced pressure. Filtration on silica gel (CHCl3 MeOH; 98:2 → 95:5)
gave the phosphorane 382 (3.74 g, 5.34 mmol, quant), which was used directly in the
next step.
1591-[(4aR,6R,7S,8aR,9aS,10aS)-2,2-Di-tert-butyl-8a-methyl-7-vinyl-octa-
hydro-1,3,8,10-tetraoxa-2-sila-anthracen-6-yloxy]-but-3-en-2-one: 296
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Molecular weight: 452.7 g.mol−1
To a solution of phosphorane 369 (3.74 g, 5.34 mmol) in Et2O (45 mL) and pH=7
buﬀer (23 mL) was added a solution of formaldehyde (4.33 mL, 53.4 mmol) in water (37
%wt). The reaction was stirred for 1.5 h and diluted with H2O (40 mL). The aqueous
phase was extracted with Et2O (2 × 50 mL), the combined organic phases were washed
with brine (50 mL), dried (MgSO4) and concentrated under reduced pressure. Puriﬁ 
cation by ﬂash column chromatography on silica gel (PE Et2O; 25% → 33%) delivered
the enone 296 (1.51 mg, 3.34 mmol, 63% (2 steps)) as a colourless oil.
Rf = 0.64 (CHCl3:MeOH; 9:1)
[α]D (22.7 ◦C, CHCl3) = −65.7 (c = 0.85)
IR : νmax 2934, 2861, 1701, 1474, 1098, 1056, 826 cm−1.
1H NMR : δ 6.53 (1H, dd, J = 17.7, 10.6 Hz, CH C14), 6.32 (1H, dd, J = 17.7, 1.3
Hz, CH2 C15a), 5.92 (1H, ddd, J = 17.5, 10.4, 6.3 Hz, CH C10), 5.82 (1H, dd, J =
10.6, 1.3 Hz, CH2 C15b), 5.41 (1H, ddd, J = 17.5, 1.8, 1.3 Hz, CH2 C11a), 5.26 (1H,
ddd, J = 10.4, 1.8, 1.0 Hz, CH2 C11b), 4.31 (1H, d, J = 16.6 Hz, CH2 C12a), 4.24 (1H,
d, J = 16.6 Hz, CH2 C12b), 4.15 (1H, dd, J = 10.1, 4.8 Hz, CH2 C1a), 4.02 (1H, dd, J
= 9.3, 6.3 Hz, CH C9), 3.94 (1H, ddd, J = 11.3, 10.3, 4.9 Hz, CH C3), 3.82 (1H, dd, J
= 10.3, 10.1 Hz, CH2 C1b), 3.39 (1H, ddd, J = 10.3, 10.3, 4.8 Hz, CH C2), 3.23−3.15
(2H, m, CH C8 and CH C6), 2.32−2.23 (2H, m, CH2 C7a and CH2 C4a), 1.68−1.53
(2H, m, CH2 C7b and CH2 C4b), 1.28 (3H, s, CH3 C16), 1.04 (9H, s, CH3 C18), 0.98
(9H, s, CH3 C18’).
13C NMR : δ 196.7 (C C13), 136.2 (CH C10), 132.2 (CH C14), 129.5 (CH2 C15),
118.1 (CH2 C11), 79.4 (CH C2), 79.2 (CH C8), 78.7 (CH C6), 73.8 (CH2 C12), 73.3
(CH C9), 72.6 (C C5), 72.4 (CH C3), 67.0 (CH2 C1), 46.3 (CH2 C4), 30.4 (CH2 C7),
27.5 (CH3 C18), 27.1 (CH3 C18’), 22.7 (C C17), 20.0 (C C17’), 15.9 (CH3 C16).
MS (CI) : m/z (Int) 453 (58), 413 (18), 367 (30), 81 (54), 69 (100). HRMS (C24H40O6Si+)
: calculated : 453.2672; found : 453.2670, (  = 0.4 ppm).
160(4aR,5aS,6aR,11aS,12aR,13aS)-2,2-Di-tert-butyl-12a-methyl-4a,5a,6,6a,
11a,12a,13,13a-octahydro-4H-1,3,5,7,12-pentaoxa-2-sila-cyclohepta[b]anthra-
cen-9-one: 295
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Molecular weight: 424.6 g.mol−1
To a solution of enone 296 (735 mg, 1.63 mmol) in CH2Cl2 (326 mL) was added
Grubbs second generation catalyst (69.1 mg, 82.0 µmol) and the reaction mixture was
stirred at reﬂux for 24h. The solution was concentrated under reduced pressure and
the crude residue was puriﬁed by ﬂash column chromatography on silica gel (PE Et2O;
25%) to aﬀord tricyclic enone 295 (584 mg, 1.38 mmol, 84%) as a white solid.
Rf = 0.24 (PE Et2O; 4:1)
m.p = 205−207 ◦C
[α]D (23.6 ◦C, CHCl3) = +44.1 (c = 0.96)
IR : νmax 2934, 2859, 1672, 1472, 1101, 1051, 826 cm−1.
1H NMR : δ 6.51 (1H, dd, J = 12.8, 2.3 Hz, CH C10), 6.03 (1H, dd, J = 12.8, 2.6
Hz, CH C11), 3.37 (1H, d, J = 18.4 Hz, CH2 C13a), 4.25 (1H, d, J = 18.4 Hz, CH2 
C13b), 4.30 (1H, ddd, J = 9.1, 2.6, 2.3 Hz, CH C9), 4.17 (1H, dd, J = 10.2, 4.8 Hz,
CH2 C1a), 3.95 (1H, ddd, J = 11.4, 9.3, 5.0 Hz, CH C3), 3.82 (1H, dd, J = 10.2, 10.1
Hz, CH2 C1b), 3.46 (1H, ddd, J = 11.1, 9.1, 5.1 Hz, CH C8), 3.39 (1H, ddd, J = 10.1,
9.3, 4.8 Hz, CH C2), 3.21 (1H, dd, J = 12.6, 3.8 Hz, CH C6), 2.26 (1H, dd, J = 11.4,
5.0 Hz, CH2 C4a), 2.24−2.19 (1H, m, CH2 C7a), 1.73 (1H, ddd, J = 12.6, 11.8, 11.1
Hz, CH2 C7b), 1.56 (1H, dd, J = 11.4, 11.4 Hz, CH2 C4b), 1.30 (3H, s, CH3 C14), 1.04
(9H, s, CH3 C16), 0.98 (9H, s, CH3 C16’).
13C NMR : δ 201.2 (C C12), 146.6 (CH C10), 128.0 (CH C11), 79.8 (CH C8), 79.5
(CH C2), 78.7 (CH C6), 77.2 (CH2 C13), 73.3 (C C5), 73.1 (CH C9), 72.3 (CH C3),
67.0 (CH2 C1), 46.1 (CH2 C4), 31.5 (CH2 C7), 27.5 (CH3 C16), 27.1 (CH3 C16’), 22.7
(C C15), 20.0 (C C15’), 15.4 (CH3 C14).
MS (CI) : m/z (Int) 425 (100), 367 (18), 69 (13). HRMS (C22H37O6Si+) : calculated
: 425.2359; found : 425.2360, (  = 0.2 ppm).
Elemental analysis: calculated : C 62.23, H 8.55; found : C 62.36, H 8.74.
161Carbonic acid allyl ester (4aR,5aS,6aR,11aS,12aR,13aS)-2,2-di-tert-butyl-
12a-methyl-4a,5a,6,6a,11a,12a,13,13a-octahydro-4H-1,3,5,7,12-pentaoxa-2-sila-
cyclohepta[b]anthracen-9-yl ester: 347
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Molecular weight: 508.7 g.mol−1
To a solution of enone 295 (0.14 g, 0.32 mmol) in THF (3.2 mL) at −78 ◦C was
added allylchloroformate (51 µL, 0.48 mmol). The mixture was stirred for 2 min at
−78 ◦C and a solution of NaHMDS (0.48 mL, 0.48 mmol) in THF (1 M) was added.
The solution was stirred for 30 min at −78 ◦C. A 5% aqueous solution of KH2PO4 (2
mL) was added and the soltuion was diluted with Et2O (15 mL). The organic phase was
washed with brine (10 mL), dried (MgSO4) and concentrated under reduced pressure.
Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 95:5→9:1→1:1)
delivered the enol carbonate 347 (130 mg, 0.26 mmol, 80%) as a white solid, as well
as 20 mg of starting material (95% BRSM).
Rf = 0.43 (PE Et2O; 4:1)
m.p = 142−144 ◦C
[α]D (24.5 ◦C, CHCl3) = −5.6 (c = 1.00)
IR : νmax 2934, 2860, 1763, 1474, 1251, 1224, 1103, 1049 cm−1.
1H NMR : δ 6.70 (1H, s, CH C13), 6.00−5.90 (1H, m, CH C16), 5.78−5.70 (2H, m,
CH C10 and CH2 C11), 5.39 (1H, dtd, J = 17.2, 1.3, 1.1 Hz, CH2 C17a), 5.31 (1H, dtd,
J = 10.4, 1.3, 1.1 Hz, CH2 C17b), 4.67 (2H, dt, J = 5.8, 1.3 Hz, CH2 C15), 4.20−4.15
(2H, m, CH2 C1a and CH C9), 3.95 (1H, ddd, J = 11.4, 9.4, 5.1 Hz, CH C3), 3.83
(1H, dd, J = 10.2, 10.2 Hz, CH2 C1b), 3.65 (1H, ddd, J = 11.4, 7.5, 5.7 Hz, CH C8),
3.41 (1H, ddd, J = 10.2, 9.4, 5.1 Hz, CH C2), 3.24 (1H, dd, J = 12.8, 4.0 Hz, CH C6),
2.39−2.33 (1H, m, CH2 C7a), 2.25 (1H, dd, J = 11.8, 5.1 Hz, CH2 C4a), 1.78 (1H,
ddd, J = 12.8, 12.0, 11.4 Hz, CH2 C7b), 1.57 (1H, dd, J = 11.8, 11.4 Hz, CH2 C4b),
1.27 (3H, s, CH3 C18), 1.04 (9H, s, CH3 C20), 0.98 (9H, s, CH3 C20’).
13C NMR : δ 154.6 (C C14), 141.9 (CH C13), 133.1 (C C12), 131.1 (CH C16), 130.7
(CH), 120.8 (CH), 119.5 (CH2 C17), 79.4 (CH C2), 78.2 (CH C6), 77.0 (CH C8), 72.4
(CH C3), 71.9 (C C5), 70.4 (CH C9), 69.2 (CH2 C15), 67.0 (CH2 C1), 46.0 (CH2 C4),
31.1 (CH2 C7), 27.5 (CH3 C20), 27.1 (CH3 C20’), 22.7 (C C19), 20.0 (C C19’), 15.2
(CH3 C18).
162MS (FAB) : m/z (Int) 509 (25), 451 (28), 423 (20), 227 (76), 213 (30), 75 (100). HRMS
(C26H41O8Si+) : calculated : 509.2571; found : 509.2575, (  = 0.8 ppm).
Elemental analysis: calculated : C 61.39, H 7.93; found : C 61.61, H 8.05.
(4aR,5aS,6aR,8S,11aS,12aR,13aS)-8-Allyl-2,2-di-tert-butyl-12a-methyl-4a,
5a,6,6a,11a,12a,13,13a-octahydro-4H-1,3,5,7,12-pentaoxa-2-sila-cyclohepta[b]-
anthracen-9-one: 338a
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Molecular weight: 464.7 g.mol−1
From carbonate 347: To a solution of tris(dibenzylideneacetone)dipalladium (8.2
mg, 9.0 µmol) in THF (2 mL) was added (S) 4 tert butyl 2 [2 (diphenylphosphino)phenyl] 
2 oxazoline (8.7 mg, 22 µmol). The solution was stirred for 30 min at rt and a solution
of enol carbonate 347 (93 mg, 0.18 mmol) in THF (3.4 mL) was added to the reac 
tion mixture, which was stirred for 2 h at rt. The solution was concentrated under
reduced pressure and puriﬁcation by ﬂash column chromatography on silica gel (PE 
Et2O; 95:5→9:1) delivered the ketone 338a (73 mg, 0.16 mmol, 87%), contaminated
with dibenzylideneacetone.
From enone 295: To a solution of enone 295 (0.14 g, 0.34 mmol) in toluene (3.4
mL) was added 1 aminopiperidine (180 µL, 1.7 mmol). The solution was heated at
100 ◦C for 20 h with a Dean Stark apparatus. The solution was concentrated under
reduced pressure and the crude was ﬁltered through a small pad of deactivated alumina
(PE Et2O; 3:1) to give the hydrazone 339 (0.12 g, 0.24 mmol) as a yellow oil, which
was used directly in the next step.
To a solution of hydrazone 339 (0.12 g, 0.24 mmol) in THF (5 mL) at −100 ◦C
was added dropwise a solution of tert butyllithium (0.23 mL, 0.36 mmol) in hexanes
(1.6 M). The solution was stirred for 30 min at −78 ◦C and allyl bromide (62 µL,
0.72 mmol) was added. The solution was stirred for 4 h at −78 ◦C and a saturated
aqueous solution of NH4Cl (10 mL) was added. The aqueous phase was extracted with
Et2O (3 × 10 mL), the combined organic phases were washed with brine (10 mL),
dried (MgSO4) and concentrated under reduced pressure to give the crude alkylated
hydrazone (0.13 g, 0.24 mmol) which was used directly in the next step.
To a solution of crude hydrazone (0.13 g, 0.24 mmol) in THF (1 mL) was added a
solution of CuCl2 (0.13 g, 0.96 mmol) in H2O (1 mL). The mixture was stirred vigor 
163ously for 1.5 h at rt and a 50% solution of NH4OH in NH4Cl (10 mL) was added. The
aqueous phase was extracted with Et2O (3 × 10 mL), the combined organic phases
were washed with brine (10 mL), dried (MgSO4) and concentrated under reduced pres 
sure. Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 4:1→3:1)
delivered the enone 338 (31 mg, 66 µmol, 19% over 3 steps) as a mixture (1:5) of
diastereoisomers as a colourless oil.
To a solution of a mixture (1:5) of diastereoisomeric enones 338a and 338b (26
mg, 56 µmol) in CH2Cl2 (8 mL) was added DBU (25 µL, 170 mmol). The reaction
was stirred overnight at rt and diluted with EtOAc (10 mL). The organic phases were
washed with a saturated aqueous solution of KHSO4 (10 mL) and a saturated aqueous
solution of NaHCO3 (10 mL), dried (MgSO4) and concentrated under reduced pressure.
Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 10%) delivered
the enone 338a (18 mg, 38 µmol, 68%) as a mixture of diastereomers (8:1, 338a:338b).
Allyl enol ether: 348
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Molecular weight: 464.7 g.mol−1
To a solution of tris(dibenzylideneacetone)dipalladium (2.7 mg, 3.0 µmol) in toluene
(1.6 mL) was added triphenylphosphine (7.7 mg, 29 µmol). The solution was stirred for
5 min and carbonate 347 (30 mg, 59 µmol) in toluene (2 mL) was added. After 3 h at
rt, the reaction mixture was concentrated under reduced pressure and puriﬁcation by
ﬂash column chromatography on silica gel (PE Et2O; 95:5→9:1) delivered the ketone
338 (18 mg, 39 µmol, 66%) as a mixture of diastereomers (3:2, 338a:338b) and allyl
enol ether 348 (7.2 mg, 16 µmol, 27%) as a colourless oil.
Rf = 0.56 (PE Et2O; 4:1)
[α]D (22.9 ◦C, CHCl3) = −4.3 (c = 0.36)
IR : νmax 2934, 2859, 1474, 1159, 1102, 1050, 843, 827 cm−1.
1H NMR : δ 6.49 (1H, s, CH C13), 5.93 (1H, ddt, J = 17.2, 10.4, 5.6 Hz, CH C15),
5.86 (1H, ddd, J = 12.5, 2.6, 1.8 Hz, CH C10 or C11), 5.68 (1H, dd, J = 12.5, 1.8 Hz,
CH C11 or C10), 5.30 (1H, ddt, J = 17.2, 1.5, 1.5 Hz, CH2 C16a), 5.22 (1H, ddd, J
= 10.4, 1.5, 1.5 Hz, CH2 C16b), 4.17 (1H, dd, J = 10.0, 4.8 Hz, CH2 C1a), 4.15−4.12
(3H, m, CH C9 and CH2 C14), 3.95 (1H, ddd, J = 11.1, 9.3, 4.8 Hz, CH C3), 3.83 (1H,
dd, J = 10.2, 10.0 Hz, CH2 C1b), 3.48 (1H, ddd, J = 11.3, 7.7, 5.4 Hz, CH C8), 3.40
164(1H, ddd, J = 10.2, 9.3, 4.8 Hz, CH C2), 3.23 (1H, dd, J = 12.8, 3.9 Hz, CH C6), 2.31
(1H, ddd, J = 12.0, 5.4, 3.9 Hz, CH2 C7a), 2.26 (1H, dd, J = 11.8, 4.8 Hz, CH2 C4a),
1.75 (1H, ddd, J = 12.8, 12.0, 11.3 Hz, CH2 C7b), 1.58 (1H, dd, J = 11.8, 11.1 Hz,
CH2 C4b), 1.27 (3H, s, CH3 C17), 1.04 (9H, s, CH3 C19), 0.98 (9H, s, CH3 C19’).
13C NMR : δ 140.0 (C C12), 136.3 (CH C13), 133.8 (CH C10), 130.4 (CH C11), 122.9
(CH C15), 117.7 (CH2 C16), 79.5 (CH C2), 78.7 (CH C6), 77.1 (CH C8), 72.5 (CH 
C3), 72.1 (C C5), 72.1 (CH2 C14), 70.8 (CH C9), 67.2 (CH2 C1), 46.3 (CH2 C4), 31.5
(CH2 C7), 27.6 (CH3 C19), 27.2 (CH3 C19’), 22.8 (C C18), 20.1 (C C18’), 15.5 (CH3 
C17).
MS (CI) : m/z (Int) 465 (16), 407 (100). HRMS (C25H41O6Si+) : calculated : 465.2672;
found : 465.2675, (  = 0.6 ppm).
Trimethylsilyl enol ether: 349
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Molecular weight: 496.8 g.mol−1
To a solution of enone 295 (52 mg, 0.12 mmol) in THF (2.4 mL) at 0 ◦C was added
triethylamine (100 µL, 0.72 mmol) and TMSOTf (54 µL, 0.36 mmol). The solution
was then warmed to rt and stirred for 1h30. A saturated aqueous solution of NaHCO3
(3 mL) was added and the aqueous phase was extracted with EtOAc (3 × 5 mL). The
combined organic phases were dried (Na2SO4) and concentrated under reduced pres 
sure. Filtration on a short plug of oven dried silica gel (PE Et2O; 5%) gave the silyl
enol ether 349 (55 mg, 0.11 mmol, 94%) as a colourless oil.
Rf = 0.68 (PE Et2O; 4:1)
[α]D (23.5 ◦C, CHCl3) = −7.2 (c = 1.04)
IR : νmax 2933, 2860, 1474, 1255, 1100, 1050, 842, 826 cm−1.
1H NMR : δ 6.43 (1H, s, CH C13), 5.74 (1H, ddd, J = 12.4, 2.5, 1.6 Hz, CH C11), 5.60
(1H, dd, J = 12.4, 1.8 Hz, CH C10), 4.17 (1H, dd, J = 10.1, 4.9 Hz, CH2 C1a), 4.13
(1H, d, J = 7.6 Hz, CH C9), 3.95 (1H, ddd, J = 11.2, 9.3, 4.9 Hz, CH C3), 3.84 (1H,
dd, J = 10.2, 10.1 Hz, CH2 C1b), 3.47 (1H, ddd, J = 11.3, 7.6, 5.5 Hz, CH C8), 3.40
(1H, dd, J = 10.2, 9.3, 4.9 Hz, CH C2), 3.24 (1H, dd, J = 12.8, 3.9 Hz, CH C6), 2.32
(1H, ddd, J = 12.1, 5.5, 3.9 Hz, CH2 C7a), 2.25 (1H, dd, J = 11.7, 4.9 Hz, CH2 C4a),
1.75 (1H, ddd, J = 12.8, 12.1, 11.3 Hz, CH2 C7b), 1.58 (1H, dd, J = 11.7, 11.2 Hz,
165CH2 C4b), 1.27 (3H, s, CH3 C15), 1.04 (9H, s, CH3 C17), 0.98 (9H, s, CH3 C17’), 0.17
(9H, s, CH3 C14).
13C NMR : δ 137.5 (CH C13), 134.8 (C C12), 129.3 (CH C10), 124.8 (CH C11), 79.3
(CH C2), 78.5 (CH C6), 76.8 (CH C8), 72.4 (CH C3), 71.9 (C C5), 70.6 (CH C9), 66.9
(CH2 C1), 46.1 (CH2 C4), 31.3 (CH2 C7), 27.4 (CH3 C17), 27.0 (CH3 C17’), 22.6 (C 
C16), 19.9 (C C16’), 15.3 (CH3 C15),  0.1 (CH3 C14).
MS (CI): m/z (Int) 496 (83), 199 (20), 169 (20), 83 (100), 73 (54). HRMS (C25H44O6Si2
+):
calculated: 496.2676; obtained: 496.2672, (  = 0.8 ppm).
(S)-2-bromo-N-(1-hydroxy-3,3-dimethylbutan-2-yl)benzamide: 383
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Molecular weight: 300.2 g.mol−1
To a solution of (S) tert leucinol (500 mg, 4.27 mmol) in CH2Cl2 (14 mL) was added
a solution of Na2CO3 (1.36 g, 12.8 mmol) in H2O (10.5 mL) and 2 bromobenzoyl chlo 
ride (648 µL, 4.96 mmol). The reaction mixture was stirred overnight at rt. The
aqueous phase was extracted with CH2Cl2 (3 × 15 mL) and to the combined organic
phases was added a 1 M solution of KOH in MeOH (2 mL). The solution was stirred
for 15 min at rt and the pH of the solution was adjusted to 7 by adding a 1 M aqueous
solution of HCl. The aqueous phase was then extracted with CH2Cl2 (2 × 15 mL),
the combined organic phases were dried (Na2SO4) and concentrated under reduced
pressure. Puriﬁcation by ﬂash column chromatography on silica gel (PE acetone =
3:1→65:35) gave the amide 383 (1.20 g, 4.00 mmol, 94%) as a colourless solid.
Rf = 0.50 (PE acetone; 1:1)
m.p. = 117−119 ◦C, lit.225 m.p. = 110−112 ◦C
[α]D (22.1 ◦C, CHCl3) = −3.1 (c = 1.00), lit.225 [α]D (21 ◦C, CHCl3) = −2.2 (c =
1.00)
IR : νmax 3240, 3069, 2961, 1636, 1555, 1468, 1367, 1052, 1020 cm−1.
1H NMR : δ 7.59 (1H, dd, J = 8.0, 1.1 Hz, CH Arom), 7.56 (1H, dd, J = 7.6, 1.8
Hz, CH Arom), 7.36 (1H, ddd, J = 8.0, 7.6, 1.1 Hz, CH Arom), 7.31−7.25 (1H, m, CH
Arom), 6.17 (1H, br s, NH), 4.07 (1H, ddd, J = 11.0, 7.6, 3.5 Hz, CH C8), 3.95 (1H,
dd, J = 11.4, 3.5 Hz, CH2 C9a), 3.68 (1H, dd, J = 11.4, 7.6 Hz, CH2 C9b), 2.39 (1H,
br s, OH), 1.04 (9H, s, CH3 C11).
16613C NMR : δ 168.8 (C C7), 138.0 (C C2), 133.5 (CH Arom), 131.5 (CH Arom), 129.9
(CH Arom), 127.8 (CH Arom), 119.2 (C C1), 63.8 (CH C8), 60.5 (CH2 C9), 33.9 (C 
C10), 272. (CH3 C11).
MS (CI): m/z (Int) 302 (63), 300 (64), 222 (100), 204 (34), 107 (31).
HRMS (C13H19BrNO2
+): calculated: 300.0599; obtained: 300.0596, (  = 1.0 ppm).
(S)-2-(2-bromophenyl)-4-tert-butyl-4,5-dihydrooxazole: 352
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Molecular weight: 282.2 g.mol−1
To a solution of amide 383 (1.2 g, 3.9 mmol) in CH2Cl2 (29 mL), was added p 
toluenesulfonyl chloride (0.97 g, 5.1 mmol) and triethylamine (2.7 mL, 19 mmol). The
reaction mixture was stirred for 22 h at 55 ◦C, then H2O (4 mL) was added and the
reaction mixture was stirred for another 2 h at 75 ◦C. The aqueous phase was extracted
with CH2Cl2 (2 × 15 mL), the combined organic phases were dried (Na2SO4) and con 
centrated under reduced pressure. Puriﬁcation by ﬂash column chromatography on
silica gel (PE EtOAc; 97:3→95:5→92:8→9:1) gave the oxazole 352 (0.83 g, 2.9 mmol,
75%) as a white solid.226
Rf = 0.54 (PE acetone; 1:1)
m.p. = 49−50 ◦C, lit.227 m.p. = 47−48 ◦C
[α]D (24.2 ◦C, CHCl3) = −70.0 (c = 1.00), lit.228 [α]D (24.2 ◦C, CHCl3) = −87.0 (c =
2.6)
IR : νmax 2959, 2866, 1661, 1588, 1477, 1358, 1273, 1241, 1207, 1096, 1023, 960, 907,
760 cm−1.
1H NMR : δ 7.66 (1H, J = 7.6, 1.9 Hz, CH Arom), 7.63 (1H, dd, J = 8.0, 1.3 Hz, CH
Arom), 7.34 (1H, ddd, J = 7.6, 7.5, 1.3 Hz, CH Arom), 7.30−7.25 (1H, m, CH Arom),
4.39 (1H, dd, J = 10.2, 8.1 Hz, CH2 C9a), 4.26 (1H, dd, J = 8.6, 8.1 Hz, CH2 C9b),
4.11 (1H, dd, J = 10.2, 8.6 Hz, CH C8), 1.00 (9H, s, CH3 C11).
13C NMR : δ 162.8 (C C7), 133.7 (CH Arom), 131.5 (CH Arom), 131.3 (CH Arom),
130.3 (C C2), 127.1 (CH Arom), 121.9 (C C1), 76.7 (CH C8), 69.0 (CH2 C9), 34.0
(C C10), 26.0 (CH3 C11).
MS (CI): m/z (Int) 284 (85), 282 (89), 204 (100). HRMS (C13H16BrNO+): calculated:
282.0494; obtained: 282.0498, (  = 1.4 ppm).
167(S)-4-tert-butyl-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole: 345
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Molecular weight: 387.5 g.mol−1
To a solution of copper iodide (8.3 mg, 44 µmol) in toluene (1.5 mL) was added
DMEDA (33 µL, 0.31 mmol) and diphenylphosphine (0.12 mL, 0.66 mmol). The reac 
tion mixture was stirred for 20 min at rt and aryl bromide 352 (0.10 g, 0.35 mmol),
cesium carbonate (0.43g, 1.3 mmol) and toluene (1.5 mL) were added. The ﬂask was
sealed and the stirring was continued for 6 h at 110 ◦C. The reaction mixture was
ﬁltered, the solid residue washed with CH2Cl2 (2 × 2 mL) and the combined organic
phases were concentrated under reduced pressure. Puriﬁcation by ﬂash column chro 
matography on silica gel (PE Et2O; 97:3→95:5→93:7) gave the phosphine 345 (86 mg,
0.22 mmol, 62%) as a white solid.
Rf = 0.21 (PE Et2O; 9:1)
m.p. = 109−112 ◦C, lit.227 m.p. = 113−114 ◦C
[α]D (23.7 ◦C, CHCl3) = −72.4 (c = 0.98), lit.229 [α]D (21 ◦C, CHCl3) = −61.9 (c =
1.76)
IR : νmax 2959, 1661, 1589, 1477, 1358, 1338, 1096, 1023, 959, 907, 760 cm−1.
1H NMR : δ 7.96−7.92 (1H, m, CH Arom), 7.38−7.22 (12H, m, CH Arom), 6.88−6.85
(1H, m, CH Arom), 4.08 (1H, dd, J = 10.2, 8.4 Hz, CH2 C9a), 4.01 (1H, dd, J = 8.4,
8.2 Hz, CH2 C9b), 3.88 (1H, dd, J = 10.2, 8.2 Hz, CH C8), 0.72 (9H, s, CH3 C11).
13C NMR : δ 162.8 (C C7), 138.9 (d, J = 25.7 Hz, C Arom), 138.6 (C Arom), 138.3
(C Arom), 138.1 (C Arom), 134.5 (d, J = 21.0 Hz, CH Arom), 134.3 (CH Arom), 133.7
(d, J = 20.2 Hz, CH Arom), 130.5 (CH Arom), 130.0 (d, J = 3.1 Hz, CH Arom), 128.6
(d, J = 10.0 Hz, CH Arom), 128.5 (CH Arom), 128.4 (d, J = 5.9 Hz, CH Arom),
128.4 (CH Arom), 128.2 (CH Arom), 76.8 (CH C8), 68.4 (CH2 C9), 33.8 (C C10), 25.9
(CH3 C11).
MS (EI) : m/z (Int) 387 (9), 272 (12), 330 (74), 302 (100). HRMS (C25H26NOP+) :
calculated : 387.1752; obtained : 387.1750, (  = 0.5 ppm).
168(4aR,5aS,6aR,8S,9R,11aS,12aR,13aS)-8-Allyl-2,2-di-tert-butyl-12a-methyl-
4a,5a,6,6a,8,9,11a,12a,13,13a-decahydro-4H-1,3,5,7,12-pentaoxa-2-sila-cyclo
hepta[b]anthracen-9-ol: 353
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Molecular weight: 466.7 g.mol−1
To a solution of ketone 338a (73 mg, 0.16 mmol) in CH2Cl2 (1.7 mL) and MeOH
(1.7 mL) was added cerium chloride heptahydrate (63 mg, 0.17 mmol). The solution
was cooled to −78 ◦C and sodium borohydride (7.7, mg, 0.20 mmol) was added. After 1
h at −78 ◦C, H2O (3 mL) was added and the aqueous phase was extracted with CH2Cl2
(3 × 5 mL). The combined organic phases were dried (MgSO4) and concentrated under
reduced pressure. Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O;
9:1→4:1) delivered the alcohol 349 (71 mg, 0.15 mmol, 95%) as a colourless oil.
Rf = 0.12 (PE Et2O; 4:1)
[α]D (26.5 ◦C, CHCl3) = −11.7 (c = 1.00)
IR : νmax 3464, 2934, 2860, 1474, 1095, 1058, 827, 764 cm−1.
1H NMR : δ 5.93 (1H, dddd, J = 17.2, 10.2, 6.9, 6.9 Hz, CH C15), 5.67 (1H, ddd,
J = 12.9, 1.8, 1.8 Hz, CH C10), 5.62 (1H, d, J = 12.9 Hz, CH C11), 5.14−5.10 (1H,
m, CH2 C16a), 5.10−5.05 (1H, m, CH2 C16b), 4.16−4.13 (3H, m, CH C9 and CH 
C12 and CH2 C1a), 3.93 (1H, ddd, J = 11.2, 9.4, 4.9 Hz, CH C3), 3.82 (1H, dd, J =
10.2, 10.2 Hz, CH2 C1b), 3.40−3.25 (3H, m, CH C2 and CH C13 and CH C8), 3.17
(1H, dd, J = 12.7, 3.8 Hz, CH C6), 2.59−2.53 (1H, m, CH2 C14a), 2.29−2.25 (1H,
m, CH2 C14b), 2.22 (1H, dd, J = 11.6, 4.9 Hz, CH2 C4a), 2.07 (1H, ddd, J = 12.0,
4.5, 3.8 Hz, CH2 C7a), 1.70 (1H, d, J = 6.0 Hz, OH), 1.62 (1H, ddd, J = 12.7, 12.0,
11.9 Hz, CH2 C7b), 1.57−1.51 (1H, m, CH2 C4b), 1.24 (3H, s, CH3 C17), 1.03 (9H, s,
CH3 C19), 0.98 (9H, s, CH3 C19’).
13C NMR : δ 135.1 (CH C15), 134.3 (CH C10 or C11), 132.5 (CH C11 or C10), 117.2
(CH2 C16), 84.1 (CH C13), 80.2 (CH C8), 79.6 (CH C2), 79.1 (CH C6), 73.9 (CH 
C12), 72.9 (CH C9), 72.6 (CH C3), 72.6 (C C5), 67.2 (CH2 C1), 46.4 (CH2 C4), 37.6
(CH2 C14), 32.0 (CH2 C7), 27.6 (CH3 C19), 27.2 (CH3 C19’), 22.8 (C C18), 20.1 (C 
C18’), 15.6 (CH3 C17).
MS (CI) : m/z (Int) 467 (96), 449 (100), 409 (28), 327 (12), 107 (15). HRMS
(C25H43O6Si+) : calculated : 467.2829; found : 467.2828, (  = 0.2 ppm).
169(4aR,5aS,6aR,8S,9R,11aS,12aR,13aS)-8-Allyl-2,2-di-tert-butyl-9-(tert-butyl-
dimethyl-silanyloxy)-12a-methyl-4a,5a,6,6a,8,9,11a,12a,13,13a-decahydro-4H-
1,3,5,7,12-pentaoxa-2-sila-cyclohepta[b]anthracene: 354
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Molecular weight: 580.9 g.mol−1
To a solution of alcohol 349 (69 mg, 0.15 mmol) in CH2Cl2 (3 mL) at 0 ◦C was added
2,6 lutidine (110 µL, 0.90 mmol) and tert butyldimethylsilyl triﬂuoromethanesulfonate
(100 µL, 0.45 mmol). The solution was stirred for overnight at rt and a saturated
aqueous solution of NaH2CO3 (5 mL) was added. The aqueous phase was extracted
with CH2Cl2 (3 × 5 mL) and the combined organic phases were washed with brine (5
mL), dried (MgSO4) and concentrated under reduced pressure. Puriﬁcation by ﬂash
column chromatography on silica gel (PE Et2O; 98:2→95:5) delivered the protected
alcohol 350 (71 mg, 0.12 mmol, 82%) as a white solid.
Rf = 0.75 (PE Et2O; 1:1)
m.p = 64−66 ◦C
[α]D (24.2 ◦C, CHCl3) = −15.8 (c = 0.98)
IR : νmax 2931, 2859, 1473, 1252, 1090, 1060, 872, 837, 767 cm−1.
1H NMR : δ 5.85 (1H, dddd, J = 17.1, 10.2, 6.8, 6.8 Hz, CH C15), 5.65 (1H, ddd, J =
12.7, 2.4, 2.4 Hz, CH C10 or C11), 5.57 (1H, ddd, J = 12.7, 2.1 Hz, CH C11 or C10),
5.08−5.00 (2H, m, CH2 C16), 4.18−4.12 (2H, m, CH C9 and CH2 C1a), 4.08 (1H, ddd,
J = 8.6, 4.1, 2.1 CH C12), 3.93 (1H, ddd, J = 11.1, 9.3, 4.9 Hz, CH C3), 3.82 (1H, dd,
J = 10.2, 10.2 Hz, CH2 C1b), 3.40−3.32 (2H, m, CH C2 and CH C13), 3.24 (1H, ddd,
J = 11.3, 9.3, 5.1 Hz, CH C8), 3.16 (1H, dd, J = 12.7, 3.9 Hz, CH C6), 2.53 (1H, dd,
J = 14.4, 6.8 Hz, CH2 C14a), 2.22 (1H, dd, J = 11.7, 4.9 Hz, CH2 C4a), 2.09−1.97
(2H, m, CH2 C7a and CH2 C14b), 1.61 (1H, ddd, J = 12.7, 12.1, 11.3 Hz, CH2 C7b),
1.58−1.51 (1H, m, CH2 C4b), 1.24 (3H, s, CH3 C17), 1.03 (9H, s, CH3 C19), 0.98 (9H,
s, CH3 C19’), 0.90 (9H, s, CH3 C22), 0.08 (3H, s, CH3 C20), 0.06 (3H, s, CH3 C20’).
13C NMR : δ 136.5 (CH C10 or C11), 135.6 (CH C15), 131.9 (CH C11 or C10), 116.6
(CH2 C16), 85.0 (CH C13), 79.9 (CH C8), 79.5 (CH C2), 79.1 (CH C6), 74.7 (CH 
C12), 73.0 (CH C9), 72.6 (CH C3), 72.5 (C C5), 67.2 (CH2 C1), 46.4 (CH2 C4), 37.2
(CH2 C14), 31.9 (CH2 C7), 27.6 (CH3 C19), 27.2 (CH3 C19’), 26.0 (CH3 C22), 22.8
(C C18), 20.1 (C C18’), 18.2 (C C21), 15.7 (CH3 C17),  4.2 (CH3 C20),  4.7 (CH3 
C20’).
170MS (CI) : m/z (Int) 581 (42), 449 (100), 133 (29), 69 (100). HRMS (C31H57O6Si2
+) :
calculated : 581.3694; found : 581.3691, (  = 0.5 ppm).
Elemental analysis: calculated : C 64.09, H 9.72; found : C 64.10, H 9.75.
Dithiane: 356
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Molecular weight: 673.1 g.mol−1
To a solution of diene 350 (0.12 g, 0.21 mmol) in THF (1.8 mL) was added a solution
of N methylmorpholin N oxide (26 mg, 0.22 mmol) in H2O (0.2 mL) and a solution
of osmium tetroxide (92 µL, 14 µmol) in H2O (4% wt). After stirring overnight at rt,
the reaction was quenched by the addition of a saturated aqueous solution of Na2S2O3
(2 mL) and stirred for another 15 min at rt. The aqueous phase was extracted with
EtOAc (3 × 5 mL), the combined organic phases were dried (MgSO4) and concentrated
under reduced pressure. Flash chromatography on a short pad of silica gel (PE Et2O;
9:1→1:1→pure Et2O) gave the diol 351 as a 1:1 mixture of diastereoisomers (69 mg,
0.11 mmol, 54%) and 36 mg of starting material (78% BRSM).
To a solution of the diol (69 mg, 0.11 mmol) in THF (0.8 mL) was added a solution
of sodium periodate (47 mg, 0.22 mmol) in H2O (0.3 mL). The solution was stirred
for 1.5 h at rt, then diluted with H2O (5 mL). The aqueous phase was extracted with
Et2O (3 × 5 mL) and the combined organic phases were washed with brine (5 mL),
dried (Na2SO4) and concentrated under reduced pressure to deliver the crude aldehyde,
which was used directly in the next step.
To a solution of crude aldehyde (60 mg, 0.10 mmol) in CH2Cl2 (1 mL) was added 1,3 
propanedithiol (20 µL, 0.20 mmol). The solution was cooled to −30 ◦C and BF3·Et2O
(12 µL, 0.10 mmol) was slowly added. The reaction mixture was stirred for 15 min at
−30 ◦C and a saturated aqueous solution of NaHCO3 (2 mL) was added. The aqueous
phase was extracted with CH2Cl2 (3 × 5 mL) and the combined organic phases were
washed with brine (5 mL), dried (MgSO4) and concentrated under reduced pressure.
Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 95:5→9:1) deliv 
ered the dithiane 352 (40.4 mg, 60 µmol, 53% over 2 steps) as a colourless oil.
Rf = 0.58 (PE Et2O; 4:1)
[α]D (23.5 ◦C, CHCl3) = +58.6 (c = 0.27)
IR : νmax 2932, 2858, 1473, 1253, 1090, 1060, 870, 838, 767 cm−1.
1711H NMR : δ 5.64 (1H, ddd, J = 12.8, 2.0, 1.8 Hz, CH C10 or C11), 5.57 (1H, ddd,
J = 12.8, 2.1, 1.8 Hz, CH C11 or C10), 4.19−4.13 (3H, CH C9 and CH C15 and CH2 
C1a), 4.06 (1H, dd, J = 8.6, 1.8 Hz, CH C12), 3.93 (1H, ddd, J = 11.0, 9.5, 4.9 Hz,
CH C3), 3.83 (1H, dd, J = 10.2, 10.1 Hz, CH2 C1b), 3.61 (1H, ddd, J = 11.0, 8.6,
2.5 Hz, CH C13), 3.39 (1H, ddd, J = 10.1, 9.5, 4.7 Hz, CH C2), 3.30 (1H, ddd, J =
10.9, 9.4, 5.1 Hz, CH C8), 3.20 (1H, dd, J = 12.6, 3.8 Hz, CH C6), 2.89−2.70 (4H,
m, CH2 C16), 2.28−2.20 (2H, m, CH2 C14a and CH2 C4a), 2.14−2.06 (2H, m, CH2 
C7a and CH2 C17a), 1.94−1.84 (1H, m, CH2 C17b), 1.72−1.52 (3H, m, CH2 C14b and
CH2 C7b and CH2 C4b), 1.24 (3H, s, CH3 C18), 1.03 (9H, s, CH3 C20), 0.97 (9H, s,
CH3 C20’), 0.90 (9H, s, CH3 C23), 0.07 (3H, s, CH3 C21), 0.06 (3H, s, CH3 C21’).
13C NMR : δ 136.2 (CH C10 or C11), 131.9 (CH C11 or C10), 81.1 (CH C13), 80.0
(CH C8), 79.5 (CH C2), 79.0 (CH C6), 74.6 (CH C12), 72.9 (CH C9), 72.6 (CH C3),
72.5 (C C5), 67.2 (CH2 C1), 46.4 (CH2 C4), 44.1 (CH C15), 38.3 (CH2 C14), 32.0
(CH2 C7), 30.3 (CH2 C16), 29.8 (CH2 C16’), 27.6 (CH3 C20), 27.2 (CH3 C20’), 26.3
(CH2 C17), 26.0 (CH3 C23), 22.8 (C C19), 20.1 (C C19’), 18.1 (C C22), 15.6 (CH3 
C18),  4.3 (CH3 C21),  4.6 (CH3 C21’).
MS (FAB) : m/z (Int) 695 (6), 615 (9), 557 (24), 228 (83), 123 (93), 78 (100).
Elemental analysis: calculated : C 58.88, H 8.98; found : C 58.71, H 9.04.
2-methylenepentyl 1H-imidazole-1-carboxylate: 370
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Molecular weight: 194.2 g.mol−1
To an aqueous solution of formaldehyde (5.7 mL, 70 mmol) was added valeraldehyde
(6.2 mL, 58 mmol) and dimethylamine hydrochloride (5.7 g, 70 mmol). The reaction
mixture was stirred for 20 h at 70 ◦C, then diluted with water (20 mL) and extracted
with Et2O (3 × 20 mL). The combined organic phases were dried (Na2SO4) and con 
centrated carefully under reduced pressure to deliver the crude unsaturated aldehyde
(5.7 g, 58 mmol), which was used directly in the next reaction.
To a solution of crude unsaturated aldehyde (5.7 g, 58 mmol) in MeOH (200 mL)
at 0 ◦C was added CeCl3·7H2O (22 g, 58 mmol) and NaBH4 (2.7 g, 70 mmol) portion 
wise. After 30 min at rt, H2O (200 mL) was added. The aqueous phase was extracted
with CH2Cl2 (3 × 200 mL), the combined organic phases were washed with brine (200
mL), dried (MgSO4) and carefully concentrated under reduced pressure. Puriﬁcation
by ﬂash column chromatography on silica gel (PE Et2O; 3:1 → 1:1) gave the allylic
172alcohol 368 (5.2 g, 5.2 mmol, 89% over 2 steps) which was used directly in the next
reaction.
To a solution of allylic alcohol 368 (2.00 g, 20.0 mmol) in THF (100 mL) at 0 ◦C was
added 1,1’ carbonyldiimidazole (4.86 g, 30.0 mmol). After 1 h at 0 ◦C, the reaction
mixture was warmed to rt and stirred for another hour. The solution was concentrated
under reduced pressure and puriﬁcation by ﬂash column chromatography on silica gel
(PE Et2O; 3:1 → 1:1) delivered the carbamate 370 (3.40 g, 17.5 mmol, 88%) as a
colourless oil.
Rf = 0.32 (PE Et2O; 1:1)
IR : νmax 2961, 2874, 1759, 1393, 1280, 1237, 1169, 1095 cm−1.
1H NMR : δ 8.15 (1H, s, CH C8), 7.44 (1H, dd, J = 1.4, 1.4 Hz, CH C9 or CH C10),
7.08 (1H, s, CH 10 or CH C9), 5.14 (1H, s, CH2 C6a), 5.06 (1H, s, CH2 C6b), 4.84 (2H,
s, CH2 C5), 2.11 (2H, t, J = 7.6 Hz, CH2 C3), 1.53 (2H, tq, J = 7.6, 7.3 Hz, CH2 C2),
0.95 (3H, t, J = 7.3 Hz, CH3 C1).
13C NMR : δ 148.5 (C C7), 142.2 (C C4), 137.1 (CH C8), 130.8 (CH C10), 117.1 (CH 
C9), 114.3 (CH2 C6), 70.5 (CH2 C5), 35.2 (CH2 C3), 20.7 (CH2 C2), 13.7 (CH3 C1).
MS (FAB): m/z (Int) 195 (100), 151 (100), 137 (37), 83 (97), 69 (100), 55 (93), 42 (91).
HRMS (C10H15O2N2
+): calculated: 195.1134; obtained: 195.1133, (  = 0.5 ppm).
(2R,4aR,9aS)-2-methyl-4a,9a-dihydro-4H-[1,3]dioxino[5,4-b]oxepin-7-yl-2-
methylenepentyl carbonate : 372
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Molecular weight: 310.1 g.mol−1
Method A: To a solution of carbamate 370 (0.11 g, 0.57 mmol) in THF (1.5 mL) at
0 ◦C was added BF3·Et2O (70 µL, 0.57 mmol). The solution was stirred for 1 h at rt.
Separately, to a solution of enone 371 (76 mg, 0.41 mmol) in THF (2.5 mL) at −78 ◦C
was added NaHMDS (0.29 mL, 0.57 mmol). After 2 min at −78 ◦C, the solution
of carbamate 370 and BF3·Et2O pre cooled to −78 ◦C was added by cannula to the
enolate solution at −78 ◦C and the reaction mixture was stirred for 30 min at −78 ◦C.
The reaction was quenched by the addition of a saturated aqueous solution of NH4Cl
(2 mL). The aqueous phase was extracted with Et2O (3 × 10 mL) and the combined
organic phases were washed with brine (10 mL), dried (MgSO4) and concentrated under
173reduced pressure. Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O;
92:8→9:1) gave the carbonate 372 (71 mg, 0.23 mmol, 55%) as a colourless oil.
Method B: To a solution of carbamate 370 (74 mg, 0.38 mmol) in THF (1 mL) at
0 ◦C was added BF3·Et2O (47 µL, 0.38 mmol). After 1 h at rt, the solution was cooled
to −78 ◦C and a solution of enone 371 (50 mg, 0.27 mmol) in THF (2 mL) was added
by cannula into the carbamate solution at −78 ◦C. The reaction mixture was stirred
for 10 min at −78 ◦C and a solution of KHMDS (0.76 mL, 0.38 mmol) in THF (0.5
M) was added. The reaction mixture was stirred for 30 min at −78 ◦C. The reaction
was quenched by the addition of a saturated aqueous solution of NH4Cl (2 mL). The
aqueous phase was extracted with Et2O (3 × 10 mL) and the combined organic phases
were washed with brine (10 mL), dried (MgSO4) and concentrated under reduced pres 
sure. Puriﬁcation by ﬂash column chromatography on silica gel (PE Et2O; 9:1) gave
the carbonate 372 (58 mg, 0.19 mmol, 69%) as a colourless oil.
Rf = 0.68 (PE Et2O; 1:1)
[α]D (23.8 ◦C, CHCl3) = −6.5 (c = 1.00)
IR : νmax 2961, 2873, 1759, 1406, 1224, 1161, 1132, 1033 cm−1.
1H NMR : δ 6.71 (1H, s, CH C7), 5.83−5.76 (2H, m, CH C4 and CH C5), 5.09 (1H,
s, CH2 C14a), 4.99 (1H, s, CH2 C14b), 4.70 (1H, q, J = 5.0 Hz, CH C15), 4.61 (2H, s,
CH2 C9), 4.36 (1H, dd, J = 10.2, 4.7 Hz, CH2 C1a), 4.07 (1H, d, J = 6.7 Hz, CH C3),
3.57 (1H, ddd, J = 10.4, 6.7, 4.7 Hz, CH C2), 3.53 (1H, dd, J = 10.4, 10.2 Hz, CH2 
C1b), 2.07 (2H, t, J = 7.6 Hz, CH2 C11), 1.50 (2H, tq, J = 7.6, 7.3 Hz, CH2 C12),
1.38 (3H, d, J = 5.0 Hz, CH3 C16), 0.93 (3H, t, J = 7.3 Hz, CH3 C13).
13C NMR : δ 154.6 (C C8), 142.9 (C C6), 142.2 (CH C7), 133.5 (C C10), 129.6 (CH),
121.5 (CH), 113.4 (CH2 C14), 98.5 (CH 15), 77.1 (CH C3), 71.1 (CH2 C9), 70.9 (CH 
C2), 68.3 (CH2 C1), 52.2 (CH2 C11), 20.8 (CH2 C12), 20.4 (CH3 C16), 13.9 (CH3 C13).
MS (FAB): m/z (Int) 311 (97), 267 (100), 183 (73). HRMS (C16H23O6
+): calculated:
311.1495; obtained: 311.1497, (  = 0.6 ppm).
(2R,4aR,9aS)-2-methyl-6-(2-methylenepentyl)-6,9a-dihydro-4H-[1,3]dioxi-
no[5,4-b] oxepin-7(4aH)-one : 374
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Molecular weight: 266.3 g.mol−1
174To a solution of Pd(PPh3)4 (8.4 mg, 7.3 µmol) in THF (1.5 mL) was added (S) 
tBu PHOX (4.0 mg, 10 µmol). The reaction mixture was stirred for 30 min at rt.
A solution of carbonate 368 (45 mg, 0.15 mmol) in THF (3 mL) was added to the
reaction mixture, which was stirred for 2 h at rt. The solution was then concentrated
under reduced pressure and puriﬁcation by ﬂash column chromatography on silica gel
(PE Et2O; 95:5→9:1) gave the enone 369 (27 mg, 0.10 mmol, 69%), as a mixture (7:1)
of isomers favouring that with cis conﬁguration, as a colourless oil.
Rf = 0.43 (PE Et2O; 4:1)
IR : νmax 2959, 29323, 2870, 1665, 1287, 1115, 905 cm−1.
1H NMR : δ (major diastereomer) 6.45 (1H, dd, J = 12.7, 2.1 Hz, CH C4), 6.02 (1H,
dd, J = 12.7, 2.6 Hz, CH C5), 4.80 (1H, s, CH2 C10a), 4.77 (1H, s, CH2 C10b), 4.74
(1H, q, J = 5.1 Hz, CH C14), 4.31 (1H, dd, J = 9.0, 3.5 Hz, CH C7), 4.19−4.14 (2H,
m, CH C3 and CH2 C1a), 3.55−3.52 (2H, CH C2 and CH2 C1b), 2.57−2.50 (1H, m,
CH2 C8a), 2.31 (1H, dd, J = 15.1, 9.0 Hz, CH2 C8b), 2.02−1.97 (2H, m, CH2 C11),
1.48−1.41 (2H, m, CH2 C12), 1.35 (3H, d, J = 5.1 Hz, CH3 C15), 0.88 (3H, t, J = 7.3
Hz, CH3 C13).
13C NMR : δ (major diastereomer) 202.7 (C C6), 144.9 (C C9), 143.2 (CH C4), 128.5
(CH C5), 111.9 (CH2 C10), 99.4 (CH C14), 86.4 (CH C7), 82.0 (CH C3), 73.8 (CH 
C2), 68.4 (CH2 C1), 39.3 (CH2 C8), 38.2 (CH2 C11), 20.6 (CH2 C12), 20.3 (CH3 C15),
13.7 (CH3 C13).
MS (EI): m/z (Int) 266 (29), 182 (32), 111 (58), 81 (100). HRMS (C15H22O4
+): cal 
culated: 266.1518; obtained: 266.1520, (  = 0.8 ppm).
Carbonate : 361
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Molecular weight:
763.0 g.mol−1
To a solution of carbamate 375 (27 mg, 66 µmol) in THF (0.5 mL) at 0 ◦C was
added BF3·Et2O (8.0 µL, 66 µmol). The solution was stirred for 1 h at rt, then cooled
to −78 ◦C. A solution of enone 295 (20 mg, 47 µmol) in THF (0.4 mL) pre cooled
to −78 ◦C was added by cannula to the ﬁrst solution. After 10 min at −78 ◦C, a
solution of KHMDS (0.13 mL, 66 µmol) in THF (0.5 M) was added slowly. The re 
175action mixture was stirred for 30 min at −78 ◦C before adding a saturated aqueous
solution of NH4Cl (1 mL) and H2O (5 mL). The aqueous phase was extracted with
Et2O (3 × 5 mL). The combined organic phases were washed with brine (5 mL), dried
(Na2SO4) and concentrated under reduced pressure. The residue was puriﬁed by ﬂash
column chromatography on oven dried silica gel (PE Et2O; 93:7→9:1→85:15) to give
the carbonate 361 (11 mg, 14 µmol, 31%), with some starting material enone 295
as a colourless oil. The mixture was directly used in the next step without further
puriﬁcation.
Enone : 362
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Molecular weight: 719.0 g.mol−1
A solution of Pd(PPh3)4 (0.8 mg, 0.7 µmol) and (S) tBu PHOX (0.4 mg, 1.0 µmol)
in THF (0.3 mL) was stirred at rt for 30 min. A solution of carbonate 361 (11 mg,
14 µmol) in THF (0.3 mL) was added to the solution of Pd complex and the reaction
mixture was stirred overnight at rt. The reactin mixture was concentrated under re 
duced pressure and the residue was puriﬁed by ﬂash column chromatography on silica
gel (PE Et2O; 9:1→85:15) to give the single diastereomeric enone 362 (5.6 mg, 7.8
µmol, 57%) as a colourless oil.
Rf = 0.40 (PE Et2O; 2:1)
1H NMR : δ 6.43 (1H, dd, J = 12.9, 2.3 Hz, CH C10), 5.98 (1H, dd, J = 12.9, 2.6 Hz,
CH C11), 4.86 (2H, s, CH2 C29), 4.34 (1H, dd, J = 9.1, 3.2 Hz, CH C13), 4.26−4.06
(5H, m, CH2 C1a and CH2 C23 and CH C9 and CH C17), 3.95 (1H, ddd, J = 11.1, 9.6,
4.0 Hz, CH C3), 3.83 (1H, dd, J = 10.2, 10.2 Hz, CH2 C1b), 3.47−3.35 (3H, m, CH C2
and CH C8 and CH C20), 3.19 (1H, dd, J = 12.6, 3.7 Hz, CH C6), 2.63 (1H, dd, J
= 15.1, 3.2 Hz, CH2 C14a), 2.37−2.05 (6H, m, CH2 C4a and CH2 C7a and CH2 C14b
and CH2 C16 and CH C19), 1.79−1.65 (4H, m, CH2 C7b and CH2 C18 and CH C21),
1.58−1.53 (1H, m, CH2 C4b), 1.30 (3H, s, CH3 C30), 1.28−1.22 (2H, m, CH2 C22),
1.19 (9H, s, CH3 C26), 1.04 (9H, s, CH3 C32), 1.04−1.02 (3H, m, CH3 C27), 0.98 (9H,
s, CH3 C32’), 0.91 (3H, d, J = 7.0 Hz, CH3 C28).
13C NMR : δ 203.2 (C C12), 178.8 (C C24), 145.1 (CH C10), 142.9 (C C15), 128.3
176(CH C11), 114.4 (CH2 C29), 86.1 (CH C13), 85.5 (CH), 79.7 (CH C2), 79.1 (CH), 79.0
(CH C6), 75.7 (CH), 73.5 (C C5), 72.8 (CH), 72.5 (CH C3), 67.1 (CH2 C1), 62.2 (CH2 
C23), 46.2 (CH2 C4), 43.3 (CH2 C16), 40.7 (CH2), 39.8 (CH2 C14), 38.9 (C C25), 35.1
(CH C19), 31.9 (CH2 C22), 31.6 (CH2 C7), 30.9 (CH2 C18), 27.6 (CH3), 27.4 (CH3),
27.2 (CH3), 22.8 (C 31), 20.1 (C 31’), 17.0 (CH3 C27), 15.7 (CH3 C30), 13.9 (CH3 
C28).
MS (FAB): m/z (Int) 719 (37), 391 (55), 241 (34), 149 (78), 95 (74), 57 (100).
Alcohol : 384
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Molecular weight: 721.1 g.mol−1
To a solution of enone 362 (5.6 mg, 7.8 µmol) in MeOH (0.2 mL) and CH2Cl2 (0.2
mL) was added cerium trichloride heptahydrate (2.9 mg, 7.8 µmol). After 5 min at
rt, the reaction mixture was cooled to −78 ◦C and sodium borohydride (0.4 mg, 9.4
µmol) was added. The reaction mixture was then stirred for another hour at −78 ◦C
and H2O (0.2 mL) was added. The aqueous layer was extracted with Et2O (3 × 1
mL) and the combined organic phases were dried (MgSO4) and concentrated under
reduced pressure. The residue was puriﬁed by ﬂash column chromatography on silica
gel (PE Et2O; 9:1→4:1→3:2) to give the alcohol 384 (5.5 mg, 7.6 µmol, 98%) as a
colourless oil.
Rf = 0.19 (PE Et2O; 1:1)
1H NMR : δ 5.67 (1H, ddd, J = 12.9, 1.9, 1.9 Hz, CH C10 or C11), 5.61 (1H, d, J =
12.9 Hz, CH C11 or C10), 4.89 (1H, s, CH2 C29a), 4.86 (1H, s, CH2 C29b), 4.23−4.06
(6H, m, CH2 C1a and CH2 C23 and CH C9 and CH C12 and CH C17), 3.93 (1H, ddd,
J = 11.2, 9.5, 4.8 Hz, CH C3), 3.81 (1H, dd, J = 10.2, 10.2 Hz, CH2 C1b), 3.50−3.44
(2H, m, CH C13 and CH C20), 3.38 (1H, ddd, J = 10.2, 9.5, 4.8 Hz, CH C2), 3.27
(1H, ddd, J = 11.1, 9.3, 5.0 Hz, CH C8), 3.17 (1H, dd, J = 12.7, 4.8 Hz, CH C6), 2.64
(1H, dd, J = 14.5, 2.9 Hz, CH2 C14a), 2.36−2.13 (5H, m, CH C19 and CH2 C4a and
CH2 C14b and CH2 C16), 2.07−2.02 (2H, m, CH2 C7a and OH), 1.81−1.66 (5H, m,
CH C21 and CH2 C7b and CH2 C18 and CH2 C22a), 1.63−1.52 (1H, m, CH2 C4b),
1.23 (3H, s, CH3 C30), 1.23−1.21 (1H, m, CH2 C22b), 1.19 (9H, s, CH3 C26), 1.03
177(9H, s, CH3 C32), 1.03−1.02 (3H, m, CH3 C27), 0.97 (9H, s, CH3 C32’), 0.91 (3H, d,
J = 7.0 Hz, CH3 C28).
13C NMR : δ 178.8 (C C24), 144.3 (C C15), 134.4 (CH C10 or C11), 132.3 (CH C11 or
C10), 114.2 (CH2 C29), 85.6 (CH), 83.7 (CH), 80.4 (CH C8), 79.5 (CH C2), 79.1 (CH 
C6), 76.2 (CH C17), 74.2 (CH C9 or C12), 72.9 (CH C12 or C9), 72.6 (CH C3), 72.5
(C C5), 67.2 (CH2 C1), 62.2 (CH2 C23), 46.4 (CH2 C4), 43.6 (CH2 C16), 40.8 (CH2 
C18), 40.0 (CH2 C14), 38.9 (C C25), 35.1 (CH C19), 32.0 (CH2 C22), 31.9 (CH2 C7),
30.9 (CH C21), 27.6 (CH3 C32), 27.4 (CH3 C26), 27.2 (CH3 C32’), 22.8 (C C31), 20.1
(C C31’), 17.0 (CH3 C27), 15.7 (CH3 C30), 13.9 (CH3 C28).
Diene : 363
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Molecular weight: 835.3 g.mol−1
To a solution of alcohol 384 (10 mg, 14 µmol) in CH2Cl2 (0.4 mL) at 0 ◦C was added
2,6 lutidine (10 µL, 84 µmol) and TBSOTf (10 µL, 42 µmol). The reaction mixture
was stirred overnight at rt and a saturated aqueous solution of NaHCO3 (0.2 mL) was
added. The aqueous layer was extracted with Et2O (3 × 1 mL) and the combined
organic phases were dried (MgSO4) and concentrated under reduced pressure. The
residue was puriﬁed by ﬂash column chromatography on silica gel (PE Et2O; 10%) to
give the protected alcohol 363 (10.1 mg, 12 µmol, 85%) as a colourless oil.
Rf = 0.26 (PE Et2O; 9:1)
1H NMR : δ 5.65 (1H, d, J = 12.8 Hz, CH C10 or C11), 5.56 (1H, d, J = 12.8 Hz,
CH C11 or C10), 4.81 (1H, s, CH2 C29a), 4.79 (1H, s, CH2 C29b), 4.23−4.05 (6H,
m, CH C9 and CH C12 and CH C17 and CH2 C1a and CH2 C23), 3.96−3.89 (1H, m,
CH C3), 3.81 (1H, dd, J = 10.2, 10.2 Hz, CH2 C1b), 3.50 (1H, dd, J = 9.1, 9.1 Hz,
CH C13), 3.45 (1H, dd, J = 9.6, 4.0 Hz, CH C20), 3.37 (1H, ddd, J = 10.2, 9.6, 4.7
Hz, CH C2), 3.26−3.20 (1H, m, CH C8), 3.16 (1H, dd, J = 12.5, 3.5 Hz, CH C6), 2.58
(1H, d, J = 14.4 Hz, CH2 C14a), 2.34 (1H, dd, J = 13.8, 6.7 Hz, CH2 C16a), 2.27−2.17
(2H, m, CH C19 and CH2 C4a), 2.08 (1H, dd, J = 13.8, 6.7 Hz, CH2 C16b), 2.05−1.99
(1H, m, CH2 C7a), 1.93 (1H, dd, J = 14.4, 9.1 Hz, CH2 C14b), 1.78−1.64 (4H, CH C21
and CH2 C18 and CH2 C22b), 1.61−1.51 (2H, m, CH2 C4b and CH2 C7b), 1.29−1.24
178(1H, m, CH2 C22b), 1.23 (3H, s, CH3 C30), 1.19 (9H, s, CH3 C26), 1.04−1.02 (3H, m,
CH3 C27), 1.03 (9H, s, CH3 C32), 0.97 (9H, s, CH3 C32’), 0.90−0.85 (3H, s, CH3 C28),
0.89 (9H, s, CH3 C35), 0.06 (3H, s, CH3 C33), 0.05 (3H, s, CH3 C33’).
13C NMR : δ 178.8 (C C24), 144.3 (C C15), 136.6 (CH C10 or CH C11), 131.8 (CH 
C11 or CH C10), 113.4 (CH2 C29), 85.5 (CH C20), 84.0 (CH C13), 80.0 (CH C8),
79.5 (CH C2), 79.1 (CH C6), 75.4 (CH C17), 74.7 (CH C12), 73.0 (CH C9), 72.6 (CH 
C3), 72.5 (C C5), 67.2 (CH2 C1), 62.2 (CH2 C23), 46.4 (CH2 C4), 43.5 (CH2 C16),
40.7 (CH2 C18), 39.4 (CH2 C14), 38.9 (C C25), 35.2 (CH C19), 32.0 (CH2 C7 or CH2 
C22), 31.9 (CH2 C22 or CH2 C7), 31.0 (CH C21), 27.6 (CH3 C32), 27.4 (CH3 C26),
27.2 (CH3 C32’), 26.0 (CH3 C35), 22.8 (C C31), 20.1 (C C31’), 18.1 (C C34), 17.0
(CH3 C27), 15.7 (CH3 C30), 13.9 (CH3 C28),  4.3 (CH3 C33),  4.7 (CH3 C33’).
Ketone : 364
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Molecular weight: 839.3 g.mol−1
To a solution of diene 363 (10 mg, 12 µmol) in THF (0.1 mL) was added a solution
of NMO (1.5 mg, 13 µmol) in H2O (10 µL) and a solution of OsO4 (3.8 µL, 0.6
µmol) in H2O (4% wt). After 3 h at rt, a solution of OsO4 (3.8 µL, 0.6 µmol) in
H2O (4% wt) was added and the reaction mixture was stirred for another 2 h. A
saturated aqueous solution of Na2S2O3 (2 drops) was added and the aqueous layer
was extracted with EtOAc (3 × 1 mL) and the combined organic phases were dried
(MgSO4) and concentrated under reduced pressure. The residue was puriﬁed by ﬂash
column chromatography on silica gel (PE Et2O; 4:1→1:2) to give the diol 376 (5.1 mg,
5.9 µmol, 49%) as a colourless oil as a mixture of diastereomers along with starting
material (2.3 mg, 2.8 µmol).
To a solution of diol 376 (5.1 mg, 5.9 µmol) in EtOH (0.5 mL) was added Pd/C
(0.6 mg, 0.6 µmol). The reaction mixture was stirred under an H2 atmosphere for 5
h, and ﬁltrated on Celite to give the corresponding saturated diol (4.5 mg, 5.2 µmol),
which was used directly in the next step.
To a solution of diol (4.5 mg, 5.2 µmol) in EtOH (0.2 mL) was added a solution of
NaIO4 (2.2 mg, 10 µmol) in H2O (0.2 mL). The reaction mixture was stirred overnight
179at rt. A saturated aqueous solution of Na2S2O3 (2 drops) was added and the aqueous
layer was extracted with EtOAc (3 × 1 mL) and the combined organic phases were
dried (MgSO4) and concentrated under reduced pressure. The residue was puriﬁed by
ﬂash column chromatography on silica gel (PE Et2O; 20%) to give the ketone 364 (2.7
mg, 3.2 µmol, 55% over 2 steps) as a colourless oil.
Rf = 0.76 (PE Et2O; 1:3)
1H NMR : δ 4.48−4.41 (1H, m, CH C17), 4.18−4.03 (3H, CH2 C1a and CH2 C23),
3.95−3.88 (2H, m, CH C3 and CH C13), 3.81 (1H, dd, J = 10.2, 10.2 Hz, CH2 C1b),
3.76−3.73 (1H, m, CH C12), 3.44 (1H, dd, J = 9.7, 4.1 Hz, CH C20), 3.40−3.33 (3H,
m, CH C2 and CH C8 and CH C9), 3.13 (1H, dd, J = 9.6, 3.8 Hz, CH C6), 2.75 (1H,
dd, J = 15.6, 6.8 Hz, CH2 C16a), 2.60 (1H, dd, J = 15.8, 9.2 Hz, CH2 C14a), 2.53−2.45
(2H, m, CH2 C14b and CH2 C16b), 2.29−2.21 (1H, m, CH C19), 2.21−2.17 (1H, m,
CH2 C4a), 2.02−1.97 (1H, m, CH2 C7a), 1.92−1.83 (1H, m, CH2 C18a), 1.76−1.64
(3H, m, CH C21 and CH2 C18b and CH2 C22a), 1.57−1.48 (2H, m, CH2 C4b and
CH2 C7b), 1.33−1.17 (4H, m, CH2 C10 and CH2 C11 and CH2 C22b), 1.25 (3H, CH3 
C29), 1.19 (9H, CH3 C26), 1.04−1.01 (3H, m, CH3 C27), 1.03 (9H, CH3 C31), 0.98
(9H, CH3 C31’), 0.92−0.86 (3H, CH3 C28), 0.89 (9H, CH3 C34), 0.05 (3H, CH3 C32),
0.04 (3H, CH3 C32’).
13C NMR : δ 207.2 (C C15), 178.8 (C C24), 85.8 (CH C20), 82.7 (CH C13), 80.5 (CH 
C2), 79.6 (CH C8), 79.5 (CH C6), 74.3 (CH C12), 74.0 (CH C9), 72.8 (CH C17), 72.6
(CH C3), 72.5 (C C5), 67.2 (CH2 C1), 62.1 (CH2 C23), 50.5 (CH2 C16), 48.2 (CH2 
C14), 46.5 (CH2 C4), 40.9 (CH2 C18), 38.9 (C C25), 35.2 (CH C19), 32.0 (CH2 C7 or
CH2 C22), 31.8 (CH2 C22 or CH2 C7), 31.1 (CH C21), 29.9 (CH2 C10 or CH2 C11),
27.6 (CH3 C31), 27.4 (CH3 C26), 27.3 (CH3 C31’), 26.0 (CH3 C34), 22.8 (C C30), 22.7
(CH2 C11 or CH2 C10), 20.1 (C C30’), 18.1 (C C33), 16.9 (CH3 C27), 16.2 (CH3 C29),
14.3 (CH3 C28),  4.3 (CH3 C32),  4.6 (CH3 C32’).
Alcohols : 365 and 366
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Molecular weight: 726.5 g.mol−1
To a solution of ketone 364 (2.7 mg, 3.2 µmol) in MeOH (0.2 mL) and CH2Cl2 (0.2
180mL) was added sodium borohydride (0.2 mg, 6.4 µmol). After 1 h at rt, H2O (0.2
mL) was added and the aqueous layer was extracted with Et2O (3 × 1 mL) and the
combined organic phases were dried (MgSO4) and concentrated under reduced pressure
to give the crude alcohol (2.7 mg, 3.2 µmol), which was used directly in the next step.
To a solution of alcohol (2.7 mg, 3.2 µmol) in MeOH (0.3 mL) and CH2Cl2 (0.15 mL)
was added (+) CSA (1.5 mg, 6.4 µmol). The reaction mixture was stirred overnight
at rt and more (+) CSA (1.5 mg, 6.4 µmol) was added. After another 7 h at rt, tri 
ethylamine (0.1 mL) and H2O (0.2 mL) were added. The aqueous layer was extracted
with Et2O (3 × 1 mL) and the combined organic phases were dried (MgSO4) and con 
centrated under reduced pressure. The two products were clearly visible on TLC, but
not enough material was obtained from ﬂash chromatography on silica gel (PE EtOAc:
9:1→3:1→1:1)
Rf = 0.50 and 0.57 (EtOAc)
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193Appendix A
Figure 1: X-ray structure of enone 295
194Empirical formula C44 H72 O12 Si2
Formula weight 849.20
Temperature 100(2) K
Wavelength 0.71073 Å
Crystal system Monoclinic
Space group P21
Unit cell dimensions a = 6.3950(7) Å α = 90 ◦
b = 46.881(6) Å β = 111.164(5) ◦
c = 8.2621(10) Å γ = 90 ◦
Volume 2309.9(5) Å3
Z 2
Density (calculated) 1.221 Mg/m3
Absorption coeﬃcient 0.135 mm−1
F(000) 920
Theta range for data collection 1.74 to 19.98 ◦
Index ranges -6≤h≤6, -44≤k≤44, -7≤l≤7
Reﬂections collected 22727
Independent reﬂections 4232 [R(int) = 0.0739]
Completeness to theta = 19.98 ◦ 99.4%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.7444 and 0.5826
Reﬁnement method Full-matrix least-squares on F2
Data / restraints / parameters 4232 / 1 / 233
Goodness-of-ﬁt on F2 3.505
Final R indices [I>2sigma(I)] R1 = 0.1064, wR2 = 0.1983
R indices (all data) R1 = 0.1196, wR2 = 0.2000
Absolute structure parameter 0.2(4)
Largest diﬀ. peak and hole 1.153 and -0.527 e.Å−3
Table 1: Table 1: Crystal data and structure reﬁnement
195Table 2. Atomic coordinates (x 104) and equivalent isotropic displacement param 
eters (Å2x 103). U(eq) is deﬁned as one third of the trace of the orthogonalized Uij
tensor.
x y z U(eq)
Si(1) -512(5) 5922(1) -1266(4) 24(1)
O(7) -1160(11) 5648(2) -290(9) 23(2)
O(8) 2085(10) 5884(2) -1090(9) 24(2)
O(9) 4116(11) 5248(2) 1607(10) 24(2)
O(10) 329(12) 4728(2) 2420(10) 29(2)
O(11) 5463(12) 4292(2) 3933(10) 32(2)
O(12) 2978(13) 3612(2) 2424(12) 49(3)
C(23) 2489(18) 5427(3) 420(16) 25(3)
C(24) 524(17) 5479(3) 958(16) 25(3)
C(25) -520(17) 5199(2) 1255(15) 23(3)
C(26) 1300(18) 5002(3) 2433(16) 29(3)
C(27) 3162(16) 4979(2) 1767(16) 22(3)
C(29) 5001(17) 4778(2) 2768(16) 24(3)
C(30) 3870(17) 4488(3) 2819(16) 24(3)
C(31) 1939(17) 4514(3) 3393(17) 29(3)
C(32) 678(18) 4256(3) 3430(15) 27(3)
C(33) 1176(19) 3978(3) 3227(16) 33(4)
C(34) 3090(20) 3874(3) 2928(17) 37(4)
C(35) 5267(18) 4006(3) 3239(17) 29(3)
C(36) -2334(16) 5887(3) -3664(13) 20(3)
C(37) -701(17) 6265(2) -126(14) 20(3)
C(38) -1560(20) 5626(3) -4280(20) 61(4)
C(39) -1990(20) 6145(3) -4683(19) 58(4)
C(40) 270(20) 6515(3) -828(18) 49(4)
C(41) -3054(19) 6341(3) -168(18) 42(4)
C(42) 730(20) 6225(3) 1753(16) 43(4)
C(28) 3624(17) 5689(3) 190(15) 26(3)
C(43) 2077(17) 5125(3) 4335(14) 26(3)
C(44) -4774(18) 5865(3) -3902(17) 47(4)
Si(2) 3895(5) 7448(1) 6221(5) 26(1)
O(1) 6230(10) 7492(2) 5913(9) 22(2)
O(2) 2313(11) 7723(2) 5408(10) 27(2)
O(3) 5422(11) 8135(2) 3176(10) 29(2)
O(4) 905(11) 8643(2) 2725(10) 36(2)
O(5) 4119(12) 9092(2) 801(10) 34(2)
O(6) 3234(12) 9767(2) 2545(11) 38(2)
196C(1) 6477(18) 7688(3) 4630(16) 31(3)
C(2) 5124(17) 7958(3) 4525(16) 25(3)
C(3) 2628(16) 7895(3) 4075(15) 22(3)
C(4) 1329(17) 8169(2) 3837(15) 26(3)
C(5) 1833(17) 8361(3) 2563(15) 23(3)
C(6) 4329(17) 8401(3) 3082(16) 26(3)
C(7) 4979(17) 8612(3) 1981(16) 26(3)
C(8) 3819(18) 8892(3) 2031(17) 29(3)
C(9) 1348(19) 8858(3) 1622(18) 34(4)
C(10) 692(18) 8253(3) 708(15) 38(4)
C(11) 137(19) 9116(3) 1800(16) 33(3)
C(12) 710(20) 9396(3) 1997(17) 38(4)
C(13) 2807(19) 9513(3) 2026(17) 34(4)
C(14) 4562(18) 9381(3) 1487(17) 33(4)
C(15) 4473(16) 7470(3) 8635(14) 25(3)
C(16) 5680(20) 7206(3) 9617(18) 47(4)
C(17) 6080(20) 7721(3) 9326(19) 53(4)
C(18) 2295(18) 7517(3) 8931(17) 45(4)
C(19) 2543(17) 7107(3) 5135(15) 23(3)
C(20) 1740(20) 7157(3) 3124(17) 49(4)
C(21) 520(20) 7014(3) 5531(18) 48(4)
C(22) 4207(19) 6870(3) 5499(17) 47(4)
197Table 3: Bond lengths [Å] and angles [˚].
Si(1)-O(8) 1.624(7)
Si(1)-O(7) 1.648(8)
Si(1)-C(37) 1.887(12)
Si(1)-C(36) 1.909(11)
O(7)-C(24) 1.431(13)
O(8)-C(28) 1.471(12)
O(9)-C(23) 1.416(13)
O(9)-C(27) 1.431(13)
O(10)-C(26) 1.427(14)
O(10)-C(31) 1.454(13)
O(11)-C(30) 1.433(13)
O(11)-C(35) 1.447(14)
O(12)-C(34) 1.291(15)
C(23)-C(28) 1.477(15)
C(23)-C(24) 1.496(14)
C(23)-H(23) 0.9800
C(24)-C(25) 1.535(16)
C(24)-H(24) 0.9800
C(25)-C(26) 1.526(16)
C(25)-H(25A) 0.9700
C(25)-H(25B) 0.9700
C(26)-C(27) 1.485(15)
C(26)-C(43) 1.576(15)
C(27)-C(29) 1.500(15)
C(27)-H(27) 0.9800
C(29)-C(30) 1.546(15)
C(29)-H(29A) 0.9700
C(29)-H(29B) 0.9700
C(30)-C(31) 1.479(14)
C(30)-H(30) 0.9800
C(31)-C(32) 1.460(16)
C(31)-H(31) 0.9800
C(32)-C(33) 1.364(16)
C(32)-H(32) 0.9300
C(33)-C(34) 1.423(16)
C(33)-H(33) 0.9300
C(34)-C(35) 1.456(16)
C(35)-H(35A) 0.9700
C(35)-H(35B) 0.9700
C(36)-C(38) 1.479(17)
C(36)-C(44) 1.504(14)
C(36)-C(39) 1.536(17)
C(37)-C(42) 1.501(15)
C(37)-C(41) 1.535(15)
C(37)-C(40) 1.536(16)
C(38)-H(38A) 0.9600
C(38)-H(38B) 0.9600
C(38)-H(38C) 0.9600
C(39)-H(39A) 0.9600
C(39)-H(39B) 0.9600
C(39)-H(39C) 0.9600
C(40)-H(40A) 0.9600
C(40)-H(40B) 0.9600
C(40)-H(40C) 0.9600
C(41)-H(41A) 0.9600
C(41)-H(41B) 0.9600
C(41)-H(41C) 0.9600
C(42)-H(42A) 0.9600
C(42)-H(42B) 0.9600
C(42)-H(42C) 0.9600
C(28)-H(28A) 0.9700
C(28)-H(28B) 0.9700
C(43)-H(43A) 0.9600
C(43)-H(43B) 0.9600
C(43)-H(43C) 0.9600
C(44)-H(44A) 0.9600
C(44)-H(44B) 0.9600
C(44)-H(44C) 0.9600
Si(2)-O(1) 1.616(7)
Si(2)-O(2) 1.627(8)
Si(2)-C(19) 1.881(12)
Si(2)-C(15) 1.895(12)
O(1)-C(1) 1.452(13)
O(2)-C(3) 1.438(13)
198O(3)-C(6) 1.418(13)
O(3)-C(2) 1.456(13)
O(4)-C(9) 1.454(14)
O(4)-C(5) 1.473(14)
O(5)-C(8) 1.448(14)
O(5)-C(14) 1.457(14)
O(6)-C(13) 1.262(14)
C(1)-C(2) 1.517(15)
C(1)-H(1A) 0.9700
C(1)-H(1B) 0.9700
C(2)-C(3) 1.531(14)
C(2)-H(2) 0.9800
C(3)-C(4) 1.502(15)
C(3)-H(3) 0.9800
C(4)-C(5) 1.507(16)
C(4)-H(4A) 0.9700
C(4)-H(4B) 0.9700
C(5)-C(6) 1.507(14)
C(5)-C(10) 1.527(15)
C(6)-C(7) 1.500(16)
C(6)-H(6) 0.9800
C(7)-C(8) 1.515(17)
C(7)-H(7A) 0.9700
C(7)-H(7B) 0.9700
C(8)-C(9) 1.501(14)
C(8)-H(8) 0.9800
C(9)-C(11) 1.471(17)
C(9)-H(9) 0.9800
C(10)-H(10A) 0.9600
C(10)-H(10B) 0.9600
C(10)-H(10C) 0.9600
C(11)-C(12) 1.359(17)
C(11)-H(11) 0.9300
C(12)-C(13) 1.443(16)
C(12)-H(12) 0.9300
C(13)-C(14) 1.484(16)
C(14)-H(14A) 0.9700
C(14)-H(14B) 0.9700
C(15)-C(18) 1.515(15)
C(15)-C(16) 1.528(17)
C(15)-C(17) 1.532(17)
C(16)-H(16A) 0.9600
C(16)-H(16B) 0.9600
C(16)-H(16C) 0.9600
C(17)-H(17A) 0.9600
C(17)-H(17B) 0.9600
C(17)-H(17C) 0.9600
C(18)-H(18A) 0.9600
C(18)-H(18B) 0.9600
C(18)-H(18C) 0.9600
C(19)-C(22) 1.495(15)
C(19)-C(21) 1.510(15)
C(19)-C(20) 1.569(17)
C(20)-H(20A) 0.9600
C(20)-H(20B) 0.9600
C(20)-H(20C) 0.9600
C(21)-H(21A) 0.9600
C(21)-H(21B) 0.9600
C(21)-H(21C) 0.9600
C(22)-H(22A) 0.9600
C(22)-H(22B) 0.9600
C(22)-H(22C) 0.9600
O(8)-Si(1)-O(7) 107.4(4)
O(8)-Si(1)-C(37) 107.3(4)
O(7)-Si(1)-C(37) 110.3(4)
O(8)-Si(1)-C(36) 107.7(4)
O(7)-Si(1)-C(36) 105.8(5)
C(37)-Si(1)-C(36) 117.8(5)
C(24)-O(7)-Si(1) 121.8(6)
C(28)-O(8)-Si(1) 122.1(7)
C(23)-O(9)-C(27) 110.7(8)
C(26)-O(10)-C(31) 113.5(8)
C(30)-O(11)-C(35) 113.6(9)
O(9)-C(23)-C(28) 108.0(9)
O(9)-C(23)-C(24) 112.2(9)
C(28)-C(23)-C(24) 113.8(10)
O(9)-C(23)-H(23) 107.5
199C(28)-C(23)-H(23) 107.5
C(24)-C(23)-H(23) 107.5
O(7)-C(24)-C(23) 111.8(9)
O(7)-C(24)-C(25) 109.3(8)
C(23)-C(24)-C(25) 111.5(10)
O(7)-C(24)-H(24) 108.0
C(23)-C(24)-H(24) 108.0
C(25)-C(24)-H(24) 108.0
C(26)-C(25)-C(24) 110.0(9)
C(26)-C(25)-H(25A) 109.7
C(24)-C(25)-H(25A) 109.7
C(26)-C(25)-H(25B) 109.7
C(24)-C(25)-H(25B) 109.7
H(25A)-C(25)-H(25B) 108.2
O(10)-C(26)-C(27) 109.5(10)
O(10)-C(26)-C(25) 108.0(9)
C(27)-C(26)-C(25) 109.8(10)
O(10)-C(26)-C(43) 108.4(10)
C(27)-C(26)-C(43) 113.0(9)
C(25)-C(26)-C(43) 108.0(10)
O(9)-C(27)-C(26) 113.2(9)
O(9)-C(27)-C(29) 109.3(8)
C(26)-C(27)-C(29) 114.6(10)
O(9)-C(27)-H(27) 106.4
C(26)-C(27)-H(27) 106.4
C(29)-C(27)-H(27) 106.4
C(27)-C(29)-C(30) 106.5(9)
C(27)-C(29)-H(29A) 110.4
C(30)-C(29)-H(29A) 110.4
C(27)-C(29)-H(29B) 110.4
C(30)-C(29)-H(29B) 110.4
H(29A)-C(29)-H(29B) 108.6
O(11)-C(30)-C(31) 109.2(9)
O(11)-C(30)-C(29) 110.5(8)
C(31)-C(30)-C(29) 113.0(10)
O(11)-C(30)-H(30) 108.0
C(31)-C(30)-H(30) 108.0
C(29)-C(30)-H(30) 108.0
O(10)-C(31)-C(32) 107.3(8)
O(10)-C(31)-C(30) 112.6(10)
C(32)-C(31)-C(30) 118.1(11)
O(10)-C(31)-H(31) 106.0
C(32)-C(31)-H(31) 106.0
C(30)-C(31)-H(31) 106.0
C(33)-C(32)-C(31) 129.2(11)
C(33)-C(32)-H(32) 115.4
C(31)-C(32)-H(32) 115.4
C(32)-C(33)-C(34) 127.1(12)
C(32)-C(33)-H(33) 116.5
C(34)-C(33)-H(33) 116.5
O(12)-C(34)-C(33) 115.5(11)
O(12)-C(34)-C(35) 113.7(10)
C(33)-C(34)-C(35) 130.6(13)
O(11)-C(35)-C(34) 113.9(10)
O(11)-C(35)-H(35A) 108.8
C(34)-C(35)-H(35A) 108.8
O(11)-C(35)-H(35B) 108.8
C(34)-C(35)-H(35B) 108.8
H(35A)-C(35)-H(35B) 107.7
C(38)-C(36)-C(44) 111.1(10)
C(38)-C(36)-C(39) 109.3(10)
C(44)-C(36)-C(39) 109.1(10)
C(38)-C(36)-Si(1) 106.1(8)
C(44)-C(36)-Si(1) 110.9(8)
C(39)-C(36)-Si(1) 110.3(8)
C(42)-C(37)-C(41) 106.1(9)
C(42)-C(37)-C(40) 107.9(10)
C(41)-C(37)-C(40) 109.7(10)
C(42)-C(37)-Si(1) 106.6(8)
C(41)-C(37)-Si(1) 115.2(8)
C(40)-C(37)-Si(1) 110.8(8)
C(36)-C(38)-H(38A) 109.5
C(36)-C(38)-H(38B) 109.5
H(38A)-C(38)-H(38B) 109.5
C(36)-C(38)-H(38C) 109.5
H(38A)-C(38)-H(38C) 109.5
H(38B)-C(38)-H(38C) 109.5
C(36)-C(39)-H(39A) 109.5
C(36)-C(39)-H(39B) 109.5
H(39A)-C(39)-H(39B) 109.5
200C(36)-C(39)-H(39C) 109.5
H(39A)-C(39)-H(39C) 109.5
H(39B)-C(39)-H(39C) 109.5
C(37)-C(40)-H(40A) 109.5
C(37)-C(40)-H(40B) 109.5
H(40A)-C(40)-H(40B) 109.5
C(37)-C(40)-H(40C) 109.5
H(40A)-C(40)-H(40C) 109.5
H(40B)-C(40)-H(40C) 109.5
C(37)-C(41)-H(41A) 109.5
C(37)-C(41)-H(41B) 109.5
H(41A)-C(41)-H(41B) 109.5
C(37)-C(41)-H(41C) 109.5
H(41A)-C(41)-H(41C) 109.5
H(41B)-C(41)-H(41C) 109.5
C(37)-C(42)-H(42A) 109.5
C(37)-C(42)-H(42B) 109.5
H(42A)-C(42)-H(42B) 109.5
C(37)-C(42)-H(42C) 109.5
H(42A)-C(42)-H(42C) 109.5
H(42B)-C(42)-H(42C) 109.5
O(8)-C(28)-C(23) 112.1(9)
O(8)-C(28)-H(28A) 109.2
C(23)-C(28)-H(28A) 109.2
O(8)-C(28)-H(28B) 109.2
C(23)-C(28)-H(28B) 109.2
H(28A)-C(28)-H(28B) 107.9
C(26)-C(43)-H(43A) 109.5
C(26)-C(43)-H(43B) 109.5
H(43A)-C(43)-H(43B) 109.5
C(26)-C(43)-H(43C) 109.5
H(43A)-C(43)-H(43C) 109.5
H(43B)-C(43)-H(43C) 109.5
C(36)-C(44)-H(44A) 109.5
C(36)-C(44)-H(44B) 109.5
H(44A)-C(44)-H(44B) 109.5
C(36)-C(44)-H(44C) 109.5
H(44A)-C(44)-H(44C) 109.5
H(44B)-C(44)-H(44C) 109.5
O(1)-Si(2)-O(2) 107.7(4)
O(1)-Si(2)-C(19) 109.1(4)
O(2)-Si(2)-C(19) 111.4(5)
O(1)-Si(2)-C(15) 108.6(4)
O(2)-Si(2)-C(15) 104.3(5)
C(19)-Si(2)-C(15) 115.5(6)
C(1)-O(1)-Si(2) 123.2(7)
C(3)-O(2)-Si(2) 121.6(6)
C(6)-O(3)-C(2) 110.2(8)
C(9)-O(4)-C(5) 112.8(8)
C(8)-O(5)-C(14) 112.8(9)
O(1)-C(1)-C(2) 110.9(9)
O(1)-C(1)-H(1A) 109.5
C(2)-C(1)-H(1A) 109.5
O(1)-C(1)-H(1B) 109.5
C(2)-C(1)-H(1B) 109.5
H(1A)-C(1)-H(1B) 108.0
O(3)-C(2)-C(1) 106.9(9)
O(3)-C(2)-C(3) 109.6(9)
C(1)-C(2)-C(3) 112.2(10)
O(3)-C(2)-H(2) 109.4
C(1)-C(2)-H(2) 109.4
C(3)-C(2)-H(2) 109.4
O(2)-C(3)-C(4) 111.0(9)
O(2)-C(3)-C(2) 110.1(8)
C(4)-C(3)-C(2) 110.4(10)
O(2)-C(3)-H(3) 108.4
C(4)-C(3)-H(3) 108.4
C(2)-C(3)-H(3) 108.4
C(3)-C(4)-C(5) 110.8(9)
C(3)-C(4)-H(4A) 109.5
C(5)-C(4)-H(4A) 109.5
C(3)-C(4)-H(4B) 109.5
C(5)-C(4)-H(4B) 109.5
H(4A)-C(4)-H(4B) 108.1
201O(4)-C(5)-C(4) 106.1(8)
O(4)-C(5)-C(6) 106.5(9)
C(4)-C(5)-C(6) 110.3(9)
O(4)-C(5)-C(10) 109.1(9)
C(4)-C(5)-C(10) 110.9(10)
C(6)-C(5)-C(10) 113.6(9)
O(3)-C(6)-C(7) 111.9(9)
O(3)-C(6)-C(5) 111.0(9)
C(7)-C(6)-C(5) 113.9(9)
O(3)-C(6)-H(6) 106.5
C(7)-C(6)-H(6) 106.5
C(5)-C(6)-H(6) 106.5
C(6)-C(7)-C(8) 108.0(9)
C(6)-C(7)-H(7A) 110.1
C(8)-C(7)-H(7A) 110.1
C(6)-C(7)-H(7B) 110.1
C(8)-C(7)-H(7B) 110.1
H(7A)-C(7)-H(7B) 108.4
O(5)-C(8)-C(9) 107.8(9)
O(5)-C(8)-C(7) 110.7(9)
C(9)-C(8)-C(7) 112.9(10)
O(5)-C(8)-H(8) 108.4
C(9)-C(8)-H(8) 108.4
C(7)-C(8)-H(8) 108.4
O(4)-C(9)-C(11) 106.2(9)
O(4)-C(9)-C(8) 111.1(10)
C(11)-C(9)-C(8) 116.1(11)
O(4)-C(9)-H(9) 107.7
C(11)-C(9)-H(9) 107.7
C(8)-C(9)-H(9) 107.7
C(5)-C(10)-H(10A) 109.5
C(5)-C(10)-H(10B) 109.5
H(10A)-C(10)-H(10B) 109.5
C(5)-C(10)-H(10C) 109.5
H(10A)-C(10)-H(10C) 109.5
H(10B)-C(10)-H(10C) 109.5
C(12)-C(11)-C(9) 132.9(11)
C(12)-C(11)-H(11) 113.6
C(9)-C(11)-H(11) 113.6
C(11)-C(12)-C(13) 125.1(12)
C(11)-C(12)-H(12) 117.4
C(13)-C(12)-H(12) 117.4
O(6)-C(13)-C(12) 116.7(11)
O(6)-C(13)-C(14) 113.6(10)
C(12)-C(13)-C(14) 129.7(13)
O(5)-C(14)-C(13) 116.2(10)
O(5)-C(14)-H(14A) 108.2
C(13)-C(14)-H(14A) 108.2
O(5)-C(14)-H(14B) 108.2
C(13)-C(14)-H(14B) 108.2
H(14A)-C(14)-H(14B) 107.4
C(18)-C(15)-C(16) 110.5(10)
C(18)-C(15)-C(17) 111.0(11)
C(16)-C(15)-C(17) 106.5(9)
C(18)-C(15)-Si(2) 109.7(7)
C(16)-C(15)-Si(2) 112.6(9)
C(17)-C(15)-Si(2) 106.5(8)
C(15)-C(16)-H(16A) 109.5
C(15)-C(16)-H(16B) 109.5
H(16A)-C(16)-H(16B) 109.5
C(15)-C(16)-H(16C) 109.5
H(16A)-C(16)-H(16C) 109.5
H(16B)-C(16)-H(16C) 109.5
C(15)-C(17)-H(17A) 109.5
C(15)-C(17)-H(17B) 109.5
H(17A)-C(17)-H(17B) 109.5
C(15)-C(17)-H(17C) 109.5
H(17A)-C(17)-H(17C) 109.5
H(17B)-C(17)-H(17C) 109.5
C(15)-C(18)-H(18A) 109.5
C(15)-C(18)-H(18B) 109.5
H(18A)-C(18)-H(18B) 109.5
C(15)-C(18)-H(18C) 109.5
H(18A)-C(18)-H(18C) 109.5
H(18B)-C(18)-H(18C) 109.5
C(22)-C(19)-C(21) 110.1(11)
C(22)-C(19)-C(20) 105.1(10)
C(21)-C(19)-C(20) 107.2(9)
202C(22)-C(19)-Si(2) 111.4(8)
C(21)-C(19)-Si(2) 115.1(8)
C(20)-C(19)-Si(2) 107.3(8)
C(19)-C(20)-H(20A) 109.5
C(19)-C(20)-H(20B) 109.5
H(20A)-C(20)-H(20B) 109.5
C(19)-C(20)-H(20C) 109.5
H(20A)-C(20)-H(20C) 109.5
H(20B)-C(20)-H(20C) 109.5
C(19)-C(21)-H(21A) 109.5
C(19)-C(21)-H(21B) 109.5
H(21A)-C(21)-H(21B) 109.5
C(19)-C(21)-H(21C) 109.5
H(21A)-C(21)-H(21C) 109.5
H(21B)-C(21)-H(21C) 109.5
C(19)-C(22)-H(22A) 109.5
C(19)-C(22)-H(22B) 109.5
H(22A)-C(22)-H(22B) 109.5
C(19)-C(22)-H(22C) 109.5
H(22A)-C(22)-H(22C) 109.5
H(22B)-C(22)-H(22C) 109.5
203Table 4: Hydrogen coordinates (x104) and isotropic displacement parameters (Å2x103).
x y z U(eq)
H(23) 1932 5328 -700 30
H(24) 1058 5585 2057 30
H(25A) -1617 5238 1786 28
H(25B) -1282 5105 151 28
H(27) 2507 4901 591 26
H(29A) 5771 4849 3936 28
H(29B) 6082 4758 2201 28
H(30) 3325 4409 1643 29
H(31) 2552 4583 4592 34
H(32) -654 4285 3620 32
H(33) 149 3843 3291 39
H(35A) 6424 3888 4044 35
H(35B) 5532 4011 2156 35
H(38A) -2 5645 -4123 91
H(38B) -2420 5598 -5495 91
H(38C) -1752 5464 -3638 91
H(39A) -2488 6315 -4280 88
H(39B) -2845 6119 -5896 88
H(39C) -431 6163 -4512 88
H(40A) 1737 6467 -797 74
H(40B) 354 6681 -122 74
H(40C) -691 6555 -2002 74
H(41A) -4039 6369 -1348 63
H(41B) -2981 6513 480 63
H(41C) -3614 6189 338 63
H(42A) 2233 6181 1854 65
H(42B) 134 6071 2227 65
H(42C) 721 6397 2378 65
H(28A) 4255 5787 1296 31
H(28B) 4848 5639 -186 31
H(43A) 813 5136 4699 39
H(43B) 2695 5312 4358 39
H(43C) 3196 5002 5106 39
H(44A) -5230 6036 -3479 70
H(44B) -4996 5704 -3266 70
204H(44C) -5652 5842 -5112 70
H(1A) 5973 7595 3503 37
H(1B) 8047 7736 4936 37
H(2) 5711 8058 5638 30
H(3) 2078 7789 2981 26
H(4A) 1718 8266 4945 31
H(4B) -263 8127 3417 31
H(6) 4866 8479 4262 31
H(7A) 4522 8543 796 31
H(7B) 6592 8638 2425 31
H(8) 4495 8973 3198 35
H(9) 672 8792 418 40
H(10A) 1058 8377 -78 57
H(10B) -903 8251 418 57
H(10C) 1202 8063 618 57
H(11) -1305 9079 1772 40
H(12) -344 9523 2122 46
H(14A) 4785 9502 610 40
H(14B) 5957 9380 2481 40
H(16A) 7071 7181 9438 70
H(16B) 4753 7041 9196 70
H(16C) 5973 7229 10833 70
H(17A) 7440 7687 9118 79
H(17B) 6414 7742 10551 79
H(17C) 5387 7893 8744 79
H(18A) 1313 7358 8477 67
H(18B) 1593 7688 8351 67
H(18C) 2599 7535 10152 67
H(20A) 678 7311 2801 74
H(20B) 1051 6986 2527 74
H(20C) 3009 7205 2813 74
H(21A) -528 7169 5309 72
H(21B) 979 6959 6728 72
H(21C) -181 6855 4807 72
H(22A) 5496 6932 5259 70
H(22B) 3537 6709 4776 70
H(22C) 4658 6815 6697 70
205Appendix B
1H Spectra of enone 295
13C Spectra of enone 295
1H Spectra of enone 362
13C Spectra of enone 362
1H Spectra of alcohol 384
1H Spectra of diene 363
13C Spectra of diene 363
1H Spectra of ketone 364
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